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An  ageing  population  increases  the  number  of  frail,  elderly  individuals.  Physiotherapists  are 
increasingly treating frail individuals due to the associated rate of rapid muscle atrophy. A rapid loss 
of  muscle  strength  can  result  in  difficulty  performing  activities  of  daily  living,  making  individuals 
more susceptible to other age‐related pathologies. Some frail individuals are unable to contract their 
muscle  sufficiently  to  complete  a  rehabilitation  programme.  This  can  be  exacerbated  in  a 
neurological  population  such  as  stroke.  The  aim  of  this  thesis  was  to  prevent  muscle  atrophy 
associated with age to allow rehabilitation to commence with a quicker onset. 
 
Neuromuscular electrical  stimulation  (NMES)  is a  treatment modality  capable of producing muscle 
contraction.  Its  use  is  poorly  understood,  with  little  guidance  surrounding  optimal  parameters  or 
muscular  response  to  treatment.  This  thesis  has  identified  optimal  stimulation  parameters  for 
strength  training  with  NMES,  and  tested  them  on  a  healthy  population  of  varying  ages,  and  in  a 
stroke  population.  A  muscle  measurement  device  was  designed  and  tested  to  allow  accurate 
measurements of moments about joints. 
 
Results  indicate  that  the protocol  is effective  in  inducing hypertrophy, as  indicated by advances  in 
pennation angle and maximal isometric force production. The protocol was effective at producing a 
small  decline  in  force  associated  with  a  hypertrophic  stimulus.  Results  indicate  that  treatment 
should be administered with the highest available stimulation amplitude to achieve optimal results. 
NMES appears to be able to advance internal muscle architecture, despite lack of volitional muscle 
control  post  stroke.  Variability  of  response  was  investigated  through  blood  biomarkers  (Creatine 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The  world’s  demographics  are  changing  as  the  population  is  living  longer  (Kowal,  Chatterji  et  al. 
2012). Older people are of upmost importance in health care as they are at greater risk of acquiring 
a chronic long term condition (for example diabetes, stroke or cardiovascular disease). As a result of 
this  the  older  population  is  at  a  greater  risk  of  acquiring  a  disability.  A  condition  such  as  stroke 
results  in  a  high  percentage  of  suffers  having  a  chronic  disability  (Teixeira‐Salmela,  Olney  et  al. 
1999). This results in an increased demand on health care services, posing a major challenge in terms 
of  cost  and  provision.  Improving  quality  of  life  in  the  older  population  is  an  important  concept, 




















Figure  1.1  reflects  how  an  individual  changes  their  dependency  status  throughout  life.  In  normal 
development, it can be difficult to predict when an individual will cross the Independence Threshold. 
An ideal trajectory will see an individual crossing the threshold at  least two times  in their  life: as a 
child  when  they  begin  to  walk  and  in  the  later  stages  of  life  when  they  are  unable  to  fulfil  the 
physical demands required of them on a day to day basis. However ill health or disability from birth 
may result in the individual not crossing the threshold at the expected time. A child with a disability 
affecting motor  control may  never  gain  the  ability  to walk,  and  thus  have  a  high  dependence  on 
another individual to help them with daily activities.  
 
When  relating  this  model  to  the  elderly  population  an  individual  may  cross  the  independence 
threshold  for  the  second  time  earlier  than  anticipated.  Crossing  of  the  independence  threshold 
indicates  that  the  individual  does  not  have  a  sufficient  amount  of  muscle  strength  to  perform 
activities  of  daily  living.  This  indicates  that  their  physical  activity  has  declined  to  a  level  that  they 
require assistance during daily activities.  It  is at this point that these  individuals become reliant on 




Threshold  is  pictured  as  an  area  of  ‘transition  to  dependency’  in  figure  1.1.  Identification  of  an 
intervention  to  prevent  frail  individuals  crossing  the  Independence  Threshold  prematurely  would 
assist in maximising independent function. Medical literature is often concerned with preventing the 
onset  of  disease  (Hayat,  Luben  et  al.  2013);  however  this  thesis  is  concerned  with  reducing  the 
progression  of  disease  to  functional  dependence.  A  thorough  understanding  of  interventions  to 






definition  of  frailty,  and  the  difference  between  frailty  and  disability  (Fried,  Ferrucci  et  al.  2004). 
Frailty  is  associated with a  reduced capacity of  the body  to withstand deterioration  from multiple 
sources,  and  a  reduced  ability  to  maintain  homeostasis.  As  frailty  develops  the  number  of  co‐
morbidities that contributes to general health decline increases, and the individual’s capacity to fight 
them  decreases  at  a  progressive  rate.  This  deterioration  in  health  often  results  in  a  decline  in 
physical activity, which is associated with a concomitant reduction of muscle mass (Hughes, Frontera 
et al. 2001).  In the elderly population, a loss of muscle strength due to disuse atrophy is increasingly 
hard  to  restore, which  is  confounded by  long  periods  of  forced  rest.  This  can  result  in  individuals 
being unable to perform exercise. When an individual  is unable to perform exercise, the decline  in 
muscle strength advances, and the individual can become dependent on others for activities of daily 
living.  This  would  result  in  early  crossing  of  the  Independence  Threshold.  This  process  is 



























with  a  growing  body  of  evidence  to  state  that  exercise  is  able  to  restore muscle  function  (Evans 
1999).  The  level  of  muscle  weakness  associated  with  old  age  varies,  and  there  is  no  known 





Exercise  rehabilitation,  or  resistance  training  is  the  gold  standard  in  reversing  muscle  weakness. 
Despite  this  levels  of  exercise  participation  in  the  older  individual  remain  low  (Mayer,  Scharhag‐
Rosenberger  et  al.  2011).  This  form  of  training  aims  to  override  the  effects  of  muscle  weakness 
(exercise  dependant  or  age  related)  by  initiating  hypertrophy,  and  therefore  increasing  muscle 
strength.  Hypertrophy occurs when the threshold of training is sufficient to cause changes in muscle 
properties.  Resistance  training  can  be  administered  in  various  forms  to  induce  strength.  These 
include  hydrotherapy,  group  exercise  classes,  and  muscle  re‐education  (Newton,  Hakkinen  et  al. 
2002).   
 
Problems  in  exercise  participation  in  the  elderly may  arise  from  lack  of  resources  (equipment  or 
staff), or simply being unable to contract the muscle to a threshold sufficient to induce hypertrophy. 
Older adults could be excluded from participating  in exercise programmes, despite a good  level of 
muscle  integrity  for numerous reasons.   Older adults often have orthopaedic conditions  (such as a 
 5 
 
joint  replacement)  contraindicating  them  from  completing  a  resistance  training  program with  the 
joint affected by pathology  (Nelson, Rejeski et al. 2007).   This population are also at a high  risk of 
heart  and  cardiovascular  disease;  hence  exercise  should  be  preceded  with  caution  and  under 










to  induce advances  in  strength.  Improvements  in muscle  strength can only be achieved by  tipping 
the  balance  between  gains  achieved  through  resistance  training  and  advancing  muscle  atrophy 
caused by prolonged inactivity. This thesis proposes that the individual has to cross an Independence 
Threshold  in  order  to  carry  out  activities  of  daily  living,  as  highlighted  in  figure  1.1.  The 







(Sacco, Kasner et al. 2013).  Incidence of stroke  is high, with somebody having a stroke every  forty 
 6 
 
seconds  in  the  United  States  of  America  (Roger,  Go  et  al.  2012).  Stroke  is  a  strong  predictor  of 
disability, which stems  from the acute  impact on mobility, and reductions  in muscle strength. This 
thesis  uses  Stroke  as  a  representative  pathology  in  the  elderly  population  that  can  result  in 




population  and  highlights  the  continued  demand  for  improved  rehabilitation  interventions  to  be 
identified  (Munyombwe,  Hill  et  al.  2014).  A  stroke  can  have  numerous  levels  of  impact  on  an 
individual’s functional independence, depending on the severity of the bleed and location within the 
brain.  In  severe  presentations  a  rapid  loss  of muscle  strength will  occur  due  to  the  disruption  to 
innervation of the muscle. Loss of muscle strength limits the functional ability of an individual due to 
the  negative  effect  on  balance  and  proprioception.  This  often  results  in  dependence  for  personal 
care.  The  resulting  impact  would  be  that  the  individuals  would  fall  below  the  Independence 
Threshold  prematurely  (figure  1.1).  Depending  on  how  the  stroke  has  affected  the  individual, 















under‐go  age  related  adaptations,  such  as  sarcopenia.  This would  assist  in  reducing  the effects  of 
frailty  to  allow  independent  function  in  daily  living  upon  discharge.  Implementation  of  an 
intervention to prevent muscle atrophy in the acute stages of a stroke, whilst physiotherapy restores 
the  ability  of  the  muscle  to  contract  is  something  that  is  not  commonly  used.  However,  it  is 
something that may enable rehabilitation to progress faster, and promote neuroplasticity to occur in 








and  the  firing  frequency.    However  the  interplay  of  stimulation  parameters  on muscle  function  is 
poorly understood, making its application in a clinical setting difficult to justify (de Kroon, Ijzerman 
et  al.  2005).  Application  requires  the  presence  of  an  intact  lower motor  neurone  (Sheffler,  Chae 
2007).  The mechanism  thought  to  be  associated  with  this  is  the  presence  of  antidromic  firing  of 





NMES  has  been  investigated  within  varying  populations,  often  with  an  aim  of  increasing  muscle 
strength.  Strength  improvements  have  been  observed  in  healthy  athletic  populations  (Maffiuletti, 
Cometti et al. 2000),  in a population of  stroke patients  (Yan, Hui‐Chan et al. 2005) and  in patients 
with spinal cord injury (Shields, Dudley‐Javoroski 2006), however this list is not exhaustive. Despite a 
growing  body  of  research  into  the  ability  to  strength  train  in  various  populations,  little 
understanding of the application or the response obtained from the muscle has been reported. Lack 
of understanding also indicates that the full potential of NMES as a treatment modality is not being 




Justification  for  the  use  of  NMES  in  clinical  practice  will  not  be  achieved  if  current  literature  is 
indecisive  as  to  its  use.  In  recent  years  (2009)  NMES  for  the  correction  of  drop  foot  has  been 
approved by the National Institute for Clinical Excellence (NICE), and is now an integral part of many 





In order  to establish  the effects of NMES on muscle  function  in  this  thesis, a measurement device 




the  effect  of  muscle  adaptability  to  an  NMES  protocol  a  more  accurate  measurement  tool  is 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required.  The  ability  to  measure  moments  with  high  sensitivity  will  allow  both  investigation  of 
individual  muscle  response  to  NMES  and  muscle  changes  over  time.  The  ability  to  transfer  the 
accuracy of  this  research  focused device  into a  clinical  setting was paramount  in  its development. 








The  overriding  aim  of  this  thesis  is  to  investigate  whether  treatment  with  NMES  can  reverse,  or 











in medical  knowledge  (Fielding, Vellas  et  al.  2011).    These people  are often unable  to  complete  a 
rehabilitation  programme  due  to muscle  weakness.  An  understanding  of  frailty  as  a  concept  will 
enable an insight as to how these individuals will tolerate a rehabilitation programme (Ikezoe, Mori 
et  al.  2011).  The  advanced  rate  of muscle  atrophy  often  supersedes  advances  in muscle  strength 
resulting  in a net decline  in force generating capacity of the muscle. However evidence that a frail 






As  an  individual  advances  in  age  the  likelihood  of  health  deterioration  increases.  An  ageing 
population  in  today’s  society  (Lagergren,  Fratiglioni  et  al.  2004,  Pahor,  Gurainik  et  al.  2014)  has 
concomitantly led to an increasing number of frail, elderly individuals (Rockwood, Song et al. 2011). 
In 2007, 18% of the United Kingdom’s population was aged 65 years and over and this is believed to 
increase  to  25%  by  2031  (Aw,  Silva  et  al.  2007).  Many  factors  are  contributing  to  this,  including 






Association highlighted  the  significance of  the ageing population  in a white paper  in 1990,  stating 
that “one of the most important tasks that the medical community faces today is to prepare for the 
problems  in  caring  for  the  elderly  in  the  1990s  and  the  early  21st  century”  (Fried,  Ferrucci  et  al. 
2004). The frail elderly has been described as a challenging population, which requires input from a 
wide  range  of  the  multidisciplinary  team.  The  ageing  process  is  not  as  aggressive  in  elderly 
individuals  who  undertake  regular  exercise  and  the  consequent  impact  on  health  care  services 
ultimately reduces in this instance (Elward, Larson 1992, Ryan, Grant et al. 2006).  A vast majority of 
elderly people grow old independently and do not show signs of frailty.  However some people show 





Clinical  agreement  in  the definition  is  lacking and  synonyms with disability  and advancing age are 
common. Frailty  can be  referred  to  as  a medical  syndrome, with  a  reduced  capacity of multiple 
systems  to  withstand  external  pressure  (Fried,  Tangen  et  al.  2001).  The  inter‐play  of  systems  is 
evident  in  common  conditions  such  as  diabetes;  which  can  consequently  render  an  individual 
susceptible  to  other  medical  difficulties  such  as  neuropathies  and  cardiovascular  disease.    An 
individual  with  diabetes  is  at  higher  risk  of  contracting  cardiovascular  disease,  which  may  be 
heightened  by  their  age,  lifestyle  or  nutritional  preferences  (Barrett‐Connor  2003).  Both  aerobic 
exercise  and  resistance  training has  been  associated with  improved  glycaemic  control  and muscle 
strength in patients with diabetes (Dunstan, Daly et al. 2002) and have subsequently been included 
in treatment recommendations. Advancing age  is  influential  in health deterioration, however the 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decreased  when  there  are  contributing  factors  affecting  health.  Co‐morbidities  have  been 
documented to be a  factor associated with mortality  in common pathologies  found  in elderly care 
(Hu, Jiang et al. 2012). Knowledge of how common health conditions affect one another would help 
clinicians  prepare  and  treat  frail  patients. Optimising health  status  in  the  elderly  is  under  analysis 
and  it  is  acknowledged  that  better  screening  of  frail  patients  is  required  to  enhance  treatment 
outcome (Roche, Wenn et al. 2005). Cardiovascular disease and lung disease are reported to be key 




is estimated  that 85% of elderly  individuals could demonstrate  improvement  in chronic conditions 
with  a  better  nutritional  intake  (Posner,  Jette  et  al.  1993). Nutritional  advice or  availability  in  this 






Disability  refers  to  the  inability  to  perform  activities  of  daily  living  (ADL)  and  the  majority  of 
researchers  and  clinicians  are  in  agreement  that  frailty  and  disability  are  two  different  medical 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entities  (Gale,  Cooper  et  al.  2015).  Fried  et  al  circulated  a  questionnaire  to  American  and  British 
geriatricians  (n=62)  to  explore  the  relationship  between  the  two  definitions, with  97.5%  agreeing 
that  there  is  a  distinct  difference  between  the  two  (Fried,  Ferrucci  et  al.  2004).  There  was  also 
agreement  that  frailty  is  an  accumulation  of manifestations  and  cannot  be  diagnosed  by  a  single 
pathology. The questionnaire required the clinicians to rank clinical observations, with respect to the 










This  indicates  that  a  combination of multiple  clinical  symptoms are  required  to  severely  reduce 





to  establish  the  cause  of  physiological  decline.  Other  medical  conditions  such  as  diabetes, 








(Rockwood,  Song  et  al.  2005).  These  elements  include:  age  associated  reduction  of  body  weight, 
muscle  strength,  endurance, balance, walking ability  and performance and physical  activity  (Fried, 
Tangen et al. 2001). The combination of these elements and other age related pathologies results in 
the  body  being  unable  to  control  homeostatic  mechanisms  required  for  a  continued  level  of  life 
quality.  The  predetermined  physiological  reserve  of  each  condition  for  frailty  to  be  present  is 




There are however exceptions  to  this  rule, such as obesity.   An obese  individual  is  likely  to have a 
reduced physical activity level, will generally hit a level of exhaustion with activity and subsequently 
have  a  reduced  walking  speed.    According  to  Woods,  this  person  would  be  categorised  as  frail.  
However, with a gradual change  in diet and exercise  level,  this person could potentially  lose some 
excess  weight,  strength  their  muscles  and  thus  their  exercise  tolerance  would  improve.    This 
indicates  that  some  caution  is  required  when  categorising  individuals  and  that  a  full  medical 
assessment is vital in this process. The exhausted functional reserve associated with frailty continues 
to  be  investigated  and  screening  tools  developed  to  aid  diagnosis  of  frailty.  There  is  unanimous 








Many  factors  have  been  identified  to make  elderly  individuals more  prone  to  frailty.  The muscles 
ability to generate power has been attributed as an  influential  factor affecting the performance of 
muscle. Research has begun to investigate a functional power activation threshold that would slow 
down  the  onset  of  frailty  (Van  Roie,  Verschueren  et  al.  2011).  Daily  functional  tasks  require  an 
acceleration component which argues that power is a vital component of muscle function. Power is 
defined  as  the  amount  of  work  done  over  a  given  period  of  time  (Macaluso,  De  Vito  2004).  As 
individuals  age,  the  speed  of  which  the  muscle  is  able  to  produce  a  force  decreases,  affecting 
reaction  time  and  overall  strength.  This  reduction  is  suggested  to  be  greater  than  that  of muscle 
strength, making power generation a contributor to frailty (Reid, Fielding 2012). Power reduction in 
the  elderly  is  due  to  a  natural  reduction  in  conduction  time  of  the  central  nervous  system  with 
senescence (Casas‐Herrero, Cadore et al. 2013). Muscle power has widely been shown to correlate 
with  function,  with  a  decrease  in  power  associated  with  a  decrease  in  the  ability  to  perform 
everyday activities (Clemencon, Hautier et al. 2008). It has been concluded that rehabilitation should 




As  co‐morbidities  develop,  one  of  the  first  aspects  of  daily  living  to  decline  is  physical  activity 
(Mutrie, Doolin et al. 2012). Physical activity is important for independent function (Pahor, Gurainik, 
et al. 2014). Physical inactivity has been shown to be one of the top four factors contributing to early 
preventable  death  in  the United  States  (Danaei, Ding  et  al.  2009). Guidelines  published  in  the UK 
recommend a minimum of 150 minutes of physical activity per week at a moderate intensity to help 
improve strength and balance (Mutrie, Doolin et al. 2012), however this is commonly not achieved. 







on  the  rate  of  fractures  in  this  population  (Forstein,  Bernardini  et  al.  2013).  An  eighteen‐month 
physical  activity  programme  has  also  been  shown  to  significantly  impact  body  fat  percentage 
(Beavers, Beavers et al 2014), which will have a  long term influence on bone health. These factors 
highlight  the  importance  of  exercise  as  a  preventative  treatment modality;  potentially  reducing 
the number of co‐morbidities  in this population. Preventing decline of cognitive performance will 
impact  other  co‐morbidities  and  allow  the  individual  to  continue  with  an  active  lifestyle.  An 
American  study  found  that  although  physical  activity  was  beneficial  to  independent  function,  it 
resulted in more hospitalizations (Pahor, Gurainik et al. 2014). This could be due to the unmasking of 




to pathologies  that  influence  their vulnerability.  In an elderly age group physical activity would be 
defined as activities of daily  living, such as washing and dressing and walking to the  local shop. As 
physical  activity  declines  muscle  mass  concomitantly  reduces  (Hughes,  Frontera  et  al.  2001). 
Although the mechanism is not fully understood, a reduction of muscle mass due to disuse atrophy 
is  increasingly  hard  to  restore  in  an  elderly population  (Rennie,  Selby  et  al.  2010). Disuse  atrophy 
results  in  a  reduction  of muscle  protein  synthesis,  partially  accounting  for  the  reduction  in  force 
capability. The timescale of atrophy is also very rapid in the elderly, resulting in a reduced capacity to 
perform  daily  activities  (Hofer,  Marzetti  et  al.  2008).  Oxidative  damage  and  increases  in  iron 
concentration  after  disuse  atrophy  have  been  associated  with  reduced  protein  synthesis,  which 




confounding  factors  such  a  stroke,  respiratory  or  cardiovascular  disease  (Dempsey,  Owen  et  al. 
2014).  The  combination  of  reduced  physical  activity  and  increasing  co‐morbidities  renders  the 
individual  susceptible  to  a  further  decline  of  health,  on  a  progressively  deteriorating  scale. 
Monitoring  physical  activity  in  elderly  individuals  has  demonstrated  some  positive  compliance; 
however participants do not always adhere to recommended time scales or intensity levels (Chastin, 
Dall et al. 2009, Mutrie, Doolin et al. 2012, Tigbe, Lean et al. 2011). A recent systematic review also 
suggests  that  self‐efficacy  techniques  that work  for  younger  adults  are  not  effective  at  increasing 
participation in physical activity in the elderly (French, Olander et al 2014). This is a key factor that 




In  order  to  understand  the  mechanism  associated  with  muscle  atrophy  in  the  elderly,  the  basic 
physiology must  first  be understood. A muscle  adapts  in  response  to  a  change  in physical  activity 
level. In order to ascertain how skeletal muscle regenerates as a consequence of resistance training, 
it is important to understand the basic composition of a muscle fibre. Strength can be defined as the 
ability  of  a muscle  to  produce  a  force  (Lieber  2009).  Skeletal muscle  is  vital  in  order  to  hold  the 
human skeleton  in an upright position: a  constant  level of  low muscle  tone allows  the body  to be 
erect  (Pereira,  Silva  et  al.  2011).  Muscles  are  also  required  to  move  bones  about  their  axis  of 
rotation. The sequential shortening and lengthening of skeletal muscle in the excitation‐contraction 
coupling  process  produces movement  at  joints.  Emerging  evidence  is  highlighting  the  role  of  the 
dihydropyridine  receptor  and  the  calcium  release  receptor  ryanodine.  Although  not  fully 
understood, it is suggested that the two receptors do not interact as previously indicated; however 
research  continues  in  this  field  (Rebbeck,  Karunasekara  et  al.  2014).  The  ability  of  the muscle  to 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proteins  are  controlled  by  numerous  regulatory  proteins,  with  myosin  being  the  key  protein  in 
driving the contractile process. The activity of myosin appears to be correlated with the orientation 
of actin filaments,  indicating that the preservation and training of the filaments  is vital to optimise 
function  (Reymann,  Boujemaa‐Paterski  et  al.  2012).  Titin  is  a molecule  under  investigation  in  the 




The  positional  interplay  of  proteins  are  collectively  known  as  a  sarcomere,  which  is  the  basic 
element  that  produces  a  muscle  contraction.  Muscle  contraction  is  initiated  by  the  arrival  of  an 
action  potential  at  the  neuromuscular  junction.  Calcium  release  invites  vesicles  containing  the 
neurotransmitter acetylcholine to cross the neuromuscular junction and initiates an action potential 
in  the  muscle  cell.  The  subsequent  activation  of  calcium  channels  allows  calcium  to  bind  to  the 
troponin  component  of  the  actin molecule.  This  initiates  a  cross‐bridge,  or  the  interplay  between 
actin and myosin, resulting in a muscle contraction. Muscle contraction is highly efficient and reliable 
due to the fact that both the impulse from the nerve and the amount of neurotransmitter released 
are both beyond the  level  that  is  required  to  reach the respective  threshold  for  transmission. This 
over‐estimated  margin  allows  for  as  much  consistency  and  availability  of  neuromuscular 






As  muscles  are  repeatedly  trained  they  can  increase  in  size  which  is  medically  referred  to  as 
hypertrophy.  Hypertrophy  refers  to  an  increase  in  the  size  of  existing  cells  and  hyperplasia  the 
addition  of  cells.  Resistance  training  is  the  stimulus  required  to  increase  force  production  of  the 
muscle and results in the addition of sarcomeres in series allowing a greater active excursion of the 
muscle. However  the addition of sarcomeres  in parallel  results  in an  improvement of  force output 
(Lieber 2009). If a muscle is over trained or stimulated beyond the threshold of the cells the muscle 
fibre can become damaged. Some muscle damage is required to stimulate hypertrophy (Schoenfeld 
2012),  however  too  much  muscle  damage  results  in  a  complete  tear  which  is  detrimental  to 
movement  or  performance.  Eccentric  exercise  is  commonly  associated  with  muscle  damage  and 
research  indicates  that  there  is  a  vast  range of  resulting damage  (Paulsen, Mikkelsen et  al.  2012). 
Damage can occur to the sarcolemma or individual contractile fibres, but has been found to mainly 
occur  in  type  two  fibres.  Damage  to  the  muscle  fibre  initiates  an  inflammatory  response,  with 
evidence that reactive oxygen species may be involved in this process. Activation of satellite cells is 
also  suggested  to  result  in  the  reversal  of  damage  and  adaptation  to  training.  Satellite  cells  are 
progenitor  cells  found  between  the  basal  lamina  and  sarcolemma.  They  proliferate  after  muscle 
fibre  trauma and differentiate  into myoblasts  before  fusing  to  existing muscle  fibres  to  repair  the 
damaged  tissue  and  stimulate  growth  of  new  tissue  (Hawke,  Garry  2001).  Proliferation  has  been 
shown to occur 2‐3 days post exercise, with the injured muscle restored to a functional level within 
10 days. The adaptability of skeletal muscle is extensive, although impacted by various factors such 











this. Age  is  a  process  that  advances  atrophy and has been  termed  sarcopenia  (discussed  in  full  in 
section 2.3).  The  rate of atrophy  related  to age  is unknown, however emerging evidence  suggests 









Age  related  reduction  in  muscle  mass  is  medically  referred  to  as  sarcopenia  (Borst  2004).  The 
reduced number of muscle fibres associated with a decrease in muscle mass consequently results in 
reduced  muscle  strength  (Brooks,  Myburgh  2012).  Sarcopenia  is  highly  influenced  by  chronic 
diseases (Pereira, Silva et al. 2011). A decrease in exercise level or reduction in the ability to perform 
functional daily  activities  contributes  to  sarcopenia. Restoration of physical  activity  in  the elderly 
appears to be sufficient to prevent age associated reduction  in muscle mass  (Starling, Ades et al. 
1999), although has not been shown to demonstrate  improvements. Maintenance of muscle mass 
suggests  that  the  number  of  muscle  fibres  remained  constant  throughout  testing  protocols  and 
 21 
 
therefore  the muscle  did  not  decrease  in  size.  It would  be  interesting  to  ascertain  the  effects  on 
muscle  power,  as  this  has  been  highlighted  as  an  important  factor  in  daily  living  in  the  elderly. 
Physical activity may  influence other confounding  factors  in an elderly population,  such as obesity 
and  diabetes,  potentially  impacting  the  overall  frail  state  of  an  individual.  Research  has  indicated 
that  the  reduction  in muscle mass  between  the  ages  of  50  and  80  can  be  as  high  as  33%  (Borst 
2004).  Sarcopenia  is  often  seen  in  frail  individuals  due  to  lack  of mobility  and  fear  of  falling.  Frail 







loss  of  strength  occurring  throughout  the  body  (Jones,  Stephenson  et  al.  2009).  The  same  review 
also  indicates that sarcopenia predominates  in type one, postural muscles. Type one muscle fibres 
are  slow  energy  release  fibres  and  used  throughout  general walking  and  during  activities  of  daily 
living. The changes in muscle fibre number and type indicate a neurogenic origin (Edstrom, Altun et 
al.  2007).  The  differences  between  acute muscle  atrophy  and  sarcopenia  have  been  discussed  at 
length (Borst 2004). Acute muscle atrophy maintains muscle fibre number and specific force despite 
a  reduction  in muscle mass,  also  displaying  a  predominance  of  type  two muscle  fibres. Whereas, 
sarcopenia demonstrates a reduction in the number of muscle fibres associated with the decrease in 
muscle  mass.  This  highlights  how  sarcopenia  is  a  more  permanent  reversal  of  muscle  structure, 
indicating the difficulty  in restoring strength  in the elderly. Research suggests that physical activity 
should  include  both  aerobic  and  anaerobic  training  to  maintain  a  level  of  functioning  in  both 













of  the  individual  (Edstrom,  Altun  et  al.  2007).  Reduction  in  neurone  innervation will  result  in  less 
neurones  innervating  the muscle  in  a motor  unit.  Rate  of  force  generation,  force  production  and 
motor dexterity will subsequently be compromised. The body naturally releases neural cell adhesion 
molecule (NCAM) at the neuromuscular junction to compensate for this reduction.  The role of the 
NCAM  is  to attract  the  remaining, or developing alpha motor neurones  to  the denervated muscle 




shown  in  elderly  individuals.  Skeletal  muscle  is  highly  adaptable  to  environmental  changes  via 
proliferation of satellite cells. Activation of satellite cells occurs  in response to trauma, resulting  in 
myoblasts fusing to the muscle fibre and regenerating the damaged tissue (Hawke, Garry 2001). The 













shown  in  the  first  three months of a  twelve month training programme, with  increases plateauing 
for  the  remaining duration. This has been attributed  to  familiarisation with  the  testing procedure, 
with  the  authors  highlighting  that  a  change  of  protocol  may  be  necessary  to  see  this  increase 
continue.  This  is  a  similar  phenomenon  to  studies  on  young,  healthy  individuals;  the muscle  will 
become accustomed to the training intensity, with demand requiring constant alteration. Numerous 
studies  indicate  that  increases  in  strength  demonstrated  in  the  elderly  are  a  response  of 
neuromuscular enhancement (Hakkinen, Alen et al. 2000). This suggests that the frequency of motor 
unit  firing  increases and  is associated with  the  short  terms  improvements  in  force output  (Hurley, 
Roth 2000). Although the mechanism  is not  fully understood, evidence suggests  the role of  insulin 
growth factors may be associated with short term improvement, although this evidence appears to 
be  conflicting  and  unsubstantiated.  These  changes  are  reported  to  precede  hypertrophy  in  both 
young and older adults. Hypertrophy of skeletal muscle has been demonstrated after a progressive 
and  intense  training  program  (Fiatarone, Marks  et  al.  1990).  The  effects  of  this  programme were 










training  has  been  postulated  to  result  in  significant  strength  gains  and  have  a  resulting  effect  on 
quality  of  life  (Evans  1999).  Exercise  is  conducted with  the  aim  of  reducing  co‐morbidities  in  the 
elderly  and  thus  resistance  training  has  the  capacity  to  impact  frailty.  Various  outcome measures 
have been utilised in assessing the benefits of resistance training on quality of life in this population; 
including muscle strength (Pyka, Lindenberger et al. 1994),  functional activities (Fahlman, McNevin 







for older participants to benefit  from resistance training  (Chiung‐Ju, Latham 2011). The  increased 
incidence  of  pathology  in  the  elderly  results  in  many  trials  evaluating  resistance  training  in 
participants with a specific pathology, making comparison more challenging (Liu, Latham 2009). Liu 
highlighted  the  beneficial  effect  of  resistance  training  on  knee  extensor  strength,  which 








been  attributed  to  neuromuscular  adaptation  (Hakkinen,  Hakkinen  1995)  and  it  may  be  that  the 
upper  limb muscles are more susceptible  to this  influence than their  lower  limb counterparts. The 
mechanism  of  increased  gene  transcription  and  protein  synthesis  has  been  demonstrated  to  be 
similar  in  younger  and  older  adults.  However  the  rate  of  change  is  slower  in  elderly  individuals 
(Pereira, Silva et al. 2011). It is suggested that 20% of a muscles adaptation capability is determined 




Research  indicates  that  both  strength  and  power  are  required  to  achieve  advances  in  optimum 
function in the elderly. Muscle power is reported to decline at a rate higher than strength, with a 3‐
4% reduction  in power per year between the ages of 65 and 89  (Macaluso, De Vito 2004). Muscle 
power  has  been  correlated  to  functional  ability  in  the  elderly  (Suzuki,  Bean  et  al.  2001)  and  is 
considered one of the most important physiological considerations for functional decline prevention 
(Foldvari, Clark et al. 2000). More specifically leg power has been identified as a main predictor. Due 
to  the  reduction  in  muscle  strength  with  senescence  power  is  utilised  with  everyday  functional 
activities, such as standing from a chair. The influence of power on quality of life therefore becomes 
greater.  Restoration  or  maintenance  of  lower  limb  power  should  be  a  vital  consideration  in 
physiotherapeutic  programmes.  The  inconsistencies  in  application  of  resistance  training  have 
highlighted  concern  with  data  comparison  and  extrapolation  of  results  (Liu,  Latham  2009).  The 
duration of training tends to be consistent, at 2‐3 times per week, however the intensity of training 









Although  the  benefits  of  resistance  training  in  this  population  have  been  well  documented, 
limitations have been highlighted and therefore stringent monitoring of  individuals conducting this 
type of  training  is  essential.  Knowledge of  limitations will  help physiotherapists  prescribe  exercise 
based on  individual needs. Resistance  training has been suggested  to  increase blood pressure and 
contribute  to muscle  and  joint  pain.  The American Heart Association has  expressed  caution when 
conducting resistance training  in an elderly population who suffer  from hypertension  (Cornelissen, 
Fagard et al. 2011). This amalgamates from studies which report rises in systolic blood pressure and 
the  consequent  risk  of  haemorrhage  from  cardiac  aneurysm.  Systolic  blood  pressure  has  been 
identified  as  a  key  determinant  in  cardiovascular  risk  prevention  and  should  be  included  in 
interventions related to hypertension (Chobanian, Bakris et al. 2003). Reductions in blood pressure 
can influence the risk of pathology in hypertensive individuals, including an 8% reduction in the risk 
of  stroke.  The  addition  of  aerobic  exercise  into  a  programme  will  help  to  reduce  hypertension 
(Collier, Kanaley et al. 2008), but also the increased risk of cardiovascular disease that results from 
obesity.  Aerobic  exercise  is  suggested  to  decrease  arterial  stiffness  and  improve  vasodilatory 
capacity after four weeks of training, demonstrating improvements to general cardiovascular health. 
Muscle  and  joint  pain  has  been  highlighted  as  a  limitation  (Chiung‐Ju,  Latham  2011),  however 
resistance  training  has  been  demonstrated  to  improve  pain  as  measured  on  a  validated 
questionnaire  in patients with osteoarthritis  (Jan, Lin et al. 2008). The muscle pain associated with 
resistance  training may arise  from delayed onset of muscle  soreness,  as  a  result on  the  increased 
training  load demanded from the muscle.  It  is recommended to avoid resistance training 3‐4 week 
post  complex  surgery  in  older  individuals  to  enable  full medical  recovery  to  take  place. However, 
 27 
 
there  appears  to  be  limited  restriction  in  terms  of  intensity  utilised  thereafter,  with  participants 
being  assessed  for  one  repetition  maximum  (Pollock,  Franklin  et  al.  2000),  with  no  precautions 









rehabilitation  setting,  primarily  as  a  response  to  impracticality  of  required  equipment  in  an  acute 
environment.  Adaptation  in  strength  witnessed  in  clinical  populations  may  be  achieved  in  small 
increments, however could result in profound functional implications (Umphred, Lazaro et al. 2013). 
Neurological  pathology  requires  a  more  sensitive  approach  to  measurement  and  often  requires 
specialist  adaptation of  patient position, making measurement  in  this  population difficult  (Ayalon, 
Ben‐Sira  et  al.  2000).  The  rate  of  strength  gain  can  be  confounded  by  pathology  in  older  age, 
resulting  in  a  slower  rate  of  hypertrophy  (Evans  1999).  Alternatively,  rehabilitation  may  aim  to 
prevent muscle atrophy from disuse; something that requires a measurement tool that  is sensitive 
to minor  changes  in  strength. Measurement  tools  can  be  considered  highly  reliable,  however  not 






There are many measurement  tools available  in  the current  literature,  including  those which have 
been  designed  specifically  for  research  purposes  (Wietrzynski,  Mazur‐Rozycka  et  al.  2013).  The 








questions  the  validity  of  its  clinical  use;  however  studies  disprove  this  finding  and  indicate  a  high 
level of validity (Paternostro‐Sluga, Grim‐Stieger et al. 2008). The MRC manual muscle test has been 
proven  to  be  a  reliable  measurement  tool  in  critically  ill  patients,  once  examiners  have  received 
standardised  training  in  its  assessment  (Ciesla, Dinglas et  al.  2011). However  categorising patients 
exhibiting strength towards the upper spectrum of grades requires subjectivity, which is notoriously 
difficult  to  standardise  in  both  young  and  old  individuals.  Manual  methods  of  assessing  muscle 




clinical  setting  due  to  ease  of  use,  adaptability  to  patient  need  and  a  strong  level  of  associated 
reliability (McGirr, Kennedy et al. 2014). It is also convenient to use in clinical settings, as compared 
to  the  larger  isokinetic  devices  which  are  forced  to  reside  in  a  single  location.  Hand  held 
dynamometry has recently been shown to demonstrate high reliability and validity  in the shoulder 
(Johansson, Cools  et  al.  2014)  and  the hip  (Thorborg,  Petersen et  al.  2010). However  the minimal 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detectable  change  required  to  induce  statistically  significant  findings  is  often  higher  than  a  result 
considered  to be  clinically  relevant  in  a  pathological  population  (Bohannon, Andrews et  al.  2013). 
Examiner  strength  required  to  counter‐balance  force  generated  by  the  muscle  has  often  been 
highlighted as a limitation, especially in the powerful lower limb muscles in healthy individuals. Intra 
examiner  strength  and  testing  position  has  been  shown  to  have  a  detrimental  effect  on 
measurement with hand held dynamometry, indicating difficulty in comparing strength measured by 
differing  examiners  (Krause, Neuger  et  al.  2014,  Stark, Walker  et  al.  2011).  Co‐treating  patients  is 
common in clinical practice and thus compromises the ability to monitor outcomes in rehabilitation. 
When  inferring  the  effect  of  moments  for  precise  measurement  of  muscle  force  capacity,  no 
commonly  applied  method  of  measurement  has  been  identified  in  the  current  literature.  This 





(Lieber  2009).  More  advanced  measurement  methods  have  been  explored  to  measure  this 





Diagnostic  ultrasound  can  be  used  to monitor  changes  in muscle  architectural  properties. Muscle 
architecture relates  to  the direction of muscle  fibres  in  relation to  the axis of strength generation, 




muscle  fibres and  results  in more muscle  fibres being stored  in parallel, having a direct  impact on 
force (Lieber 2009). Muscle fibres can be identified on ultrasound imaging, with the angle at which 
they  insert  into  the  muscle  aponeurosis  (pennation  angle)  indicative  of  their  strength  producing 
























defined  as  an  acute  cerebral  injury  which  results  from  vascular  origin  and  results  in  neurological 
deficit.  However  the  requirement  of  an  updated  definition  has  been  acknowledged  in  line  with 
advances  in  clinical  practice  and  research  (Sacco,  Kasner  et  al.  2013).  A  stroke  most  commonly 
occurs from ischaemic causes, resulting in a blood clot occluding the passage of blood to the brain. 
Hypertension can often result in weakening of the blood vessels causing lipohyalinosis and bleeding 
into  the  surrounding  tissue  (Haemorrhagic  stroke).  The  area  to which  the  blood  supply  has  been 
reduced  or  occluded  is  otherwise  known  as  the  penumbra.  This  area  may  have  a  blood  supply, 
however  does  not  reach  the  concentration  required  to  permit  electrical  activity  in  order  for  the 
nervous  system  to  fire  (Obrenovitch  1995).  Stroke  is  often  characterised  by  hemiparesis  (Dragert, 
Zehr 2013) which  is presented as a  loss of  function on one half of  the body and occurs  in 88% of 
stroke  survivors  (Ambrosini,  Ferrante  et  al.  2011).  This  consequently  renders  stroke  survivors 
participants of an  intense rehabilitation programme. This  is often difficult  to partake  in due to the 
advancing effects of age related muscle wasting diseases and a profound  lack of motivation whilst 
coming to terms with the psychological effects of the stroke (Watkins, Wathan et al. 2011). Research 




Incidence  of  stroke  has  a  strong  relation  to  lifestyle  and  recent  years  have  seen  a  rise  in  stroke 
incidence  in  Eastern  Europe  and  Central  Asia  due  to  the  unhealthy  lifestyle  associated  with 
industrialisation  (Kinlay  2011).  The  rate  of  stroke  occurrence  has  reduced  in  the  western  world, 
which has been attributed to improved lifestyle choices (nutrition and exercise) and advanced public 
education, resulting in quick identification of symptoms (Jauch, Saver et al. 2013). Severity of stroke 















the majority of  functional  recovery occurs within  the  first  four months of  a  stroke  (Dobkin 2005), 
however  some  research  indicates  that  the  first  four weeks  demonstrates  optimal  plasticity  of  the 
brain and thus exercise should be concentrated within  this  time period  (Verheyden, Vereeck et al. 
2008).  Other  articles  indicate  that  motor  recovery  reaches  a  plateau  after  six  months  (LeBlanc, 
Paquin et al. 2013). This implies that rehabilitation should be intensive and progressive in the acute 
phase  post  infarct.  However  it  is  also  apparent  that  there  is  a  wide  amount  of  variability  within 
motor  recovery.  Although  repetitive  practice  is  essential,  research  suggests  that  neuroplastic 
changes  can  be  limited  if  exercises  are  not  progressive  (Bowden,  Woodbury  et  al.  2013). 
Neuroplasticity is a result of rehabilitation and spontaneous recovery, which has been demonstrated 
to  occur  in  varying  degrees. Many  factors  such  as  age,  lifestyle  and motivation will  influence  this 
time  scale.  Recovery  of  brain  function  in  neurological  disease  has  been  correlated  with  that  of 
normal learning and thus neuroplasticity or the restoration of functional process post stroke can be 





The mechanism  of  recovery  post  stroke  is  not  fully  understood.  Initial  advances  in  recovery  have 
been associated with absorption of oedema  in an attempt  to create homeostasis within  the body. 
Thereafter  neuroplasticity  is  thought  to  occur,  resulting  in  modification  and  adaptation  in  neural 
connections (Carmichael 2003). Neurones within the motor cortex adjacent to an infarct have been 
shown to demonstrate an increased firing frequency that lasts for several months after initial injury. 
This  suggests  that  the  role of damaged neurones  is absorbed by surrounding  intact neurones. The 
mechanism  associated  with  a  change  in  firing  frequency  has  been  associated  with  an  increased 
concentration  of  glutamate  and  gamma‐aminobutyric  acid  (GABA);  neurotransmitters  primarily 
concerned  learning  and  inhibition  respectively  in  the  central  nervous  system.  Axons  of  motor 
neurones have been suggested to formulate new connections through a process of sprouting that is 










each  stroke,  depending  on  the  type  and  severity  results  in  every  stroke  patient  presenting  with 
different symptoms. This makes understanding the level of recovery difficult, but also the response 
to  a  physiotherapeutic  intervention.  Some  individuals  will  respond  well  to  an  intervention  of 






muscles  tend  to  compensate  and  take  over  the  role  of  muscles  that  are  unable  to  function. 
Compensatory  behaviours  to  complete  functional  tasks  are  a mechanism  often  utilised  by  stroke 
patients  to  achieve  goals  (Carmichael  2003).  Rehabilitation  post  stroke  is  currently  seeking  novel 
therapies  to  enhance  functional  outcome. Muscle  weakness  is  a  common  focus  of  rehabilitation, 
which has been shown to be a high predictor of functional ability post stroke. Resistance training has 




Muscle  activation  is  a  key  concept  required  in  the  initial  stages  of  rehabilitation, which  demands 
volitional control of the neuromuscular system and appropriate muscle  integrity (Umphred, Lazaro 
et al. 2013). Acute rehabilitation seeks to  induce neuroplasticity and thus  is concerned with neural 
control  mechanisms  and  muscle  activation.  Interventions  such  as  mirror  therapy  have  been 
demonstrated to be a beneficial adjunct to a traditional physiotherapy programme. Mirror therapy 
induces changes in cortex activity as demonstrated by brain imaging (Michielsen, Smits et al. 2011), 
which suggests  that movement of  the non‐affected  limb can affect  the paretic  limb  (Dragert, Zehr 
2013). A  lack of proprioceptive input to the paretic  limb is thought to be substituted by the mirror 
illusion,  helping  to  recruit  the  pre‐motor  cortex.  (Yavuzer,  Selles  et  al.  2008).  Constraint  induced 
movement  therapy  is another  treatment modality aimed at  improving neural circuitry post stroke. 
Restriction  of  the  non‐paretic  limb  forces  activities  to  be  conducted  with  the  paretic  limb, 
encouraging  repetitive  activation  and  enhancement  of  neural  pathways  that  are  damaged  post 
stroke  (Grotta,  Noser  et  al.  2004).  Research  is  supportive  in  its  use  and  indicates  that 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changes  in  the  functional ability post  stroke. Research  into  robotic  therapy  in stroke  rehabilitation 
was initiated in response to a development in technology, restrictions in resources able to conduct 
rehabilitation  and  a  push  to  achieve  early  discharge  from  hospital  (Lum,  Burgar  et  al.  2002).  The 
ability  to  apply  a  robotic  assistive  device  to  a  severe  stroke  patient  allows  improved  quality  of 
rehabilitation,  ultimately  achieving  enhanced  outcomes.  Video  gaming  has  been  extensively 
researched  in  stroke  rehabilitation,  which  results  in  an  improved  motivational  drive  to  perform 
rehabilitation and a subsequent improvement in function (Saposnik, Teasell et al. 2010).  
 
Robotic  and  virtual  devices  tend  to  focus  on  upper  limb  rehabilitation  (Saposnik, Mamdani  et  al. 
2010), which  falls  outside  the  scope of  this  thesis. Devices  that  assist  gait  help  to  rehabilitate  the 
50% of stroke survivors that are unable to walk. Body weight support has been used to reduce the 
amount  of  physical  effort  required whilst  rehabilitating walking  ability, whilst  inflicting  changes  in 
motor recovery (Barbeau, Visintin 2003). Partial body weight supported treadmill training (PBWSTT) 
has been extensively proposed  to  fulfil  a gap  in gait  re‐education, which  is  identified as a primary 













nerve bundles  in  superficial muscles  to  cause muscle  contraction  (Maffiuletti  2010).  The electrical 
current  is  required  to  meet  the  threshold  of  the  unmyelinated  muscular  nerve  branches  which 




the  required  contraction  or  movement;  re‐positioning  of  electrodes  can  be  conducted  to  alter 








Setting  of  stimulation  parameters  is  paramount  to  achieving  the  desired muscular  response  with 
NMES. The  frequency of  stimulation  refers  to  the number of pulses delivered per  second and has 
been  shown  to  influence muscle  outcome with  NMES  (Miyamoto,  Fukutani  et  al.  2012).  NMES  is 
often applied with low stimulation frequencies (Peckham, Knutson 2005), however frequencies less 
than 15 Hz have been shown to  initiate a  twitch  response and are not  recommended  in achieving 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advances  in  muscular  output  (Peckham,  Knutson  2005).  High  frequency  stimulation  has  been 
recommended in the literature to maximise motor output of the muscle (Collins, Burke et al. 2001). 
The most common frequencies utilised in the literature appear to be 20‐50 Hz (Baldwin, Klakowicz et 
al.  2006).  The  incomparable  parameter  base  has  been  identified  as  a  problem  in  systematic 
reviews,  (Glinsky,  Harvey  et  al.  2007),  making  the  effect  of  treatment  difficult  to  conclude  and 
transfer  to a clinical  setting. Frequency  is  strongly associated with  impacting  the effects of  fatigue 
associated  with  NMES  application  (Maffiuletti,  Vivodtzev  et  al.  2014,  Schuhfried,  Crevenna  et  al. 
2012). As a result a high range of frequencies are used in clinical applications. This is often linked to 
the apparent non‐selective recruitment of nerves associated with NMES ‐ please see below for full 
review  (Bickel,  Gregory  et  al.  2011).  New  paradigms  are  being  explored  to  minimise  discomfort 
associated with high frequency application, to improve tolerate and compliance in a clinical setting 
(Maffiuletti, Vivodtzev et al.  2014). Higher  frequencies have also been  recommended  to maximise 
the  volley  sent  to  supra‐spinal  centres  (Maffiuletti,  Minetto  et  al.  2011,  Mang,  Lagerquist  et  al. 
2010). The associated increase in the activation of motor neurones in the corticospinal pool results 
in enhanced plasticity of function; hence higher stimulation intensities have been recommended for 
neurological  rehabilitation.  Despite  this  recommendation,  the  guidance  in  terms  of  frequency 
setting remains bleak (Schuhfried, Crevenna et al. 2012). NMES is often administered with a gradual 
rise  of  the  frequency  and  intensity  to  improve  comfort.  This  helps  patients  tolerate  higher 









The  pulse  width  and  stimulation  intensity  used  to  administer  NMES  are  inversely  related  (Baker, 
Wederich et al. 2000) and care must be taken to ensure participant comfort during application. Pulse 
width  relates  to  the  time  span  of  a  single  pulse,  with  longer  pulses  indicative  of  performance 
enhancement due to larger recruitment of muscle fascicles (Doucet, Lam et al. 2012). Longer pulses 
have also been shown to penetrate deeper  into sub‐cutaneous tissue, which may be imperative to 
fulfil  specific  treatment  aims.  A  shorter  pulse  width  requires  a  larger  stimulation  intensity 
(amplitude)  to  produce  the  same muscular  response.  Treatment  response  and  comfort  are  often 
influenced by altering stimulation intensity in clinical practice; however pulse width adjustment has 
been  shown  to  improve  both  comfort  and maximal muscle  recruitment.  This  suggests  that NMES 
should  be  administered with  the  highest  available  pulse width  and maximal  tolerated  stimulation 
intensity (Brull, Silverman 1995).   The effects of pulse width appear consistent and reliable in the 







2011).  Fatigue  has  been  associated  with  inconsistent  and  inappropriate  stimulation  parameters 
(Schuhfried, Crevenna et al. 2012) and the effects of altered recruitment patterns (Baker, Wederich 
et  al.  2000).  NMES  is  proposed  to  activate  larger  diameter  axons  before  small  diameter  axons,  a 
pattern which is opposite to that of volitional muscle contraction as documented by the Henneman 
size principle. The larger axons have a lower resistance to current and are able to conduct impulses 




Wederich  et  al.  2000).  However,  this  evidence  is  not  conclusive  with  data  suggesting  that  NMES 
activates muscles  in  a  random  pattern  of  recruitment  (Kim,  Bangsbo  et  al.  1995).  The method  of 
stimulation (direct or cutaneous) results in differing physiological responses of the muscle fibre. This 












induce  plasticity  within  muscle,  resulting  in  a  carry‐over  effect  of  treatment  aims  (Chipchase, 
Schabrun et  al.  2011).  This has been demonstrated  in healthy and pathological populations  in  the 
form  of  peripheral  adaptation  in  response  to  strength  training  (Gondin,  Guette  et  al.  2005).  The 
mechanism of  how  this  occurs  has  been  part  of  considerable  debate, which  is  heightened  by  the 
varying outcomes emitted from treatment with NMES (Trimble, Enoka 1991).  
 
As  well  as  the  peripheral  effect  on  muscle  properties,  NMES  has  been  documented  to  induce  a 
central,  supraspinal  effect,  which  is  thought  to  contribute  to  the  observed  carry‐over  (Mang, 
Lagerquist  et  al.  2010). NMES  induces  a  strength  response  in  a  quicker  time  scale  than would  be 
associated with muscle  hypertrophy;  indicating  a  change  in  the  neural  response  and  thus  further 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evidence of  a  central  component  to  training  (Trimble,  Enoka 1991). The  considerable  variation  in 
reported treatment effect, over a varying amount of time and with differing applications makes a 
clear  understanding  of  the  mechanisms  involved  difficult  (Gondin,  Brocca  et  al.  2011).  NMES 
produces  both  an  orthodromic  and  antidromic  response  from  the  motor  nerve,  which  results  in 
repeated stimulation of the anterior horn cell at segmental spinal level (Rushton 2003). This unique 
firing mechanism is thought to contribute to plasticity caused via NMES, which has been witnessed 
after  neurological  insult.  The  strengthened  synapses  associated with  both  forms  of  activation  are 
thought  to  encourage  long  term  potentiation,  a  form  of  long  term  memory.  An  upper  motor 
neurone  insult,  such  as  a  stroke  damages  the  pyramidal  tract  (Thomalla,  Glauche  et  al.  2004), 
effectively reducing input to the anterior horn cell which results in a reduction of function with little 
recovery.  NMES  could  therefore  be  a  treatment  modality  to  influence  this  mechanism  of 
deterioration  (Rushton  2003).  The  importance  of  volitional  input  associated  with  this  finding  has 
been noted, indicating the use of NMES as an adjunct to a physiotherapy programme.  
 
NMES is able to  induce an afferent volley to the motor cortex, resulting  in  increased excitability of 






not  fully  understood  to  date  (Mang,  Bergquist  et  al.  2012).  This  indicates  that  inhibitory  action  is 
activated as a result of NMES to compensate for the reduced excitatory response after neurological 
insult,  resulting  in  cortical  plasticity.  The  cortical  effect  of  NMES  is  thought  to  be  related  to  the 
intensity of the administered stimulus, which is required to meet the threshold for a strong muscle 








There  is  a  broad  range  of  literature  investigating  the  use  of  NMES  in  physiotherapeutic  settings. 
There are both studies which have advocated  the use of NMES  in neurological  rehabilitation  (Yan, 
Hui‐Chan et  al.  2005, Ambrosini,  Ferrante et  al.  2011)  and who have achieved varying  results  and 
proceed  to  recommend  findings with caution  (Elboim‐Gabyzon, Rozen et al. 2013). NMES has also 
been under  scrutiny  in  the  field of orthopaedic  rehabilitation  (Palmieri‐Smith, Thomas et al. 2010, 
Stevens‐Lapsley,  Balter  et  al.  2012)  and  athletic  performance  (Maffiuletti,  Cometti  et  al.  2000, 
Babault, Cometti et al. 2007). Studies are also emerging  in specialised groups assessing NMES with 
clinical  treatments  such as Botulinum Toxin  (Galen, Wiggins et al. 2012, Wilkenfeld 2013). Despite 
this literature, there is little guidance on application (Schuhfried, Crevenna et al. 2012) or complete 
understanding  of  the  mechanism  associated  with  training  effects  (Gondin,  Guette  et  al.  2005, 
Chipchase, Schabrun et al. 2011).  
 
Incomplete  understanding  results  in multiple  proof  of  concept  studies, which  do not  employ  high 
quality  research  designs.  This  causes  limitation  in  the  ability  to  drive  basic  science  into  clinical 
practice (Chipchase, Schabrun et al. 2011). Proof of concept trials also tend to investigate different 








this  method  flaw  and  recruit  a  higher  number  of  participants;  50  participants  (Elboim‐Gabyzon, 
Rozen et  al.  2013),  41 participants  (Bruce‐Brand, Walls  et  al.  2012),  however  sample  size  remains 













• Orthopaedic  [OR]  Rehabilitation  [OR]  Performance  [OR]  Stroke  [OR]  Cerebrovascular 
Accident  
 








Frail  elderly  individuals  are  often  unable  to  contract  a  muscle  with  sufficient  intensity  to  cause 
hypertrophy  (Evans 1999).  This  can preclude  them  from  taking part  in  a  rehabilitation protocol. A 
treatment modality  aimed  at  restoring  this  ability  would  allow  patients  to  begin  rehabilitation 
quicker, and therefore reduce the impact of sarcopenia (Park, Kim et al. 2012). 
 
NMES has been explored to  improve muscle strength  in participants who demonstrate difficulty  in 
volitional  contraction  (Bax,  Staes  et  al.  2005). Muscle weakness  is  considered  a major  problem  in 
patients  after  total  knee  arthroplasty,  affecting  over  60%  of  patients  one  month  post‐surgery 
(Mizner, Petterson et al. 2005). Voluntary activation reduces after surgical procedures; swelling and 
pain are thought to alter afferent input from the joint, resulting in a compromised efferent signal to 
the  quadriceps which  limits  their  ability  to  contract.  Recovery  of  voluntary  activation  via NMES  is 
possible in patients with osteoarthritis (Elboim‐Gabyzon, Rozen et al. 2013), a population which is at 
high  risk  of  knee  arthroplasty.  Effects  on  strength  were  not  documented  after  receiving  12 
treatment sessions with NMES (75 Hz, 200 µs).  It  is postulated that a  longer during of treatment is 
required  to  induce  strength  gains.  However,  a  6‐week  intervention  with  NMES  (50  Hz,  250  µs) 
alongside  standard  rehabilitation acutely  after  total  knee arthroplasty has been  shown  to prevent 
loss  of  skeletal  atrophy  and  improve  functional  ability  (Stevens‐Lapsley,  Balter  et  al.  2012). NMES 
was  found  to  be  effective  3.5  weeks  into  the  treatment  programme.    The  reversed  motor  unit 
recruitment has been attributed to these gains above traditional rehabilitation. Similar findings have 
been documented in patients after an 8 week NMES intervention, with additional changes in muscle 
architecture  (Vaz,  Baroni  et  al.  2013)  in  patients  who  have  undergone  hip  replacement  surgery 
(Suetta, Aagaard et al. 2004) and who have rheumatoid arthritis (Piva, Goodnite et al. 2007). Lack of 
muscle adaptation after 4 weeks of NMES training (50 Hz) has been attributed to a time period that 
was  too  short  to  induce muscle adaptation  (Palmieri‐Smith,  Thomas et al.  2010), with a  review of 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methodology  recommended.  Literature  concludes  that  NMES  is  able  to  influence  voluntary 
activation of the quadriceps muscle force production post‐surgery and has the ability to improve 
muscle strength (Lewek, Stevens et al. 2001, Bruce‐Brand, Walls et al. 2012). The method of testing 
muscle  strength  may  be  responsible  for  some  of  the  variation  witnessed  within  this 
recommendation.  
 













Much of  the  literature surrounding NMES  in athletic populations  focuses on outcome measures to 
improve  performance;  jump  height  (Martinez‐Lopez,  Benito‐Martinez  et  al.  2012),  sprint  time 
(Brocherie, Babault et al. 2005) and squat jump (Maffiuletti, Cometti et al. 2000). The goal of NMES 
in a performance  setting  is  to elicit  a  supra‐maximal muscle  contraction  to  improve output  (Seyri, 









in  corporation with  ice‐hockey  training.  The  short  duration  of  treatment  is  likely  to  induce neural 
adaptation  in  the  muscle  (Maffiuletti,  Pensini  et  al.  2002),  with  the  assumption  that  fast  twitch 
muscle  fibres  have  been  preferentially  recruited  based  on  the  eccentric  gains.  Fast  twitch muscle 
fibres have also been shown to have a greater hypertrophic potential (Brandenburg, Docherty 2002). 
Interestingly  isometric application of NMES  is able  to  translate  into dynamic strength when paired 
with  appropriate  volitional  training  (Maffiuletti,  Pensini  et  al.  2002,  Seyri,  Maffiuletti  2011, 
Brocherie, Babault et al. 2005, Babault, Cometti et al. 2007). Dynamic strength refers to the ability to 
produce  repeatable,  functional muscle  contractions  (Lieber 2009), however  the ability of NMES  to 
demonstrate  advances  in  dynamic  strength  without  associated  volitional  training  remains  to  be 
concluded (Gondin, Cozzone et al. 2011). This assumes that isometric NMES can be administered in 
conjunction  with  a  physiotherapy  protocol  in  a  pathological  population  to  induce  functional 
improvements.  Some  argue  that  explosive movements with  a  horizontally moving  centre  of mass 









which  require  high  intensity  training  loads.  NMES  can  be  used  as  a means  of  developing muscle 
strength during rest periods as it allows the remaining body to rest and is less time consuming than 
conventional  resistance  training  (Malone,  Coughlan  et  al.  2012).  Research  into  this  process  is 





the  nerve  pathways  used  to  produce  a  movement  and  continued  stimulation  heightens  the 
sensitivity of these pathways, allowing for better ‘tuning of control’. This repetitive stimulation falls 
under the reflex based neurofacilitation approach to motor relearning (Shumway‐Cook, Woollacott 
2007). This  theory  suggests  that normal movement occurs  from higher  cortical  centres  initiating a 
chain of reflexes that allows the lower centres within the nervous system to produce movement. If 
these higher cortical centres are damaged then abnormal movement patterns occur. This research 
group  states  that  restoration of  function can be  returned  if  abnormal movement  is  inhibited. This 






New  technologies  are  constantly  emerging  to maximise  functional  independence  in  patients  who 
have suffered stroke (Lum, Burgar et al. 2002). Many technologies are impractical to use in an acute 
environment,  as  a  result  of  high  cost  and  large  specialised  pieces  of  equipment.  NMES  has  the 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potential to be used in an acute hospital setting, as  it  is  inexpensive and simple to apply. Research 






dorsiflexors  has  been  assessed  in  46  acute  stroke  patients  (one  week  post).  Improvements  in 
strength as a result of 3‐weeks of NMES (30 Hz, 300 µs) was applied to multiple lower limb muscles 
(Yan, Hui‐Chan et al. 2005). Antidromic activation of motor neurone pools has been postulated as a 







(more  than  6  months)  was  improved  with  6‐weeks  of  NMES  (35  Hz,  250  µs),  with  concomitant 
advances  in walking  ability.  However  the  case  report  of  three  participants  limits  the  reliability  of 
extrapolating these findings. A meta‐analysis (Glanz, Klawansky et al. 1996) conducted to ascertain 
effects of NMES  in  improving muscle  strength  identified  four  studies dating  from 1978‐1992, with 
which  only  three were  conducted  on  the  lower  limb. Despite  this, muscle  strength was  improved 





















perceived  thought  that  they are  receiving an  ‘extra’  treatment. Many clinicians underestimate  the 
effect of a placebo treatment in rehabilitation (Margo 1999) and the power it can have in a clinical 










studies  with  a  neurologic  basis,  eleven  of  which  focused  on  stroke;  the  condition  in  which most 
research  has  been  conducted. However,  of  the  eleven  articles  included  there was  a mix  between 
upper  and  lower  limb  application,  with  varying  muscles  being  treated  in  the  lower  limb 
(gastrocnemius, quadriceps femoris and tibialis anterior). NMES also differed in mode of application, 
including  lower  limb  articles  with  EMG‐triggered  NMES  (Gabr,  Levine  et  al.  2005),  NMES  plus 
standard rehabilitation (Newsam, Baker 2004, Winchester, Montgomery et al. 1983, Yan, Hui‐Chan 
et al. 2005) and NMES plus a functional task (Peurala, Tarkka et al. 2005). The number of weeks that 
treatment  was  delivered  varies  from  three  to  eight,  with  frequencies  varying  from  20‐80  Hz  and 
pulse widths  from  100‐300  µs.  Strength  of  the  dorsiflexors was  shown  to  improve  by  220%  after 
treatment, a result that displays narrow confidence intervals and a moderate methodological quality 
(Maher,  Sherrington  et  al.  2003).  The  effect  was  less  substantial  in  the  quadriceps  femoris 
(Winchester,  Montgomery  et  al.  1983).  The  review  recommends  the  use  of  NMES  for  strength 
training  in  stroke  in  combination  with  conventional  physiotherapy,  however  highlights 
methodological  flaws  as  a  limitation  within  this.  Limited  guidance  exists  as  to  the  application  of 
NMES and limits justification for a high powered study to be conducted at present. Although Glinsky 
has  provided  a  comprehensive  review  of  the  literature,  the  variation  described  makes  it 
increasingly difficult to draw any conclusions to take forward to future studies.  
 
The ability  to walk  is commonly affected by  lack of ankle control, which  is often a consequence of 
weak dorsiflexor muscles as a result of stroke (Yavuzer, Geler‐kulcu et al. 2006). This can lead to an 






response  of  NMES  above  traditional  physiotherapy  alone  (Sabut,  Sikdar  et  al.  2011).  However, 




exists after 3‐weeks of  training  (Yavuzer, Geler‐kulcu et al. 2006) and highlights  the need  to  study 
optimal  time  lengths  of  applications  to  optimise  effects.  Although  NMES  used  in  a  functional 
pattern such as walking is considered beneficial,  isometric application is able to apply a stronger 
level  of  stimulation  highlighting  a  positive  attribute  of  this  non‐functional  application  (Knutson, 
Chae  2010).  Walking  is  often  difficult  to  reliably  measure  post  stroke.  Patients  often  adopt 
compensatory strategies to achieve tasks (Carmichael 2003). A lack of knee flexion in swing is often a 
result of quadriceps weakness or spasticity, or an increase in knee flexion can compensate for a drop 
foot.  However  compensations  tend  to  be  specific  to  individuals  and  measurement  of  various 
parameters  should  be  employed  to  ascertain  functional  improvements  (Kerrigan,  Karvosky  et  al. 
2001).  
 
Although neuroplastic  changes are believed  to occur within  the  first  few weeks post  stroke, many 
studies do not apply treatment within such an acute period (Yan, Hui‐Chan et al. 2005). The ability to 
infer  on  the  effects  of  NMES  aiding  neuroplasticity  are  disadvantaged  by  testing  on  a  chronic 
population  although  the  concept  is  still  of  functional  importance.  A  wide  spectrum  of  time  post 
stroke has been utilised within studies with one particular study including patients who ranged from 
2‐227 days post  stroke  (Bogataj, Gros et  al.  1995).  Length of  time post  stroke has been  shown  to 
have  strong  implications  with  regard  to  neurological  recovery  (Kwakkel,  Wagenaar  et  al.  1997). 
Method of application also varies  including studies that apply surface electrodes (Yan, Hui‐Chan et 
al. 2005),  intramuscular electrodes  (Daly, Roenigk et al. 2006) and  functional electrical  stimulation 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functional  mobility  were  reported  with  discussion  surrounding  how  FES  cycling  can  be  used  as  a 
means  of  restoring  trunk  control  in  the  acute  phase  post  stroke.  Trunk muscles were  not  directly 
stimulated  and  FES was  thought  to  induce  improved motor  co‐ordination  and  symmetry  between 
both legs in functional tasks (Ambrosini, Ferrante et al. 2012). Trunk control has been highlighted as 
a  vital  early  task  in  rehabilitation  with  lack  of  control  highlighting  increased  risk  of  prolonged 






on  lower  limb  muscle  strength  and  walking  ability  (Ambrosini,  Ferrante  et  al.  2011,  Ferrante, 
Pedrocchi et al. 2008, Yan, Hui‐Chan et al. 2005).  Odds ratios allow interpretation of the probability 
of  walking  post  stroke.  Analysis  of  odds  ratio  allows  comparison  of  current  statistics  used  in 
physiotherapy literature and analysis dependant on small sample size, as experienced in this field of 
study (Schechtman 2002). Combination of methodologies results in an individual being 11.3 times 
more  likely  to  walk  with  NMES  than  without  NMES  compared  to  either  placebo  treatment  or 
standard rehabilitation. Although sample sizes are small in the aforementioned studies and we have 
combined studies  that utilise various methodologies,  this  result  is a good  indicator  that NMES  is a 








neurological  insult  (Glinsky  and  Harvey  2007).  This  is  based  on  a  small  cohort  of  studies  with 
relatively  small  changes  in  strength  displayed.  The  ability  to  transfer  this  knowledge  of  strength 
increase to a clinically functional improvement is also lacking. Although the current literature into 
NMES  in  neurological  impairment  has  some  methodological  flaws  at  present,  the  current 
understanding has given an  insight  into  the mechanisms  involved.   The current  research base has 
also gone some way in beginning to establish proof of concept in this population. Further clinical 
trials are required to confirm the effects of NMES  in Stroke and establish a parameter base that 




The  current  literature  surrounding  the  effects  of  neuromuscular  electrical  stimulation  (NMES)  on 
muscle  function  is  variable  (as  highlighted  above).  This  is  both  within  orthopaedic,  athletic  and 
neurological  populations  (Elboim‐Gabyzon,  Rozen  et  al.  2013, Gondin,  Brocca  et  al.  2011, Glinsky, 








The effects of  blood biomarkers during high  intensity  exercise have been well  documented  in  the 
sports  literature  (Brancaccio,  Maffulli  et  al.  2007).  To  our  understanding  knowledge  is  sparse 
regarding the physiological effects of NMES on blood biomarkers in either animal or human studies. 
A study has  investigated the use of biomarkers  in animals which  implies  that effects are similar  to 
that  of  volitional  strength  training  (Pette,  Vrbova  1992).  However,  the  low  frequency  chronic 
stimulation that is applied throughout this review shows considerable difference in terms of primary 
aims  and  application  to  NMES  strength  training  literature.  A  biomarker  is  a  molecule  whose 
concentration  changes  in  response  to  tissue  damage  (Tsimikas, Willerson  et  al.  2006).  This  is  an 






activity  has  a  greater  impact  on  muscle  function.  This  allows  researchers  to  understand  muscle 
function  and  allows  exercise  and  rehabilitation  protocols  to  be  administered  with  scientific 
justification.  Biomarker  research  also  allows  us  to  understand  the  events  of  how  a  muscle 
hypertrophies  and  the  micro‐trauma  associated  with  this  hypertrophy  under  various  stresses 


























markers  which  have  the  same  goal.  Broader  groups  (such  as  oxidative  stress,  inflammatory  and 
cardiac) allow trends  to be  identified and highlight  the similar  role of various molecules. Oxidative 
stress biomarkers measure the level of free radicals and reactive oxygen species (ROS) in the cell, the 
levels of which are increased by muscular exercise (Alessio, Hagerman et al. 2000). Many scientists 





to  level  of  cardiovascular  disease  (Olson,  Dengel  et  al.  2007).  In  terms  of  physiotherapeutic 
management of patients with obesity, this work plays a role in understanding exercise prescription 
within  safe  limits.  Finally,  cardiac  biomarkers  such  as  troponin(s)  can  be  monitored  in  both 
endurance athletes and pathology to monitor cardiac function with the increase in pressure placed 





a  treatment  protocol  with  NMES.  This  has  been  employed  in  attempt  to  justify  some  of  the 
variability  portrayed  when  strength  training  with  NMES.  Creatine  Kinase  was  chosen  as  the 
biomarker  to monitor  due  to  the  advanced  understanding  of  its  interplay  with  lifestyle  factors 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ATP.  This  is  mainly  required  during  high  intensity  exercise  when  consumption  exceeds  synthesis 
(Gabr, El‐Sharkawy et al. 2011). ATP is a vital source of energy during muscle contraction and if not 
regenerated  muscle  contraction  would  cease  to  continue  (Lieber  2009).  CK  is  therefore  a  vital 
enzyme in regulating the process of muscle contraction and aims to keep ATP at a constant level to 




molecule  to  adenosine  diphosphate  (ADP)  to  make  adenosine  triphosphate  (ATP).  This  gives  the 
muscle a source of energy which does not require any oxygen or produce any by products, such as 
lactic acid  (Lieber 2009). Phosphocreatine  is a molecule  that  is produced from the resting creatine 
within the muscle. Creatine is a compound made from arginine and glycine which is produced in the 
liver. Creatine is transported from the cytoplasm of cells to the mitochondria where creatine Kinase 


















CK  acts  as  a  temporal  energy  buffer  as  described  above  by maintaining  supply  of  ATP  to muscle 
tissue.  Short  term  energy  is  produced  by  anaerobic  respiration  and  utilised  in muscle  contraction 
before aerobic forms of energy are utilised. The role of CK in energy transport was first described by 
Bessman and Geiger  in 1981 and has had numerous other authors contribute  to  its understand  in 
more recent years (Wallimann, Tokarska‐Schlattner et al. 2011). This role relates to phosphocreatine 
linking the sites of energy production with those of energy utilisation. This allows smooth transfer of 
energy  and  use  of  the  appropriate  energy  system.  Creatine  and  phosphocreatine  can  then  be 
considered  plausible  ‘energy  carriers’  (Greenhaff  2001).  The  third  function  describes  how  the  PCr 
system  prevents  a  build‐up  of  intracellular  ADP which would  result  in  accumulation  of  unwanted 
molecules  in  the  cell.  Lastly,  by buffering protons  the PCr  system prevents unwanted acidification 
which is vitally  important in early energy production before glycogenolysis  is activated (Wallimann, 







CK‐BM).  In  human  skeletal muscle  CK  is  expressed  as  98% of  the CK‐MM  isoform and 2% CK‐MB. 








and  women  24‐170  units  per  litre  of  blood  (Mougios  2007).  Although  normal  values  have  been 
established,  there  are  factors  that  can  influence  these  resting  levels  which  are  dependent  on 
numerous  factors.  These  factors  can  include  age,  gender  and  race.  Males  have  a  higher  resting 
serum  level  of  CK  compared  to  females  which  decline  slightly  in  later  years.  Females  display 
reductions in resting serum CK during pregnancy; however this increases back to normal during late 
gestation. After high intensity exercises these gender differences remain unchanged resulting in the 
interpretation  of  serum  CK  becoming more  complex.  Race  also  influences  resting  serum  CK  with 
black men having  a higher CK  concentration  than Caucasians;  however  reviews have debated  this 
considerably (Eliakim, Nemet et al. 1995). It is also important to note that CK is related to body mass 










levels  (Baird,  Graham  et  al.  2012).  It  is  suggested  that  high  intensity  exercises  damages  the 
membrane permeability resulting in the release of enzymes. The level of CK increase is usually lower 
in  trained  subjects  compared  to  untrained  subjects  with  trained  subjects  who  partake  in  regular 
physical activity displaying continued elevation of CK  (Vincent, Vincent 1997). CK activity has been 
shown  to  demonstrate  the  greatest  post‐exercise  increase  after  prolonged  exercise  such  as 
marathon  running  (Kyrolainen,  Pullinen  et  al.  2000),  however  high  intensity  especially  eccentric 
exercise  has  been  proven  to  show high  serum CK  elevation  (Malm,  Sjodin  et  al.  2004).  Serum CK 
elevation can peak up to 8 hours after exercise and has been shown to remain elevated for 24 hours 
with elevations continuing depending on the amount of subsequent exercise  (Baird, Graham et al. 
2012).  Some  studies  suggest  that  activity  has  been  at  its  highest  after  5  minutes  of  exercise 
demonstrating a broad range of data present in the literature (Koutedakis, Raafat et al. 1993). This 
particular  article  suggests  that  exercise  intensity  and duration  are  the main  contributing  factor  to 
elevations rather than the individual fitness level.  
 
In  clinical  practice  Creatine  Kinase  (CK)  is  tested  to  help  diagnose  and  identify  acute  myocardial 
infarction  (MI),  severe muscle  break  down  (rhabdomyolysis), muscular  dystrophy  and  acute  renal 
failure  (Brancaccio, Maffulli  et al. 2007).  In  these  instances CK  is a marker  that  is well understood 
and easily  tested via blood extraction.  In  research settings CK can be used as a marker  to  identify 
when a muscle has been working to assess both the types of muscle contraction on muscle function 












guide  its  place  in  clinical  practice,  determining  whether  it  is  an  effective  treatment  to  include  in 
rehabilitation protocols or not. If we can establish whether people will respond to treatment with 




The  frail  elderly  are  a  vulnerable  population  who  are  at  high  risk  of  contracting  further  co‐
morbidities.  Pathology  (such  as  a  stroke)  results  in  a  spiralled  decline  of  function  which  is 
confounded  by  a  rapid  loss  of  muscle  strength  witnessed  in  older  age.  The  continued  decline  in 
health  status  results  in  a  reduced  amount  of  physical  activity  and  renders  these  individuals 
increasingly hard  to  rehabilitate. Resistance  training  is  a method  that has been  shown  to  increase 






Emerging  evidence  suggests  that  NMES  is  able  to  induce  strength  changing  properties  in  skeletal 





of  strength  gain  and why  strength  gains  have  been  produced without  functional,  goal‐orientated 
application of NMES. NMES may be  a  treatment  that  could  be used  to  prevent  unwanted muscle 
atrophy  in  the  initial  stages  of  a  physiotherapy  programme.  However,  NMES  has  demonstrated 
variability  in  the  literature  which  contributes  to  a  lack  of  understanding  around  its  use.  Creatine 











This will  determine  if  it  is  a  tolerable  treatment dose  that has potential  to  increase  force‐
generating capacity. 
2. To investigate the use of the NMES protocol on different populations, namely different aged 
muscle  and  stroke  patients.  Associated  morphological  changes  will  be  investigated  (e.g. 
hypertrophy). These studies will form proof of concept to guide larger clinical trials.  





















The  development  of  a measurement  tool was  paramount  for  achieving  the  outcome measures  of 
this thesis. A commercial device was not available that allowed adjustment for patient size and have 
the  ability  to  be  used  on  an  acute  hospital  ward.  The  ability  to measure muscle  strength,  whilst 
allowing adaptability of movement at the knee and ankle joints was paramount. The development of 
this tool would also fill an existing gap in clinical practice. Practitioners are dependent on unreliable 
and  often  subjective  measures  of  measuring  muscle  strength  (Bohannon,  Andrews  et  al.  2013, 








maintaining  comfort  throughout  testing  periods.  The  following  criteria  were  used  as  guidance 
















to  produce  a  device  suitable  to  achieve  the  thesis  aims.  A  design  team  was  responsible  for 
developing the LMD based on the specification above. Materials were sourced, and clinical engineers 
constructed the device. The author of this thesis was responsible for ensuring practicality and ease 


























relation  to  each  other,  to  determine  the  required  position.  The Allen  key was  then  used  again  to 
tighten the lock when aligned with the joint centre of rotation, and prevent the side member or joint 
from moving.  This  allowed  accurate  measurement  of  joint  moments  around  the  knee  and  ankle 
joint.  In  order  for  this  to  be  accurate  the  position  of  the  patient  in  the  LMD  required  some 
standardisation,  and  subsequent  padding  and  strapping  to  maintain  this  position  was  employed. 
Straps were placed across the femur and anterior ankle joint to prevent unwanted movement. Extra 





transducers  were  used  in  the  foot  plate,  and  two  in  the  thigh  strap.  The  thigh  strap  was 








The  force  transducers  on  the  footplate  and  knee  strap  were  calibrated  (as  described  below)  to 









potentiometers  became  the  reference  point  for  joint  centre  positioning  within  the  LMD.  The 
potentiometers  were  positioned  on  each  side  of  the  ankle  joint,  which  is  encompassed  by  an 
adjustable cuff.  The cuff is adjustable in the sagittal plane to allow accurate positioning of the ankle 
joint  centre  (malleoli)  with  the  potentiometers.  This  allows  measurement  of  ankle  range  of 
movement, within the limits of the ankle joint.   The foot  is held  in place by two Velcro straps; one 
over the forefoot, and one across the anterior ankle joint.   
 






both  100  mm  and  200  mm  forwards  from  this  point.    The  device  was  loaded  with  25  kg,  in 
increments of 5 kg via a vertical loading apparatus.  The LMD was connected to a software package 




    *        300 mm      * 




























The  moment  about  the  ankle  is  determined  by  multiplying  the  force  by  the  distance  you  are 


















from  the  combined  effort  of  the  force  and  transducer  ‘a’  are  equal  to  the  turning  moment  of 
transducer  ‘b’  and  ‘c’  (because  the  foot  plate  is  in  equilibrium).   We  are  able  to  determine  ‘y’  by 
dividing this equation by the total force (i.e. a, b and c).  Therefore we are now able to calculate ‘x’ 





















    *      100 mm      * 



























The  recordings were collected via external  software  (Biometrics DataLink  system), and  transferred 
into a calibration spreadsheet for analysis. Data was collected at a sampling rate of 20 Hz, which was 
used for data collection throughout all studies in this thesis. Data for Force, Moment and Centre of 
Pressure  was  calculated.    To  ensure  that  the  shin  strap  was  being  loaded  vertically,  the  whole 





system, which was comparable  to  the DataLink system (Image 3.11). The shin strap was  loaded at 
the  central point between  the  two  force  transducers,  and at 25mm either  side of  this point.    The 




































Calibration  indicated  that  the  LMD was  able  to  provide measurement  comparable  to  literature.  It 


































be  the  focus  of  this  study,  as  literature  surroundings  its  application  remains  elusive  (Schuhfried, 
Crevenna et al. 2012). The selected frequency will then be tested in one full training session, which 
has  been proposed based on  volitional  strength  training  literature  as  indicated  below.  If  aims  are 
achieved, this protocol will be utilised throughout the remaining studies in this thesis. The secondary 




Stimulation  with  Neuromuscular  Electrical  stimulation  (NMES)  will  only  produce  a  muscle 
contraction if it is strong enough to depolarise the axon (Gobbo, Gaffurini et al. 2011). The resultant 
muscle  contraction  must  also  be  of  sufficient  intensity  to  elicit  changes  in  muscle  properties  for 
alterations  in  strength  to  occur  (Maffiuletti  2010).  Parameter  setting  must  comply  with  patient 








studies  using  a  variety  of  frequencies  to  administer  NMES with  limited  or  no  scientific  reasoning 
behind choices  (Chipchase, Schabrun et al. 2011). Comparability with current  literature appears  to 
be  the  most  common  choice  for  parameter  selection  when  using  NMES  for  strength  training 
(Palmieri‐Smith,  Thomas  et  al.  2010,  Bruce‐Brand,  Walls  et  al.  2012).  Frequency  selection  varies 
according to the pathology being treated making comparison difficult. A recent review indicates that 
NMES  for  treatment  of  osteoarthritis  uses  a  range  from  25‐50  Hz.  The  reasoning  behind  this 
variability  is  unexplained  (Giggins,  Fullen  et  al.  2012).  Frequencies  higher  than  50  Hz  have  been 
highlighted  to  cause  unnecessary  muscle  fatigue  (Schuhfried,  Crevenna  et  al.  2012),  however 
application in research continues to rise beyond this level (Maffiuletti 2010, Maffiuletti, Pensini et al. 
2002, Seyri, Maffiuletti 2011). Limited research has been conducted to reason why parameters have 




Once  a  stimulation  frequency  has  been  identified  it  must  be  tested  on  a  full  strength  training 
protocol.  Guidance  on  protocol  development  is  currently  not  available  from  the  NMES  literature 
(Glinsky,  Harvey  et  al.  2007,  Chipchase,  Schabrun  et  al.  2011).  In  the  absence  of  any  guidelines 
recommendation must be  sought  from volitional  strength  training  literature.  Current  guidance  for 
volitional strength training indicates that exercise should be performed two to three times per week. 
Intensity  values  vary  within  the  literature.  Guidance  states  that  40‐50%  of  the  subjects  one 
repetition maximum  (1RM)  should  be  used  for  untrained  individuals  looking  to  improve  dynamic 
strength,  and  80‐85%  1RM  for more  advanced  strength  training  and  neural  adaptation  (Kraemer, 






Although  a  decline  in  maximal  force  output  after  repeated  stimuli  indicates  that  the  muscle  is 
undergoing an element of fatigue (Campbell, Neil et al. 2012), Enoka 2012), research indicates that 
fatigue can be an  important stimulus  for muscle development  (Stevens‐Lapsley, Balter et al. 2012, 







Although  using  the  same  parameters  in  order  to  compare  results  to  clinical  practice  has  some 
justification  for  helping  NMES  to  be  accepted  into  the  clinical  world,  practitioners  will  not 
incorporate NMES into clinical protocols unless there is evidence as to the benefits and guidance to 
its application. Some practitioners will use NMES as a treatment for acute muscle wasting, however 
this  is  not  a  treatment  that  is widely  used. NMES has  been extensively  researched  as  a means of 
preventing  drop  foot,  and  has  recently  been  recommended  by  NICE  for  use  in  clinical  practice 




The  aim  of  this  study  was  to  investigate  the  effect  of  varying  frequencies  on  force‐generating 











Design:  An  experimental  design  was  utilised.  Ethical  approval  was  obtained  from  The  South 
Staffordshire  Local  Research  Ethics  Committee  to  conduct  this  study  (reference  number: 
09/H1203/92, see appendix 1). 
 































Testing  position:  Testing  took  place  on  the  non‐dominant  Gastrocnemius,  as  determined  by  the 
participant.  The  non‐dominant  leg  was  regarded  as  the  stabilising  leg  (the  leg  which  was  most 
commonly grounded) during an activity. This leg was utilised as it was anticipated that a low level of 
muscle tone would be required for stabilisation instead of powerful eccentric actions, which would 
be  utilised  through  functional  or  sporting  activities  (Young,  Rath  2011).  Throughout  all  testing 
procedures  the  participant was  positioned  in  the  leg measurement  device  (LMD), with  their  knee 
joint in 60° flexion, and their ankle in a plantargrade position (Image 4.1). Velcro straps were placed 






Electrodes  (50 X 90 mm) were placed horizontally  across  the  two heads of Gastrocnemius,  as per 
current  recommended guidelines  (Baker, Wederich et  al.  2000).  Experience  lead  the placement of 
electrodes over the muscle belly, as this is often more comfortable for the participant. The proximal 
electrode was placed 3cm below  the posterior  knee  fold,  and  the distal  electrode 2cm below  the 
proximal  (Image 4.2).  Immediately prior  to  testing,  an acclimatisation  session was  conducted with 
the participant to ensure that they were comfortable with the sensation of NMES and the intensity 




intensity  for  the  testing  protocol  to  be  set  before  testing  begun.  Once  the  participant  was 
comfortable  and  happy  to  proceed  the  researcher  explained what  the  remaining  session  entailed 
(approximately  15  minutes).  This  rest  period  eliminated  any  possible  effects  of  fatigue  from  the 
muscle that may have resulted from the acclimatisation session.  
 
The  one  off  training  session  (part  two) was  conducted  one week  after  the  initial  identification  of 
optimal  frequency  (part  one).  The  same  limb  position  and  electrode  placement  procedure  was 












In  part  one  the  participant  was  stimulated  with  eight  different  frequencies,  whilst  all  remaining 
parameters remained constant. Research suggests that pulse width has a proportional relationship 
with  maximal  force,  indicating  that  the  higher  the  pulse  width,  the  higher  the  resultant  force 
produced from the muscle (Alon, Allin et al. 1983, Baker, Wederich et al. 2000). This study utilised a 
pulse  width  of  450  µs  as  this  was  the  highest  available  pulse  width  on  the  stimulator  used 
throughout this thesis.  There is also evidence to suggest that the higher the pulse width, the lower 
the intensity that will be needed to produce equal force production with the same frequency. This 
holds  advantage  as  higher  intensities  are  likely  to  cause  noxious  stimuli  (Baker,  Wederich  et  al. 
2000).  The  stimulation  time  was  set  to  3  seconds,  and  the  rest  period  between  contractions  90 





by  the participant  (established  in acclimatisation  session) and  remained constant  throughout each 
testing  session. This allowed a maximal muscle  contraction  to be produced. Frequency was varied 
with the following values (in order of administration): 20, 30, 40, 50, 60, 70, 80, 100 Hz. This was the 
range  available  on  the  NeuroTrac  2  stimulator  (Verity  Medical  LTD).  The  frequencies  were 
administered  to  the Gastrocnemius  twice, with  20 minutes  between  testing  sessions.  Participants 
were encouraged to use the same or a higher current intensity on the second application. They were 
asked  to  relax  throughout  testing  procedures,  and  not  assist  the  muscle  contraction  that  was 

















































The  second  administration  of  frequencies  was  considered  for  analysis,  as  customisation  to  the 
protocol was  considered  to be an  influential  factor  from  the  first  set of data. The participant may 
have  been more  relaxed  in  the  second  attempt,  which would  allow  the muscle  to  respond more 
freely to stimulation with NMES. 
 
During part two a stimulation frequency of 50 Hz was  identified as  ‘optimal’  (see results below for 






























transferred  into  mathematical  analysis  software  (Mathcad).  Each  of  the  45  contractions  was 
identified when the force output reached 20% over the baseline reading. This figure was chosen due 


























• The    frequency  identified  in  the  updated  analysis  (60Hz)  and  the  maximum  frequency 
(100Hz) 
(NB: A  repeated measure ANOVA was  not  carried  out  as  our  sample was  small  and we had  eight 
different frequencies, i.e. 8 repeated measures for each subject) 
 






An  individual’s  muscle  response  to  changes  in  frequency  was modelled  using  a method  of  linear 
regression (Matthews, Altman et al. 1990). We split the data set into three sets of frequencies (a) 20 
to 40Hz, (b) 40 to 60 Hz and (c) 60 to 100Hz. The range of frequencies used in literature varies, but a 
common  frequency  is  40Hz.   Our  initial  analysis  suggested  the  optimal  frequency was  50  and  the 














MFP‐ES  values  (low),  and  3  exceeding  this  (high).  When  testing  for  differences  with  a  one‐way 
ANOVA,  no  statistically  significant  finding  was  noted.  Patterns  in  muscle  response  to  the  45 
contractions were also  identified on an  individual basis.  This was  initially  conducted by  identifying 
the  difference  between  first  and  last  contraction.  This  allowed  a  descriptive  approach  to  the 
analysis. Rate of  change was also  taken  into consideration by using  linear  regression analysis. This 
 87 
 








the  stimulation  intensity  used  for  both  parts  of  the  study.  Both  internal  and  external  factors  can 
influence tolerance to NMES and therefore may alter muscle response. Comparison was made on a 




A  linear  relationship was  identified  between  stimulation  intensity  and MFP‐ES.  This  indicates  that 






leg  measurement  device  (LMD)  not  recording  all  data  points  in  5  participants.  For  these  five 
participants  stimulation  peaks  were  not  able  to  be  identified  with  mathematical  analysis,  and 





summarised  in  table 4.2 below. There were a higher number of males  than  females participate  in 
this study, with a low mean age of 39 years. 
 












attempt  one.  The  peak  MFP‐ES  tended  to  be  higher  during  attempt  two.  Analysis  was  initially 




  20  30  40  50  60  70  80  100 
Mean  10.1  10.9  12.1  15.5  14.5  14.2  14.3  16.3 
SD  5.8  7.4  8.5  18.6  9.2  8.1  8.8  11.3 





followed by 50 Hz  (15.5 Nm). 20 Hz produced the smallest  force of 10.1 Nm. There  is a decline of 
 89 
 
moment  evident  between  50  Hz  and  60  Hz  (‐1  Nm),  which  is  the  greatest  drop  in  moment 
throughout the dataset. When considering individual data, results are more varied, showing rise and 
fall of maximal moment  in varying patterns. This  is reflected by the high standard deviation (mean 
9.7),  which  peaks  at  50  Hz  (18.6).  100  Hz  also  has  a  high  SD.  Remaining  frequency  values 
demonstrate smaller standard deviations,  indicating  less variability  in data within participants. The 
Coefficient of Variation remains similar in all frequencies except 50 Hz, indicating the highest level of 






















Subsequent  studies  in  this  thesis  have  been designed based on  assumptions made up until  this 
point  in  analysis.  Analysis  was  conducted  in  a  short  turn  around  time  to  allow  the  same 
participants to be used in both parts of this study. Data was further explored upon writing of this 
thesis and is presented below. On reflection the updated analysis may have been more reflective 




Participant  two  is  excluded  from  Graph  4.3,  and  it  is  interesting  to  see  that  a  level  of  variability 
remains.  The mean  value  for  50 Hz  has  reduced  to  11.1 Nm,  a  decline  of  4.4 Nm.  The  frequency 
causing  the  highest maximal moment  before  decline  has  risen  to  60 Hz  instead  of  50 Hz  as  seen 







A  paired  t‐test  was  used  to  ascertain  whether  there  was  a  difference  of  MFP‐ES  production  at 
different frequencies. Three pairs were tested as detailed in table 4.4 below. The significance value 
was  adjusted  for multiple  comparisons  using  the  Bonferroni method  of  correction  (Bland,  Altman 
1995). A difference was found between 20 Hz and 100 Hz (P= 0.063), however was not significant. 
This  indicates  that  frequency has a  linear effect on MFP‐ES. However no  statistical difference was 










1  20‐100  ‐11.192  0.343  0.063 
2  50‐100  ‐9.683  1.974  0.177 
3  60‐100  ‐3.791  1.526  0.374 
Table 4.4 Results of t‐test for MFP‐ES based on frequency 
 
Literature  often  presents  data  as  a  percentage  of  maximum.  Percentage  maximum  allows  the 
differing stimulation intensities to be accounted for, without impacting coefficient of variation. The 
results  are  presented  as  a  percentage  of  maximum  in  table  4.5  and  graph  4.4.  When  reviewing 
frequency data as a percentage of maximum the greatest rise in mean moment is again between 50 
Hz and 60 Hz, with an  increase of 10.7%. The  increase  in percentage maximum  increases by 7.8% 
from 20‐50 Hz, and 3.7% from 60‐100 Hz. This indicates that the greatest amount of increase in peak 
moment  is  found  between  20  and  50  Hz  frequencies.  40  Hz  and  50  Hz  produced  the  same 





   20  30  40  50  60  70  80  100 
Mean  61.1  63.5  68.9  68.9  79.6  81.1  78.6  83.3 
SD  26.0  27.5  23.6  26.7  18.2  15.9  17.7  20.3 











In order  to  ascertain whether  there  is  a  frequency  that would be  considered optimal  for  strength 
training  with  NMES,  it  is  important  to  understand  the  variability  of  the  results.  Linear  regression 
analysis  indicates  that  a  high  level  of  variability was  found within  the dataset  of  each participant. 
Table 4.6  indicates  the rate of change  found at each  frequency. Frequencies were sub‐categorised 
into  smaller  groups  to  enable  identification  of  trends.  The  group  with  the  highest  number  of 













1  0.166  0.426  0.001 
3  0.034  1.38  0.186 
4  0.308  ‐0.242  0.113 
5  0.093  0.17  0.026 
6  ‐0.097  0.08  0.032 
7  0.142  0.24  ‐0.083 
8  0.002  0.062  0.039 
9  0.068  0.105  0.018 
10  ‐0.174  ‐0.036  0.049 
11  0.031  ‐0.05  ‐0.054 
12  0.591  ‐0.487  ‐0.032 
13  0.123  ‐0.054  0.311 
14  ‐0.099  0.192  ‐0.06 







taken  into  consideration.  For  analysis  purposes  stimulation  intensity  has  been  grouped  into  three 














a  higher  intensity  whilst  stimulating  produced  a  higher  output  from  the  gastrocnemius.  The 
moderate category of intensity produced two MFP‐ES values that were higher or equal to the MFP‐





















stimulation with NMES.  There were  a wide  range of MFP‐ES  values  between participants,  ranging 
from 5.8 Nm to 55.9 Nm. Standard deviations tend to be quite low (average 3.1), despite the range 
of MFP‐ES. There are  two participants, 3 and 6 who demonstrate  standard deviations higher  than 
expected compared to the remaining data. Participant 3 produced the highest MFP‐ES of 55.9 Nm, 
and a standard deviation of 9, whilst participant 6 had a MFP‐ES of 9.2 Nm and a standard deviation 




  1  2  3  4  5  6  7  8  9  10  11 
Mean  11.0  18.4  55.9  11.5  16.0  9.2  46.4  7.6  37.4  5.8  12.0 
SD  2.1  2.0  9.0  1.3  1.8  4.9  2.8  3.0  2.9  2.8  1.6 










Given  the  variability  witnessed,  it  is  important  to  look  at  the  results  based  on  individual 
presentation. Graph 4.6  indicates that 8 participants had similar MFP‐ES values, and 3 participants 
exceeded this. Table 4.9 groups MFP‐ES into categories. Participants 3, 7 and 9 produced a MFP‐ES in 












When  exploring  within  participant  data,  multiple  trends  were  identified.  Some  participant’s 
demonstrated  positive  linearity  in  their  MFP‐ES,  indicating  that  MFP‐ES  increased  over  the  45 











participants  who  demonstrated  increases  or  decreases  in MSP‐ES  over  the  45  stimulated muscle 
contractions.  A  stable  response  has  been  identified  as  a  change  in  MFP‐ES  of  0‐1  Nm.  The 


















Linear  regression  analysis  was  conducted  to  establish  the  variance  of  force  output  during  the 
stimulation  protocol  (instead  of  pre‐post).  Analysis  grouped  responses  into  three  presentations: 
stable, fatiguing and increasing. Four participants demonstrated increases in their MFP‐ES over the 
45  stimulated muscle  contractions  (participant  2,  4,  5  and  7).  This  indicates  that  five  participants 
witnessed  decline  as  a  result  of  the  NMES  programme.  Two  participants  demonstrated  overall 
stability of response. The average decline of participants over the treatment protocol was ‐0.13 Nm 











variance  of  data,  indicating  voluntary  involvement  to  assist  NMES.  The  reduction  of  the  intensity 
during  the  second  part  of  participation  could  be  a  consideration  for  the  decreased  variability 
witnessed  in participant 2 data  (standard deviation of 2). Participant 12 demonstrated  the highest 
decline in intensity (25 ma), and produced a low mean MFP‐ES of 5.8 Nm in this part. Participant 3 
produced the highest  increase  in stimulation over  the  two parts of 21 ma.  It  is  interesting  to note 











1  42  34  8 
2  39  35  4 
3  31  52  21 
4  29  23  6 
5  22  27  5 
6  18  32  14 
7  26     
8  34  39  5 
9  20  30  10 
10  27  39  12 
11  20     
12  47  22  25 
13  25  28  3 
14  24     























MFP‐ES  over  the  45  stimulated muscle  contractions  (R2=  0.727).  This  is  similar  to  the  relationship 
identified during part one. There appears to be a relationship between the intensity category (low, 
moderate or high) and variability of MFP‐ES during the 45 muscle contractions. When conducting a 
one‐way ANOVA a statistical  significance was  identified between MFP‐ES and stimulation  intensity 
























Results  were  initially  analysed  using  data  from  all  participants,  which  was  carried  forward  for 
subsequent  study  design.  This  resulted  in  50  Hz  being  regarded  as  ‘optimal  frequency’. 
















Part  two  aimed  to  test  the  proposed  ‘optimal  frequency’  in  one  session  of  a  strength  training 
protocol. There was a degree of variability witnessed within the results, with multiple trends being 
identified when assessing individual data. When comparing the full cohort of participants there was 
a  greater  decline  of  MFP‐ES  over  45  muscle  contractions  than  there  was  incline,  as  evidenced 





A  positive  relationship  was  identified  between  stimulation  intensity  and  MFP‐ES:  the  greater 
intensity  used,  the  greater  the MFP‐ES.  Part  two  has  identified  that  50  Hz  produces  a  variety  of 
muscular  responses when administering a NMES  strength  training protocol;  increasing, decreasing 





The aim of  this  study was  to  investigate whether an optimal  frequency exists, and  if  it  is effective 





inform  further  studies  in  this  thesis,  where  the  protocol  will  be  administered  on  different 
populations.  
 
Study  one  was  the  first  study  that  utilised  the  leg  measurement  device  (LMD).  This  study  was 
conducted on the gastrocnemius, resulting in the foot plate being our sole means of measurement. 
The LMD proved to be simple and effective to set up. Alteration to the side members in response to 
participant  limb  length  was  easy  to  conduct  whilst  the  participant  was  seated,  and  provided  a 
standardised measurement of  knee  and ankle position during  stimulation.  The Velcro  straps were 
efficient  at  maintaining  limb  position.  Standardisation  of  limb  position  was  vital  as  the 
gastrocnemius  is a bi‐articular muscle. The electrodes were easiest  to apply before  the participant 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was  positioned  in  the  LMD;  a  factor  that  was  retrospectively  reflected  upon  for  future  testing. 
Subjective  feedback  was  positive;  the  device  was  comfortable,  and  all  participants  reported  that 
they would accept  this position during a  treatment session  for a  longer period of  time  if  required. 
Due to the young and healthy nature of our sample, no problems were encountered with positioning 






converted  to Newton meters,  and  transferred  to a mathematical  software programme  (Mathcad). 






example  of  both  a  noisy  and  a  clean  dataset  is  presented  in  image  4.3  below.  Noisy  data  was 









contraction  was  identified  by  reading  data  after  20%  of  maximal  jerk  (measured  in  seconds  and 
shown  in  blue  on  image  4.3).  This  value  was  more  consistent  in  identifying  a  true  effort  when 
compared to a 10% or 30% cut‐off.  It was considered to be the value that gave the most detail from 
the data  considering  its  variation.  In  future  studies we propose  to  continue  to use  the method of 
analysis developed for this study, as any change would run the risk of not being able to identify small 
changes  in  force,  which  could  have  a  clinical  impact  on  a  patient  population.  When  testing 
pathological populations, such a stroke, small changes  in strength are anticipated given the strong 















When  looking  at  the participants who were excluded on  this  basis,  there were  three  females  and 
one male. It could be inferred that a female population have less tolerance to the sensation of NMES 
that males. This is supported by recent research, which indicates that sensory thresholds are lower 
in  females  compared  to males,  and  that  this  should  be  taken  into  consideration  when  designing 
stimulation  protocols  (Maffiuletti, Morelli  et  al.  2011).  This maybe  a  result  of  a  higher  peripheral 
adipose  layer, which  has  been  reported  in  females,  compared  to males  (Karastergiou,  Fried  et  al. 





two.  A  convenience  sample  was  recruited  from  staff  at  the  hospital  where  the  research  was 
conducted. This sample was used for ease of participants volunteering to take part in the research. 
The  benefits  included  having  limited  travel  and  time out  of  a working  environment.  The  research 
team  also  had  the  benefit  of  internal  email  communication,  which  given  the  time  constraint  to 
collect data (based on funding implications) was vital. The convenience sample used was beneficial 
for recruitment, but limits the ability to translate the results to a wider population (Marshall 1996). A 
convenience  sample  is  not  necessarily  reflective  of  the  wider  population  and  could  have  similar 










protocol  development  in part  two. Although a  larger  sample  size may have  given  this  study more 
strength to reliably infer from the results, the data was going to be further tested in a full strength 
training  protocol.  Given  the  limited  time  available  to  collect  data,  a  smaller  sample  was  deemed 
sufficient.  In  order  to  fully  achieve  the  aim  of  this  study  a  power  calculation  could  have  been 
performed  to  ascertain how many participants would be  required  to  generalise  results  to  a wider 
population. There are a variety of methods available to calculate sample size (Dupont, Plummer Jr. 
1998). A power calculation was not conducted as the logistical issues outweighed the need given the 




the  results of  this  study. During part one  testing each  frequency was administered  twice,  and  the 








have  induced  a  learning  effect  during  the  protocol.  Participants  were  not  informed  which  order 
frequencies were administered,  in  the thought  that  they would not be affected by the ordering of 




increase  in  strength  could  have  initiated  a  learning  effect  whereby  the  perceived  increase  in 
volitional strength could be transferred into actual strength gains. Learning effects can be a powerful 
placebo when referring to treatment response (Flatten, Blumenthal 1999). In order reliably say if this 
were  true  the study design should ensure  that a control group  is employed  for comparison, and a 
larger sample size used for testing. Sham treatments with NMES are difficult to implement. Sensory 
outputs  from NMES  result  in  tingling, muscle  twitching  or  contractions,  and  even  noxious  stimuli 
(Baker, Wederich  et  al.  2000). Delivery  of  a  sham  treatment would  result  in  the participant  being 
aware of the lack of sensation from NMES; effectively breaking the blinding. Blinding is also difficult 
within the research team as participants who have received stimulation with NMES are commonly 
left  with  an  erythema  under  the  electrode  site  as  a  result  of  heat  from  the  electrodes  (Brunoni, 
Nitsche et al. 2012). The use of another person for analysis was not available within the scope of this 
PhD research. When considering the results obtained from this methodology there is no significant 
indication that a  learning effect occurred.  It  is  therefore presumed that  this has not occurred, and 
these results are deemed reliable to take forward for further analysis in a full 6‐week program.  
 
Part  one  of  this  study was  conducted with  a  90  second  rest  between  electrically  induced muscle 
contractions.  This  rest  period  was  incorporated  into  the  protocol  based  on  recent  literature 
highlighting the impact of fatigue whilst using NMES (Gobbo, Maffiuletti et al. 2014). Although only 
producing  16 muscle  contractions  (both  sessions),  a  protocol  that  induced  direct  fatigue was  not 
appropriate  in achieving study aims. Fatigue  is often highlighted as a negative training  influence  in 
NMES  literature  (Schuhfried,  Crevenna  et  al.  2012,  Gregory,  Bickel  2005).  It  must  be  noted  that 
volitional  strength  training  literature uses  the overload  training principle  to  induce muscle  fatigue. 
This induces eccentric muscle contractions and a stimulus for hypertrophic changes (Vogt, Hoppeler 





Much  of  the  NMES  literature  discusses  the  concept  of  fatigue  as  an  influential  factor  during  its 
administration. Fatigue is often thought to be due to a build‐up of metabolites such as lactic acid in 
the muscle tissue (Westerblad, Allen et al. 2002), which is regarded as peripheral fatigue. Peripheral 
fatigue often occurs  from anaerobic exercise, and  is a  result of a build‐up of hydrogen  ions  in  the 
muscle  cell,  causing  acidosis.  Westerblad  (2002)  also  discusses  the  idea  of  increased  inorganic 
phosphate from the break‐down of creatine phosphate as another contributor to the mechanism of 
peripheral  fatigue.   There  is debate as  to whether  fatigue contributes  to  the processing at Central 
Nervous System (CNS)  level. The  impact on CNS  functioning  is  regarded as central  fatigue and has 
been extensively  researched during muscle  training  (Gandevia 2001). This  results  in a  reduction  in 




Short‐term  training with NMES  is  thought  to  induce changes  in  the central  components of muscle 
activation  (Maffiuletti,  Pensini  et  al.  2002).  This  indicates  a  development  in  the  muscles 
neuromuscular  response  rate.  It  is  assumed  that  some  central  fatigue  as  a  result  of  training  is 
required  for  this change to occur, although research to support  this  is  limited. Literature proposes 
that the synchronous firing of muscle fibres during NMES develops fatigue with a quicker onset than 
volitional  muscle  contraction  (Baker, Wederich  et  al.  2000).  Rest  between  contractions  has  been 
shown to be  the optimal way  to eliminate  fatigue during stimulation  (Gandevia 2001). This means 
that  we  are  able  to  reliably  assume  that  the  frequency methodology  (part  one)  has  not  induced 
fatigue, however the contraction as a direct result of the stimulation was at an intensity sufficient to 
induced  fatigue.  Fatigue  has  been  highlighted  in  the  NMES  literature  as  a  vital  stimulus  in  the 
development  of  muscle  hypertrophy  (Stevens‐Lapsley,  Balter  et  al.  2012).  The  level  of  fatigue 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required  to  induce hypertrophic  changes and  the  threshold when  fatigue  results  in  a  reduction of 





impact over 45 muscle contractions  requires consideration. Literature  indicates  that  stimulating at 
higher frequencies for a long period of time will produce undue fatigue (Neyroud, Dodd et al. 2014). 
Interestingly,  the  level of detrimental  fatigue has not been verified. NMES  induced contractions of 
the plantarflexors at 75Hz resulted in both peripheral and central fatigue, which resulted in a motor 
function decline (Boerio,  Jubeau et al. 2005). Functional decline was associated with reduced axon 
propagation,  resulting  in a decreased firing capacity of  the neuromuscular system. NMES does not 
initially  favour  type  one muscle  fibres  as  seen  during  voluntary muscle  contraction  (Lieber  2009). 
Synchronicity of stimulation activates type two muscle fibres, resulting in a strong contraction due to 
their fast properties. This can be beneficial as a strong muscle contraction is produced which is often 
stronger  than  volitional  capacity  in  an  impaired  population  (Bax,  Staes  et  al.  2005).  However  the 
impact of fatigue as a stimulus for change or a detrimental influence has not been tested here. Until 
this  relationship  is  investigated  this  study  will  follow  guidance  from  the  literature  and  consider 
higher frequencies to have the potential to be detrimental over a longer period of training.  
 
Variability has been  identified at all  frequencies,  indicated by  the high number participant outside 
the  interquartile range on box plot analysis  (graph 4.1). This  indicates that there are differences  in 
how a muscle  responds  to NMES. On  consideration of  individual participants, participant  two was 





Hz,  the remaining  frequencies produced moments  in  line with other participants. This  implies  that 
the participant assisted the contraction at 50 Hz, rather than detrimental fatigue from the previous 
exercise. It may be that he altered position in the leg measurement device (LMD), or pushed his foot 




gastrocnemius  was  unable  to  hold  the  level  of  muscle  contraction  when  all  muscle  fibres  were 
stimulated  synchronously.  This may have  considerable  implications when administering a  strength 
protocol with NMES,  as  the muscle may  not  have  time  to  replenish  its metabolites  in  the  time  it 






are  aware  limited  research  has  been  conducted  in  artificially  stimulated muscle,  however  factors 
that  influence voluntary muscle contraction are assumed to apply to artificially contracted muscle. 
Aspects  such  as  nutrition,  hydration,  previous  level  of  exercise  and  sleep  all  have  an  effect  on 
volitional  exercise  (McArdle,  Katch  et  al.  2010),  and  although  afferent  signals  are  artificially 
produced,  the  efferent  response  is  comparable.  Minimal  qualitative  data  was  extracted  from 
participants in this study; however deeper understanding of the condition of a muscle would allow 
more  accurate  assumptions  on  the  relationship  between  force  and  frequency  to  be  made.  This 
would  also  indicate  people  who  are  more  likely  to  respond  to  treatment  with  NMES,  and  allow 
certainty  in  clinical  outcomes  to  be used  if  incorporated  into  a  treatment  programme.  It must  be 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variability  also  hindered  the  use  of  plateaux  identification  as  an  indicator  of  optimal  frequency. 
When  considering  mean  values,  the  greatest  rise  in  MFP‐ES  was  between  40  and  60  Hz.  This 
prompted  linear  regression  analysis.  The  rate  of  change  identified  the  frequency  producing  the 
greatest response to stimulation with NMES. This has profound clinical implications as an increase in 
frequency  is only warranted  if  the muscle  is  still producing an  increased  response  to  the stimulus. 
The muscle may produce  a higher  force  as  a  result  of  stimulation,  but  given  the  variability  in  this 
aspect of analysis, the higher force must be justified by an increased muscle response. The optimal 





production  (MFP‐ES)  that  was  surprisingly  higher  than  the  other  participants  (although  non‐
significant on testing). These participants also used the highest stimulation intensities. This indicates 
that the higher the stimulation intensity used to administer NMES the higher the force output of the 
muscle  being  stimulated.  This  is  supported  in  literature  (Stevens‐Lapsley,  Balter  et  al.  2012). 

















There  was  one  participant  who  responded  to  NMES  differently  to  other  participants.  Participant 
three was a 27 year old male. This particular participant increased their stimulation intensity by 21 
mA  from part one  to part  two.  The  results  from  this participant  indicate a  varied  response of  the 
gastrocnemius to stimulation, as  indicated by graph 4.7. The decline of MFP‐ES witnessed over the 
training programme suggests that this muscle produced a response to the stimulation. This may be a 
result  of  muscle  fatigue.  Muscle  fatigue  results  in  a  reduced  force  output  (Enoka  2012),  as  was 
witnessed  in  this  participant.  Damage  to  the  muscle  sarcolemma  has  been  suggested  to  initiate 




became  accustomed  to  the  intensity  of  the  contraction  causing  force  decline.  Increasing  the 
stimulation intensity throughout the testing protocol may have resulted in either a smaller amount 
of  force  decline,  or  an  increase  in  force  output.  Other  studies  report  much  higher  stimulation 










The  stimulation  intensity  that  participants  used  during  the  testing  protocol  was monitored  and  a 
linear relationship identified (graph 4.5 and 4.7). This indicates that the participants who stimulated 
with a higher intensity produced a greater maximal electrically stimulated force production (MFP‐ES) 
of  the  gastrocnemius.  This  implies  that  the  participant  should  be  encouraged  to  use  a  high 
stimulation  intensity  to  gain  the  greatest  force  from  the  muscle.  Further  investigation  as  to  the 




Participants  did  not  report  discomfort  during  stimulation,  and  were  comfortable  with  testing 
procedures. Research has recently been conducted  into the use of NMES  in a hospital setting with 
similar  subjective  results  reported  (Broderick,  Kennedy  et  al.  2011).  Reported  sensation  of  NMES 
tends to generate reluctance to its use in an acute clinical setting from clinicians (Gobbo, Maffiuletti 
et  al.  2014,  Schuhfried,  Crevenna  et  al.  2012).  A  clear  understanding  of  the  effect  of  stimulation 
parameters  on  patient  comfort  and  guidance  of  their  use  would  help  to  address  this  issue. 
Participant comfort assumes that  the acclimatisation session was effective  in ascertaining maximal 







The aim of  this  study was  to highlight whether an optimal  frequency exists,  and  is effective when 
stimulating  to  develop  strength  with  NMES. An  optimal  frequency  of  50  Hz  was  identified  with 
initial analysis and will be carried forward to future studies within this thesis. The greatest rate of 
change  in  force production was produced between 40 and 60 Hz. The middle value of  these three 
frequencies  was  considered  to  be  optimal,  as  it  would  result  in  the  largest  force  change  during 
stimulation.  
 
Subsequent  analysis  indicates  that  variability  influenced  our  results  and  the  optimal  frequency 







using  NMES  for  strength  training.  Further  investigation  into  the  impact  of  fatigue  for  a  NMES 
strength  training  protocol  should  be  considered.  The  variation  of  both  stimulation  protocols  and 
muscle  response  in  the  literature  makes  it  difficult  to  apply  recommendations  to  protocol 
development within this thesis.  
 





than  this  with  trends  indicating  an  increase,  decrease  and  stable  response  of  MFP‐ES  to  the 
training  protocol.  The  majority  of  participants  demonstrated  a  small  average  decline  of  MFP‐ES, 





stimulation  intensities.  Further  investigation  into  participant  tolerance  to  stimulation  would 
therefore  positively  affect  the  output  from  the muscle.  Further  use  of  the  acclimatisation  session 











The  protocol  used  in  study  one  (Chapter  4)  produced  a  response  that would  allow  the muscle  to 
hypertrophy  if  continued.  The  protocol  will  therefore  be  carried  forward  into  this  study.  A  key 
outcome  was  the  variation  in  response  from  the muscle.  This  will  be monitored  throughout  this 
study to ascertain whether it continues and highlight any trends within this.  
The protocol will now be tested  in a full 6‐week training protocol on different aged participants.  It 





Much  of  the  NMES  literature  has  focused  on  improving  sporting  performance,  and  has  therefore 
used a young population to conduct their testing (Maffiuletti, Cometti et al. 2000). Research that has 
been  conducted  on  an  older  population  is  often  inconclusive,  or  highlights  the  need  to  conduct 
further testing (Elboim‐Gabyzon, Rozen et al. 2013). When used in a clinical setting the aim of NMES 
is primarily  restoration of muscle  strength or prevention of disuse atrophy. This  indicates  that  the 
fundamental population  requiring  intervention  is  the  frail elderly, and  the neurologically  impaired. 
Research  has  begun  to  investigate  the  effects  of  NMES  primarily  for  strength  training  in  various 
pathological  populations,  including  osteoarthritis  (De  Oliveira Melo,  Aragao  et  al.  2013)  and  total 
knee  arthroplasty  (Stevens‐Lapsley,  Balter  et  al.  2012).  However,  inconsistencies  in  application  of 
NMES  and  varying  outcome  measures  have  limited  the  ability  of  NMES  to  be  integrated  into  a 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clinical  setting  (Giggins,  Fullen  et  al.  2012,  Schuhfried,  Crevenna  et  al.  2012).  Understanding  the 
fundamental  principles  of  NMES  application  would  allow  intervention  to  be  applied  with  more 
certainty.  This  understanding  is  required  for NMES  to  be  accepted  as  an  intervention  in  a  clinical 
environment.  
 





The  population  of  frail  elderly  individuals  is  increasing  given  advances  in medical  technology  and 
education (Mackenbach, Slobbe et al. 2012). Advancing age is concurrent with a decrease in muscle 
strength,  and  subsequent  increased  risk of  falls  (Evans 2010). Muscle  strength has been  shown  to 
increase with  a  volitional  strength  training  protocol  delivered  to  the  elderly,  which  has  positively 
impacted on daily functional activities (such as sit to stand endurance) and a decreased risk of falling 




Muscle  strength  is  increasingly  hard  to  restore  with  age,  given  the  rapid  onset  of  sarcopenia.  In 
order  to achieve this an externally stimulated  intervention to  initiate  the strength training process 
may be useful.  It  is  important  to  focus on  increasing  this population’s  level of mobility, which will 
have a direct consequence on their quality of life (Li, Fisher et al. 2003). A greater understanding of 
different  aged  muscle’s  response  to  strength  training  with  NMES  will  also  help  to  prepare 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This  study  aimed  to  test  the  proposed  protocol  on  healthy  participants  of  differing  ages.  The 
comparison of a younger population compared to that of an older population will help to establish 
treatment  effect  and  address  some  of  the  gaps  in  the  current  literature.  The  effects  on  an  older 











Method  of  recruitment:  Participants  were  recruited  from  the  Robert  Jones  and  Agnes  Hunt 
Orthopaedic NHS Foundation Trust  staff, and a  local University of  the  third age group  (U3A). Both 
hospital staff and external participants were approached via email, providing contact details of the 




were  given  24  hours  to  decide  whether  they  would  like  to  participate,  and  this  time  period  was 
followed up with a telephone call to discuss any questions that arose. 
 











Informed  consent:  Written  informed  consent  to  participate  in  the  study  was  obtained  once  the 






labelled  ‘control  old’  (n = 5) or  ‘control  young’  (n = 5).  Randomisation  cards were placed  in blank 






Testing position:  Testing was  conducted on  the non‐dominant Gastrocnemius,  and  the participant 




Electrodes  (50  X  90  mm)  were  placed  horizontally  across  the  two  heads  of  gastrocnemius,  as 
detailed  in  study  one  (Baker,  Wederich  et  al.  2000).  See  image  4.2.  Modifications  to  electrode 
position were made  if  the participant  reported noxious  stimuli  associated with  stimulation. NMES 
depolarises cutaneous sensory nerve endings, which have a lower propagation threshold than alpha 
motor  neurones,  due  to  their  superficiality  (Sheffler,  Chae  2007).  Alteration  of  electrode  position 
and  application  of  some  water  on  the  under  surface  of  the  electrode  are  recommended  in  the 
literature to make stimulation more comfortable.  
Before the  first  treatment session an acclimatisation session was performed where the participant 
was  introduced  to  the  sensation of NMES, and  the  intensity of  a  single  contraction  that would be 
administered  during  the  protocol.  This  also  allowed  an  understanding  of  participant  tolerance  to 
stimulation. Stimulation intensity was gradually increased over a number of muscle contractions to a 
level  that  the  participant was  comfortable with,  but  considered  their maximal.  This  intensity was 
used to stimulate the muscle on two more occasions, allowing a  further  increase  if  the participant 
became accustomed to the setting. Once the stimulation intensity was set for the initial treatment 









assessment  to  be  implemented.  We  chose  to  test  the  Gastrocnemius  as  it  has  been  shown  to 
produce training responses that are representative of all muscles (Lieber 2009).  
 
Treatment  sessions  involved  45  individual  muscle  contractions  on  their  non‐dominant 
Gastrocnemius, on 3 different days a week, over a 6 week period.  The participant was positioned in 
the  LMD  during  each  treatment  session.  Stimulation  parameters  are  detailed  in  table  5.1. 
Stimulation  parameters  were  utilised  due  to  recommendations  from  the  scientific  literature  (see 
literature review, chapter 2), and from the results of previous studies (Chapter 4). Chapter 5 details 













Stimulation  intensity  was  set  to  maximal  at  the  beginning  of  each  testing  session.  This  allowed 




















Isometric  volition  force  production was  assessed,  to  establish  any  carry  over  effects  of  treatment 
with NMES. Volitional Maximal  Isometric  force production (MIFP) was assessed via the LMD which 
was  designed  to  measure  moments  about  the  knee  and  ankle  joints  (further  details  provided  in 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chapter  3).  The  participant  was  positioned  in  the  LMD,  as  described  previously.  Volitional 
gastrocnemius  force  production  was  measured  with  the  participant’s  ankle  in  a  plantargrade 
position,  and  the  knee  joint  at  60°  flexion. Mid‐range  of  the  gastrocnemius  fibres will  enable  the 









Pennation  angle  was  considered  to  be  the  angle  that  which  the  muscle  fibre  inserted  into  the 
superficial  muscle  aponeurosis,  as  measured  by  2D  ultrasonography.  Pennation  angle  has  been 
shown  to  relate  to muscle  strength  (Aagaard, Andersen  et  al.  2001),  therefore  this would  give  an 
indication of muscle adaptation to the NMES protocol.  
 
Pennation  was  measured  both  at  baseline  and  after  the  6‐week  intervention  period.  The 
measurements were conducted with  the participant  lying  in a prone position. The participant was 
asked  to  hang  their  feet  off  the  edge  of  a  treatment  plinth,  in  order  to maintain  a  plantargrade 
position. The lateral head of the gastrocnemius used throughout testing was measured.  
 





point  as  possible  to  obtain  a  clear  image  of  the  muscle  fibres.  Multiple  images  were  taken  for 
analysis.  
 








MFP‐ES  was  considered  to  be  the  maximal  plantarflexion  moment  (Nm)  achieved  during  each 
contraction  of  the  NMES  protocol.  Previous  literature  has  suggested  that  NMES  predominantly 
recruits  type 2,  fatigable muscle  fibres  in a synchronous  fashion  (Maffiuletti 2010). For  this  reason 
NMES is often thought to cause detrimental fatigue, which has been implied as a reason for its lack 






MFP‐ES was calculated once  the data  from the NMES protocol was extracted and  transferred  to a 
mathematical  software  spreadsheet  (Mathcad).  Data  was  extracted  from  each  of  the  45  muscle 
contractions. Maximal moment from each contraction was identified and regarded as peak moment; 
this  value  will  be  referred  to  as  MFP‐ES.  This  outcome  measure  also  provides  a  measure  of 




DUR  was  calculated  for  each  muscle  contraction  produced  from  the  NMES  protocol.  Data  was 
extracted from the LMD, and calculated in the Mathcad spreadsheet. DUR was considered to be the 
period  of  time  (seconds)  that  the  muscle  was  in  a  contracted  state  as  a  response  of  the  NMES 



















When  considering Maximal  Isometric  Force  Production  (MIFP)  three measurement  attempts were 
reduced  to  one  for  analysis.  The  maximum  of  three  attempts  was  considered  for  analysis,  as 
opposed to calculation of the mean. Maximal consideration of MIFP both encouraged the participant 











A  proportional  relationship  was  observed when  comparing  differences  in  pennation  angle  before 
and after  treatment.  This  indicates  that pennation angle  increased post NMES,  an effect  that was 
greater  in  the  under‐30  treatment  group.  A  relationship was  also  investigated  between MIFP  and 
 129 
 
pennation  angle,  however  this  was  not  clearly  distributed.  Paired  T‐tests  indicate  a  significant 
difference during the six‐week intervention period for both treatment groups.  
 
When  looking  at  Maximal  Electrically  Stimulated  Force  Production  (MFP‐ES)  we  firstly  compared 
descriptive values over time, comparing among age groups. It appeared that variation within groups 
was dependant on  initial  tolerance to stimulation. Error bars highlighted trends within age groups, 
and  variation  within  this.  The  variation  was  greater  in  the  over‐60  treatment  group.  Curve 
estimation  analysis  indicates  a  rise  in  mean  rate  of  improvement  over  time,  indicating  that  the 
muscle  was  able  to  increase  its  artificial  force  generating  capacity.  Within  session  data  suggests 




small measurement  of  change within  the  3‐second  stimulation  period;  percentage  increases were 
able to demonstrate this as a clinically relevant change. Error bars indicated the changes within age 
categories,  which  were  described  on  an  individual  basis.  The  under‐30  treatment  group 





Nineteen  participants  completed  the  six  week  strength  training  intervention  with  NMES  to  their 
gastrocnemius.  One  treatment  participant  withdrew  in  the  early  stages  of  the  study  due  to  time 
constraints preventing attendance of  treatment sessions. Raw data  is presented  in appendix 4 a‐c. 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Table  5.2  identifies  the  sample  size  within  each  group.  All  participants  were  able  to  tolerate 
























The  age  of  participants  recruited  into  this  study  had  a  low  standard  deviation, which was  slightly 
higher in the over‐60 category (table 5.3). This is reflective of the convenience sample recruited. The 
gender split between allocated treatment arms differs between age group. There were 2 males and 









MIFP  has  been  defined  as  the  maximal  of  three  attempts  of  gastrocnemius  voluntary  force 



























When  looking  at  table  5.4  it  is  clear  to  see  that  the MIFP  varies  significantly  from  each  group  at 
baseline.  Baseline  considerations  were  not  taken  into  account  during  analysis,  due  to  the  small 
sample  size  in  each  group.  Measurements  were  considered  in  relation  to  participant  individual 
baseline  attempt,  helping  to  make  analysis  of  strength  changes  as  accurate  as  possible.  A  small 
sample  size  also warrants  individual  analysis of  results. As expected  the under‐30 groups baseline 
mean maximal MIFP is higher than the over‐60 groups, however there is also a difference between 




in MIFP  over  the  6‐weeks  (1.3  Nm),  which  was  the  only  decline  witnessed  in  this  sub‐group.  P9 
demonstrated  a  small  increase  of  MIFP  in  comparison  to  other  participants  (20.69  Nm  smaller). 




















T30  Pre‐Post  -49.495 -11.222 .005 
C30  Pre‐Post  -8.147 6.013 .751 
T60  Pre‐Post  -32.074 -9.766 .001 



















U30  1.5  ‐13.4  16.4 




Pennation  angle  of  the  lateral  head  of  gastrocnemius  was  measured  via  2D  ultrasonography. 
Measurements were  taken at baseline  (PRE) and after  the 6‐week  intervention period  (POST). The 







C30  14.8  15.3  0.4 
T30  13.2  15.6  2.4 
C60  11.2  11.3  0.1 





Table  5.7  indicates  that  both  treatment  groups  increased  pennation  angle  over  the  6‐week 
intervention period. The under‐30 treatment increased pennation angle by 0.2° more than the over‐




















Pennation  angle  was  also  analysed  in  relation  to  maximal  isometric  force  production  (MIFP),  to 
ascertain relationship with increases in voluntary strength (graph 5.4). Both control groups (red and 
blue  circles)  demonstrate  a  small  increase  in MIFP  and  a  small  increase  in  pennation  angle.  The 
relationship within  the  treatment groups  is more varied. When  looking at  the under‐30  treatment 
group (green circles) the increases in pennation angle were higher than the respective control group, 
however  a wide  range  of  increases  in MIFP  is  demonstrated  (‐1.3 Nm  to  66.20 Nm).  The  over‐60 
treatment  group  (turquoise  stars)  again demonstrated  some variability.  The  increase  in pennation 









Comparison  of  pennation  angle  differences  between  age  and  treatment  group  was  conducted 
through a paired t‐test. Table 5.8 indicates that a significant finding was observed for both treatment 
groups  (P=<0.05).  This  implies  that  the  response  of  the muscle  to NMES  can  be  attributed  to  the 
treatment.  The  wide  confidence  intervals  must  be  noted.  Both  control  groups  did  not  display  a 






C30  PRE‐POST  -1.342 0.276 .179 
T30  PRE‐POST  -3.416 -1.351 .000 
C60  PRE‐POST  -0.624 0.304 .472 







contraction  of  the  NMES  protocol.  Control  group  participants  did  not  take  part  in  the  NMES 
protocol,  hence  are  not  included  in  this  analysis.  The  NMES  protocol  delivered  45  muscle 
contractions during each treatment session, which were measured by the leg measurement device 
(LMD). These have been converted into Newton Metres (Nm), and the average per week displayed in 




Participant  Week1  Week2  Week3  Week4  Week5  Week6 
             
P1 (O60)  15.14  12.02  15.97  30.76  20.08  28.94 
P2 (O60)  21.62  25.06  26.69  29.72  25.67  23.66 
P3 (O60)  16.92  18.79  21.80  26.71  28.13  22.09 
P4 (O60)  40.66  49.49  76.31  50.71  67.47  76.39 
P5 (O60)  35.71  62.66  76.07  62.38  70.61  75.52 
P6 (U30)  29.23  79.05  74.59  117.75  138.35  185.44 
P7 (U30)  63.01  88.08  104.52  128.24  141.02  152.44 
P8 (U30)  177.97  147.36  162.66  190.27  181.96  208.04 







Table 5.9  indicates  that mean MFP‐ES  increased  for all participants over  the six week  intervention 
period. Table 5.10 demonstrates the  increase  in MFP‐ES from week one to week six. The under‐30 
sub group produced a higher mean force production as a result of the NMES contraction (72.6 Nm 
higher),  but  also  a  mean  increase  of  91.9  Nm  between  week  1  and  6.  The  over‐60  participants 
increased  by  a mean  total  of  19.31  Nm.    P6  from  the  treatment  category  displayed  the  greatest 
increase in MFP‐ES (156.21 Nm), which is 66.79 Nm greater than P7 and 126.14 Nm greater than P8. 
When  looking  at  the  raw  data  P8  has  the  greatest  MFP‐ES  value  of  208.04  Nm  in  week  6.  This 
participant  produced  a MFP‐ES of  177.97 Nm  in week  1,  indicating  a  good  initial  tolerance of  the 
treatment protocol. P6 had a  low MFP‐ES  (29.23 Nm)  in week 1, which  increased by 49.82 Nm by 
week  2.  A  steady  rise  in MFP‐ES was  then demonstrated over  the  following weeks.  This  indicates 






























than  the over‐60 participants.  (P= <0.05, 95% CI 97.11‐101.88) However,  the error bars  indicate a 























ES)  per  week.  However,  it  is  important  to  take  the  variation  within  participant  data  into 
consideration. Graph 5.7 demonstrates the variability within participant 1. The response to NMES in 
week 4 (left hand graph)  is proportional;  the response of the muscle to NMES declines  in a steady 






















Over‐60  .073  .148  3.42 









MFP‐ES over  the 6 week  intervention period. When  looking at  the  raw data of Maximal  Isometric 





Participant  Week 1  Week 2  Week 3  Week 4  Week 5  Week 6  Mean 
P1 (O60)  29  30  30  31  35  35  32 
P2 (O60)  61  72  80  80  80  80  76 
P3 (O60)  39  45  49  52  50  52  48 
P4 (O60)  39  42  42  41  44  48  43 
P5 (O60)  35  54  53  47  52  55  49 
P6 (U30)  50  57  68  65  68  73  64 
P7 (U30)  28  37  33  38  43  47  38 





Stimulation  intensity was considered  in  relation  to MFP‐ES,  in order  to establish any  trends within 
age  groups  (graph  5.9).  As  expected MFP‐ES  is  higher  in  the  under‐30  category  compared  to  the 
over‐60  category.  There  is  a wide  range of  stimulation  intensities  across both  age  groups,  and no 













table  below  (5.13)  displays  the  mean  value  of  DUR  during  each  week  of  contraction  for  each 
participant. Control group participants did not receive intervention with NMES and are therefore not 
included  in  this  analysis.  Total  number  of  data  points  for  all  treatment  participants  N=5055.  The 
table  below  displays  a  consistency  of  DUR  over  the  six‐week  intervention  period,  with  some 











Week1  Week2  Week3  Week4  Week5  Week6 
             
P1  0.78  1.06  0.68  0.84  0.78  0.90 
P2    1.18  1.51  1.58  1.63  1.70 
P3  1.16  1.22  1.23  1.23  1.26  1.28 
P4  1.45  1.40  1.46  1.56  1.49  1.50 
P5  1.33  1.42  1.43  1.44  1.48  1.53 
P6  0.79  0.82  0.88  0.93  1.15  1.14 
P7  1.28  1.13    0.95  1.33  1.35 
P8  1.33  1.44  1.45  1.50  1.46  1.53 
             












































the greatest, with a  rise of 0.15  seconds. The  response  to  stimulation  stabilised between weeks 2 
and three, which was followed by the only decline throughout the intervention programme between 
week 3 and 4: 0.02 seconds. Another rise was produced between week 4 and 5 (0.12 seconds), again 












which  is  the  only  decline  within  this  age  group.  When  looking  at  the  raw  data  participant  7 
demonstrated a decline in mean DUR of 0.18 seconds between week 2 and 4. Unfortunately data is 








The mean  DUR  for  over‐60  participants  increases  by  0.2  seconds  from week  1  to  week  6  (graph 
5.12).  This  is  0.11  seconds  less  than  the under‐30  category.  This  group demonstrates  a  sharp  rise 
from week 1 to week 2, with an  increase of 0.13 seconds. The mean DUR demonstrates two small 










Although  there  was  no  formal  qualitative  measurement  to  report  treatment  feedback,  some 






more confident walking  longer distances after  the 6‐week  intervention. A change  in sensation was 
noted from this participant (spinal stenosis has resulted in a reduction in sensation to the leg prior to 
study involvement). The participant reported that although his sensation was not fully restored, the 
subjective  change  in  sensation was  notable,  and  appeared  to  influence  his  daily  function.  P4  also 
reported a specific change that should be taken into account. Although no reference to strength was 















Maximal  isometric  force  production  (MIFP)  was  assessed  both  before  and  after  treatment  with 
NMES. The  treatment group of both age groups demonstrated a  rise  in MFIP,  the under‐30 group 
more than the over‐60 group. All participants (excluding one‐ under‐30) increased MIFP (treatment 
and  control), with  the  under‐30  age  category  demonstrating more  variability within  this  outcome 
measure.  Similar  results  were  seen  with  pennation  angle,  both  treatment  groups  improved  after 
treatment with NMES, with the under‐30 age category showing a greater improvement. The greatest 




it  was  important  to  investigate  changes  related  to  this.  Maximal  electrically  stimulated  force 
production  (MFP‐ES) was a measure of how the muscle  responded  to  the NMES stimulus. MFP‐ES 
increased in all participants, with a greater increase in the under‐30 age category. This indicates that 
the muscle responded to treatment over time and was able to increase its force generating capacity. 










Duration of NMES contraction  (DUR) demonstrated that  the time the muscle was activated by  the 
NMES  increased  after  treatment  in  all  participants.  This  increase  is  small,  but  potentially  relevant 










NMES protocol over a  full  training period.  Identifying differences between age groups on protocol 
acceptance was  vital  in  transferring  results  from  this  study  into  a  clinical  setting where  both  age 
groups would be targeted. Although the Leg Measurement Device (LMD) has previously been used in 
study  one,  this  was  the  first  time  it  was  subjected  to  a  full  training  protocol  making  this  an 






When  designing  this  study  a  sample  size  of  twenty was  targeted.  Of  this  sample,  one  participant 
withdrew their consent  in the second week of the NMES protocol. This reduced our sample of the 
under‐30 treatment group to four participants. P10 withdrew consent due to work restrictions, not 
allowing  sufficient  time  to  attend  the  training  sessions.  The  participant  reported  that  neither  the 
study design, sensation of NMES nor the testing methods used in this study influenced this decision. 
The  reduction of  this  sub‐group  to  four participants  limited our  analysis  to descriptive means and 
restricts our ability to infer our results to a wider population. The data produced for each outcome 
measure  was  maximised  (considering  the  small  sample)  due  to  the  high  number  of  treatment 
repeats. This allowed analysis  to be as  reliable as possible. Adopting a  randomised controlled  trial 
(RCT) study design allowed us to compare the treatment group to a non‐intervention group, which 
gives  justification  for a  larger RCT to be conducted. When planning  this  study, we were  limited by 
both  funding  and  time  constraints,  which  limited  the  sample  size  we  could  recruit.  One  person 
collecting data along with the high number of sessions (3 sessions every week for 6 weeks) was time 
consuming.  Inclusion of specific assessment from each NMES contraction (MFP‐ES, DUR) as part of 






related  to  volitional  capacity  of  the muscle have been used  throughout  analysis.  P9 was  a  female 
(aged 22) who used an average stimulation  intensity of 42 ma. The  inability  to  read  the data may 











software had a wide range of data points  in  this participant  (P9). The variation at baseline did not 
allow identification of moment peaks during analysis. The moment peak may not have reached the 
threshold required to be identified as a peak, or the participant could have moved their foot on the 
footplate.  Data  available  is  unable  to  identify  the  reason  for  this.  An  example  graph  of  a  noisy 
dataset  is  provided  in  image  4.3.  Participants  were  encouraged  to  relax  and  remain  in  a  fixed 
position throughout the protocol (not assisting the NMES). This is difficult to identify visually during 
data collection due to the high level of sensitivity of the force transducers. Again further time could 
have  been  spent  explaining  procedures  to  participants  and  providing  reminders  during  data 




clinical  populations  (Stevens‐Lapsley,  Balter  et  al.  2012),  although  its  mechanism  is  not  fully 
understood. The application of NMES in a clinical setting is therefore not something that is regularly 
used. By categorising our cohort of participants  into two age groups we were able to compare the 
effects  of  an  elderly  population  to  their  younger  counterpart,  in  whom  the  effects  of  NMES  for 







and assessment makes  it difficult  to highlight an exact age of onset  (Bijlsma, Meskers et al. 2013). 
Recruiting  participants  who  were  over‐60  into  this  study  also  had  some  practical  benefits. 
Participants were still able to work at 60, hence could be recruited from the host hospital without 




vital  for  this  study design. Practical  advantages  in  terms of  recruitment were also  considered;  this 
age range was readily available within the host hospital for participation.  
 
A  wide  array  of  outcome  measures  were  utilised  when  assessing  both  volitional  and  artificial 
responses  of  the  muscle  to  NMES.  The  LMD  recorded  all  outcome  measurements  and  allowed 
accurate, repeatable measurements: something that is difficult to produce in a clinical rehabilitation 
setting. Outcome measures relating to muscle function or performance tend to be subjective (often 
based  on  a  numerical  scale),  and  therefore  can  commonly  be  seen  as  a  limitation  in  a  research 
design. Clinicians are required to assess muscle weakness on a numerical scale, with boundaries for 
each point on  the  scale notoriously  subjective  (Vanhoutte,  Faber et  al.  2011, Harbo, Brincks et  al. 




Research  indicates that advances  in muscle strength can be caused as a result of  improvements  in 
the  neuromuscular  capacity  of  the muscle;  the  nervous  system  is  able  to  respond with  a  quicker 




neuromuscular  capacity  of  the muscle  can  be  addressed  via  the  LMD  during  the  protocol,  as  this 
monitors  moments  about  the  ankle  with  a  high  level  of  sensitivity.  Advances  in  neuromuscular 
function  will  be  clinically  portrayed  as  improvements  in  volitional  strength  capacity.  Neural 
adaptation  has  been  likened  to  improvements  in  motor  learning,  whereby  the  neuromuscular 
system has adapted to the training stimuli resulting in functional  improvements (Carroll, Riek et al. 
2001).  It  is  the  voluntary  ability  of  the muscle  to  improve with  NMES  that would make  a  clinical 
difference to the lifestyle of an individual. For this reason we investigated the ability of the muscle to 
produce  an  isometric  contraction. Although  isometric  contractions  are  not  functional movements, 
we felt  it  important to make our results as accurate as possible, given our small sample size.  If we 
had investigated a functional task such as walking distance or sit to stand ability, the results would 









obtained  via  the  LMD  with  internal  muscle  structure.  These  outcome  measures  give  a  wide 
understanding of muscle  function,  allowing us  to  gain  a  large depth of  information  from  the data 
collected.  The  mean  of  three  measurements  was  taken  as  this  has  been  shown  to  produce  the 




likelihood of  intra‐examiner measurement error  as much as possible.  This method of  analysis was 
used throughout this thesis.  
 
When  looking  at  Maximal  Isometric  Force  Production  (MIFP)  both  the  under‐30  and  over‐60 
treatment  groups  improved  their  gastrocnemius  force  generating  capability  compared  to  their 
control  group.  This  indicates  that  a  six  week  strength  training  protocol  with  NMES  is  capable  of 
producing  adaptation  of  the  gastrocnemius  in  both  age  ranges.  Both  control  groups  produced 
marginal  strength gains, highlighting a possible  learning effect  from the assessment process  in  the 
LMD. However these gains were not sufficient to infer that this would affect our results.  
 
There  was  a  high  level  of  baseline  variability  demonstrated  in  all  participants  when  considering 
maximal isometric force production (MIFP). This was anticipated, due to the presence of sarcopenia, 
and degeneration of the neuromuscular system in the older participants (Lang, Streeper et al. 2010).  
The primary  aim of  this  study was  to  investigate  the  effects  of  the  treatment  protocol  on muscle 
strength, where differences in strength were monitored. The baseline variation is therefore a factor 
that did not influence analysis. The under‐30 treatment group showed a greater volitional strength 
increase  than  the  over‐60  treatment  group  over  the  6  week  intervention  period,  however  both 
groups improved. Muscle of young individuals is more plastic than older individuals, which has been 
attributed  to  an  abundance  of  myoblast  activity,  and  an  enhanced  neuromuscular  system  (Raue, 
Trappe et  al.  2012).  The  increased differentiation of myoblasts  into myotubes demonstrated after 
mechanical stress  to the muscle as a result of  resistance training has been shown to contribute to 
strength development in both trained and untrained young individuals. Although gene transcription 
alteration  has  been  demonstrated  in  old  muscle  (80  years  +)  the  number  of  genes  affected  is 
reduced  compared  to  their  young  counterpart  (30‐40  years),  and  occurs  after  an  extended  time 
period compared to young muscle  (Raue, Trappe et al. 2012). Satellite cell  function  in response to 
 158 
 
muscle  damage  has  been  demonstrated  to  be  delayed  with  advanced  age,  along  with  a  wide 
variance of gene alterations between young and old muscle, despite similar Creatine Kinase serum 
increases.  This  demonstrates  that  old muscle  has  the  ability  to  regenerate with  exercise,  but  the 




requires  extending.  The  6‐week  training  period  may  not  have  been  sufficient  to  elicit  the  full 




amount  of  variability  in  MIFP  than  the  over‐60  participants.  P8  was  a  24  year  old  male  who 
demonstrated a decline in MIFP (1.3 Nm), despite producing a MIFP in line with other participants. 
P8 regularly conducted resistance training at a gym, where he conducted both lower and upper limb 
exercises.  It  may  be  that  this  participant  was  suffering  from  muscular  fatigue  and  causing  the 
strength  of  his  contraction  to  be  reduced.  Peripheral  fatigue  is  often  associated  with  lactic  acid. 
However the build‐up of hydrogen ions  in the cell has been shown to demonstrate acidosis, which 
hinders the strength of contraction post exercise  (Westerblad, Allen et al. 2002).  If  this participant 
were  to  be  suffering  with  a  build‐up  of  metabolites  in  his  muscle,  it  may  have  hindered  his 
performance when performing his maximal MIFP.  
 
This  participant  (P8)  produced  the  highest  force  output  during  the  NMES  protocol  (Maximal 





supra‐maximal  contraction  that  has  been  produced  via NMES  (Bergquist,  Clair  et  al.  2011). NMES 
also  produces  a  sensory  volley  as  a  result  of  contraction,  resulting  in  an  afferent  signal  being 
produced  from  the  muscle  receptors  (e.g.  muscle  spindle),  which  is  sent  to  the  central  nervous 




have  been  spent  ensuring  he was  confident with  testing  protocols.  The  small  sample  size  utilised 
limits our ability to rule this factor out.  
 
Improvements  in  force  generating  capacity were  shown  in  the over‐60  participants  in  the  6‐week 
NMES intervention period. Volitional resistance training research is gradually accepting the fact that 
elderly  individuals are able  to undergo muscle hypertrophy  (Cadore, Moneo et al. 2014). However 
evidence  is  still  conflicting  as  to  the  effects  of  NMES  on  elderly  populations  (De  Oliveira  Melo, 
Aragao et al. 2013). Variation in MIFP improvements were witnessed in the over‐60 category in this 
study,  and  testing  a  larger  proportion  of  individuals  to  assess  whether  this  improvement  is 
consistent would  be beneficial.  Improvements  in  strength  ranged  from 1.9 Nm  to  41.6 Nm  in  the 
older  treatment  category.  When  looking  back  at  participant  activity  levels  there  are  some 
differences.  P3  (1.9  Nm  increase)  is  a  sedentary  male,  in  his  early  sixties,  whereas  P5  (41.6  Nm 
increase)  is  an  active  73  year  old  lady.  Logic  would  dictate  that  the  older  individual  should 
demonstrate less improvement in strength, as the neuromuscular system has had longer to decline 
with  age  (Stenholm,  Tiainen  et  al.  2012).  It  could  be  inferred  that  the  older  participant  in  this 
instance was more active, and thus her muscle had maintained a greater ability  to  regenerate. An 
increased  functionality  of  an  individual  has  been  shown  to  reduce  the  decline  of  muscle  mass 










Current  literature  suggests  that  initial  increases  in  strength  with  NMES  are  attributable  to 
modifications  in  the  neuromuscular  system  as  opposed  to muscle  hypertrophy  (Maffiuletti  2010). 
The  time  scale  from  which  neuromuscular  adaptation  results  in  muscle  hypertrophy  is  poorly 
understood which  is heightened by the diversity of protocol application  in the  literature. Ability to 
transfer knowledge from voluntary strength training literature is also difficult due to the difference 
in physiological principles of muscle recruitment in NMES (Gondin, Brocca et al. 2011). Application of 
this  protocol  over  6 weeks  indicates  that  neuromuscular  adaptation may  have  been  produced  as 





Measurement  of  pennation  angle  allows  assumptions  based  on  voluntary  contractibility  of  the 
muscle  to  be made.  Pennation  angle  has  shown  to  have  a  proportional  relationship  with muscle 
force, indicating that increases in pennation angle occur alongside improvements in force generating 
capacity (Aagaard, Andersen et al. 2001). Pennate muscle allows more muscle fibres to be arranged 
in  parallel,  which  increases  the  physiological  cross  sectional  area  of  the muscle. Measurement  of 




group  by  more  than  the  over‐60  treatment  group.  This  correlates  with  the  under‐30  treatment 
group  showing  a  greater  improvement  of  voluntary  strength.  The  changes  in  pennation  angle 
indicate  that  adaptation  to  the  muscle  fibre  occurred  as  a  result  of  the  NMES  protocol: 
improvements  in  pennation  angle  suggest  that  the muscle  had  increased  the  number  of  fibres  in 
parallel  (Strasser,  Draskovits  et  al.  2013).  Monitoring  changes  in  pennation  angle  over  shorter 
periods within the 6‐week programme would allow indication as to when muscle changes begun to 
occur  within  the  programme.  The  relationship  between  pennation  angle  and  maximal  isometric 
force  production  (MIFP)  in  this  study  is  small  (r2=0.011).  The  small  sample  size may  be  a  limiting 




without  voluntary  control  (MFP‐ES).  We  decided  to  monitor  this  as  a  variable  as  this  gives  an 
indication  of  how  the  muscle  responds  to  NMES  over  time,  and  whether  the  muscle  is  able  to 
increase  its  peak  force  generating  capacity;  i.e.  train  to  induce  a  higher  level  of  strength.  It  also 
indicates whether  the participants’ muscle  is  resisting  the NMES, which would prevent  the muscle 
producing  a  peak  force,  affecting  the  training  effect  of  the  protocol  (participant  treatment 
compliance). By monitoring  this during each  session we were able  to  instruct participants  to  relax 
through  the  stimulation,  or  adjust  the  stimulation  intensity  level  to  a  setting  sufficient  for  the 
resistance  to  reduce.  This  then  builds  up  the  participant’s  confidence  level,  enabling  a  gradual 
increase in the stimulation intensity gradually throughout the protocol. 
 
When  looking  at  the  MFP‐ES  results,  both  treatment  arms  were  able  to  improve  in  the  level  of 












The results  from this study suggest  that  the under‐30 participants spent  less  time adjusting  to  the 
sensation of NMES; however they were not able to tolerate NMES to a greater level than the over‐60 
age group.  This result is interesting and not one which was expected. Younger muscle was expected 
to be of a better  internal  integrity  than older muscle; more muscle  fibres,  larger muscle  thickness 
and well‐structured alignment of  fibres  (Lieber 2009). The muscle properties along with a  reduced 
sub‐cutaneous  adipose  layer  associated  with  a  larger  muscle  would  indicate  that  under‐30 
participants would be able  to  tolerate a higher  current  intensity, with a  corresponding  increase  in 
the  level  of muscle  contraction  produced.  However  the  fact  that  the  average  current  intensity  in 
both  groups  was  very  similar,  and  the  second  lowest  intensity  was  from  an  under‐30  participant 
suggests  otherwise.  This  suggests  that  the  greater  muscle  integrity  and  neuromuscular  function 
under  30  participants  indicates  that  the  under‐30  participants  do  not  require  a  high  level  of 
stimulation intensity to produce a strong muscle contraction. The threshold of nerve propagation in 







contraction  (Thalacker‐Mercer,  Dell'Italia  et  al.  2010).  Although  requiring  similar  stimulation 
intensity,  this  study  suggests  that  the  over‐60  participants  were  not  producing  the  same  level  of 
contractile  ability.  This  links  back  to  the  changes  in  responsiveness  of  the  neuromuscular  system 
with age, showing how it is more difficult for frail, elderly individuals to contract a muscle, in both an 
artificial and external environment. When linking this to frail individuals with pathology, performing 
a  rehabilitation  program,  it  is  easier  to  understand why  they  find  it  difficult  to  perform  activities 
required of them by gold standard rehabilitation programs.  
 
It  is  interesting  to  see  the  variability  in  MFP‐ES  across  all  participants,  but  especially  within  the 
under‐30 treatment category. P6 demonstrated an increase of 156 Nm, whereas P8 only  increased 
by  30  Nm  over  the  6 week  intervention  period.  It  is  interesting  to  note  that  P8  tolerated  a  high 





adaptation  to exercise  allows greater  force  to be placed on  it  through  training, which will  allow a 
greater muscle  contraction  to  be  produced  via  NMES.  As  previously  discussed,  P8  declined  in  his 









Andersen  et  al.  2011).  This would  account  for  the  high  level  of MFP‐ES  increase  over  the  6‐week 
period;  the muscle  had  a  solid  underlying  integrity,  and demonstrated  rapid  response  to  the new 
training stimuli. The lack of maximal force training in the aerobic endurance programme would also 
suggest  that  the muscle  is not accustomed  to high  intensity  load being placed on  it;  resulting  in a 
reduced initial tolerance to the stimulation with NMES. Results from MFP‐ES indicate that there is a 




from  NMES  was  assessed  by  the  outcome  measure  DUR;  duration  of  which  the  muscle  was 
producing a force during the NMES contraction. It was hypothesised that DUR would increase over 








Both  treatment  groups  displayed  an  increase  in  the  DUR  over  the  3  week  period,  with  increases 
showing a small  level of variation. The under‐30  treatment group displayed a slightly higher mean 
increase than the over‐60 participants, however this effect was small.  In  fact variation between all 
participants  was  small.  Similar  high  adaptation  responses  to  DUR  were  witnessed  in  both  age 
categories,  demonstrating  that  age does not  influence  the  ability  of  the neuromuscular  system  to 
adjust  to  intervention  with  NMES.  Despite  low  values,  it  is  still  thought  that  these  values  are  of 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significant  interest  to  clinical  practice,  especially  given  the  short 3  second  stimulation  time  frame. 
For this reason we have been unable to perform substantial statistical analysis on the data, however 






The  under‐30  participants  displayed  more  variation  within  their  results  than  the  over‐60 
participants, suggesting that this response was not repeatable. The increase in DUR suggests that the 
time of  the neuromuscular  system to  respond to  the stimulus and activate  the muscle  to contract 
has  decreased.  Clinically  this  improved  efficiency  of  the  muscle  may  contribute  to  improved 
function. A quicker response of the muscle to a stimulus would enable the body to better anticipate 
threat.  The  response  generated  in  the muscle may  prevent  injury,  or  prevent  the  individual  from 
falling. The initial generation of muscle power occurs quicker than peak muscle contraction, and has 
been shown  to  improve  in an elderly population previously  (Suetta, Aagaard et al. 2004).    Further 
testing  is  required  to  ascertain  whether  the  improved  neural  control  of  the  muscle  transfers  to 
volitional activities, or whether further training to induce these effects in daily function is required.  
 
The  over‐60  participants  demonstrate  a  sharp  increase  in  DUR,  which  is  followed  by  a  relatively 
stable  response  thereafter. This  indicates  that we elicited some adaptation  in elderly muscle, with 
alteration  of  the  neuromuscular  system.  Early  adaptation  could  be  reflective  of  background  in 








by  0.52  seconds.  P2  tolerated  the  highest  stimulation  intensity  of  all  participants.  The  increase  in 
DUR may  be  a  reflection  of  this,  or  an  indication  that  substantial  advances  in  the  neuromuscular 
system were made. P2 has a low level of spinal stenosis (consultant permission was sought to recruit 
this participant), which effects his walking ability. The reduced function of his lower limb muscles as 
a consequence of  this may have  induced a rapid early response, as  the neuromuscular system has 
the ability to contract, but  it has been operating with  limited stimulus. The subsequent  increase  in 
efferent  motor  drive  after  exercise  displays  a  rapid  increase  in  muscle  function,  despite  little 
adaptation  in  the  muscle  fibre  (Cadore,  Izquierdo  et  al.  2013).  Adaptation  in  the  muscle  fibre 
(hypertrophy) has been witnessed  in an elderly population. Although variation  in  time scales have 
been reported (Valenzuela 2012), strength increases in the elderly have been demonstrated to occur 
after  approximately  4 weeks.  This  particular  participant  increased  the  stimulation  intensity  to  the 
maximum the stimulator would allow. This may have been a result of having a high tolerance to the 
sensation  of  NMES,  coupled  with  a  high  level  of  self‐competitiveness  driving  improvements.  The 






Regardless  of  age  group,  the mean  increase  of  DUR  in  all  treatment  participants  is  1.25  seconds, 




time of both age groups  to produce a  response  to  the NMES stimulus, and  that  clinical  guidelines 








indicative  of  physiological  change.  An  over‐60  treatment  participant  (P2)  made  contact  after  the 
study  had  finished  reporting  that  he  could  walk  further,  with  less  pain  in  his  leg.  This  particular 




results  in  the peripheral nerve being activated without having  to  travel  through  the  stenotic area. 
Research  indicates  that  an  afferent  response  is  emitted  as  a  result  of  artificial  stimulation  to  a 
muscle,  which  would  travel  through  up  through  the  spinal  area  (Bergquist,  Clair  et  al.  2011). 
Repetitive neural  input to this muscle from NMES could  influence the ability of the neuromuscular 
system to restore  its  function, which would result  in  improvements  in pain. A prolonged period of 
time with limited or no stimulation to a muscle would result in disuse atrophy (Hofer, Marzetti et al. 
2008), and an elderly male who  is  scared of walking due  to pain would walk  less, heightening  the 
atrophy  (Parry,  Finch  et  al.  2013).  Fear  of  falling  has  also  been  correlated  to  adaptations  in  gait 





Another  over‐60  participant  (P4)  reported  a  subjective  feeling  that  their muscle  had  ‘increased  in 
definition’ compared to its counterpart. This would indicate that the muscle had undergone a degree 
of  hypertrophy,  which  is  reflected  by  this  participant  demonstrating  the  greatest  increase  of 
pennation  angle  in  all  participants.  Subjective  responses  provide  indication  that  effects  of  NMES 
correlate with functional improvements. This would heighten the clinical justification for using NMES 









to  a  level  sufficient  to  induce  strength  adaptations,  due  to  various  confounding  reasons  including 
pain, pathology and surgical procedures. NMES could therefore be an adjunct  to a physiotherapy 
program,  aimed  at  activating  the  muscle  to  a  level  sufficient  to  produce  strength  adaptations. 
Application of both traditional rehabilitation plus NMES could rehabilitate to a more functional level, 
in  a  shorter  time  scale.  In  terms  of  the  younger  age  group,  NMES  has  the  potential  to  shorten 
recovery times post‐surgery, allowing muscle contraction when post‐operative swelling or pain does 
not  volitionally  allow  this.  NMES  could  also  be  administered  during  a  non‐weight  bearing  period 
after  surgery  as  this  does  not  affect  joint  compression.  The  NMES  would  stimulate  blood  flow, 
helping  to  bring  nutrients  and  fresh  blood  to  the  area,  resulting  in  a  maximised  potential  for 
advances  in  muscle  strength  and  reduction  in  swelling.  NMES  could  also  help  to  improve 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• Although  unable  to  fully  ascertain  whether  the  improvement  in  volitional  force  output 
was adaptations in the neuromuscular system or muscle hypertrophy, this is of significant 










The  results  from  this  study  have  highlighted  areas  that  NMES  can  be  considered  beneficial  to 
rehabilitation.  Although  suggesting  a  positive  result  from  our  intervention,  there  are  still 
confounding factors that require addressing before we can make definitive assumptions.  
 
The  variability  witnessed  throughout  all  outcome  measures  suggests  that  some  people  respond 
better  to  treatment  than  others.  Testing  on  a  pathological  population will  enable  us  to  ascertain 
whether  this variability  remains, and whether  it affects  the  response of muscle  to stimulation  in a 
 170 
 
specific  population.  At  present  physiological  and  lifestyle  properties  have  not  been  able  to  given 












Study  two  (Chapter  5)  indicates  that NMES  can be  a useful  intervention  to  strength  train  in older 
muscle as well as young muscle. This indicates that the effects of sarcopenia associated with frailty 
have  the  ability  to  be  reversed.  In  order  to  study  this  effect  further  and  investigate  the  clinical 
impact  the protocol must be  tested  in a pathological population. Stroke  is a condition  that affects 


















contraction,  which  is  fundamental  for  independent,  functional  living.  Stroke  results  in  impaired 
motor unit recruitment, ultimately leading to a rapid incidence of muscle atrophy which is difficult to 
restore  (Prado‐Medeiros,  Silva  et  al.  2012).  Restoration  of muscle  strength  is  a  problem  faced  by 
Physiotherapists, which  is  confounded by  the  initial  focus  of  developing  proximal  control,  such  as 
sitting  balance  and  mid‐line  awareness  before  distal  focus  can  begin.  Proximal  control  must  be 
developed to allow independent function. The time delay in neurological recovery results in further 
atrophy  of  muscles;  an  intervention  to  prevent  this  rapid  decline  in  function  is  paramount  for 
maximising rehabilitation potential.  
 
Rehabilitation  research  investigates modern  technologies  aimed  at  restoring  function  post  stroke 
(Dipietro,  Krebs  et  al.  2012), which  can often be expensive  and  impractical  on  a day‐to‐day basis. 





some  conflicting  results  and  varying  methodologies.  Lack  of  understanding  of  stimulation 
parameters  has  resulted  in  multiple  stimulation  frequencies  and  number  of  repetitions  within  a 
protocol  (Chipchase, Schabrun et al. 2011). Advances  in muscle strength as a  result of NMES have 
been  reported,  with  studies  using  manual  muscle  testing  or  dynamometry  as  primary  outcome 
measures (Sujith 2008). Although this has some benefit in terms of comparability with assessment in 
a  clinical  setting,  little  understanding  has  been  developed  as  to  how  the muscle  is  responding  to 






accurately  measuring  the  muscle  response  to  stimulation  with  NMES.  Reporting  moments  as  a 
measurement  unit  provides  a  precise  way  to  accurately  measure  muscle  function.  Ultrasonic 
monitoring  of  muscle  architecture  remains  a  novel  approach  in  stroke  rehabilitation,  which  has 
received little attention to date. Research that has focused on muscle architecture relates to upper 
limb muscles,  or  does not  include  the use of  pennation angle  (Gao,  Zhang 2008), which has been 










Design:  This  study  adopted  a Randomised Controlled  Trial.  Ethical  approval was obtained  through 
the South Manchester Local Research Ethics Committee (Reference number: 08/H1003/44).  
 





Method  of  recruitment:  Participants  were  identified  from  inpatient  records.  Inpatient  lists  were 
screened on a daily basis, and information of patients who fulfilled the inclusion criteria were passed 
to the consultant associated with the research study. Participants were approached by conversation 
with  the  consultant.  Interest  in  the  study  resulted  in  them  being  given  an  information  sheet 
(appendix 5). Further questions from the participant or family were answered by the lead researcher 




















Informed consent: The participant or  their  family were able  to speak  to  the research  team, or  the 





Method of  randomisation: Participants were  randomly allocated  to  the  treatment  (n=5) or control 
group  (n=5).    Randomisation was performed by placing  allocations  in  blank envelopes,  and  asking 





electrodes  (50mm X 90mm) were placed 5cm proximal  to  the patella,  and 5cm proximal and 3cm 
lateral  to this. Two (50mm X 90mm) electrodes were placed  longitudinally and centrally over both 
heads  of  the  Gastrocnemius,  3cm  below  the  knee  joint  and  2cm  apart  (figure  6.1  a  &  b).    This 
position  was  subject  to  change  if  the  participant  reported  discomfort.  NMES  can  induce  noxious 
sensations, due  to  superficial  stimulation  innervating  cutaneous  receptors;  altering  the position of 








The  participants’  affected  leg was  positioned  in  the  leg measurement  device  (LMD)  that  could  be 
used to measure strength of the knee extensors and ankle plantarflexors during application of NMES 
(Chapter  3).  The  LMD was  altered  to  allow  transducers  to  be  aligned with  the  joint  centre  of  the 
knee and ankle joints of each participant. Limb position was fixed to allow allowed 60° knee flexion 
and plantargrade at the ankle (figure 6.2). Straps were placed across the thigh and anterior ankle to 
maintain  position  throughout  testing.  The  participant  was  appropriately  padded  into  the  LMD  to 
ensure the joint centre of the limb aligned with the device in the case of a flaccid limb. Data was not 

















a moderate  to  severe  stroke.  Both  treatment  and  control  groups were monitored  over  a  6‐week 
period, with outcome measures being assessed at study enrolment (baseline), at 3‐weeks and at the 




Participants  in  the  treatment  group  underwent  a  6‐week  strength  training  program  with  NMES.  
Before  testing began participants were  introduced  to  the  sensation of NMES  in an acclimatisation 
session  on  both  the  Quadriceps  Femoris  and  Gastrocnemius  muscles  of  their  affected  limb. 
Stimulation  parameters  were  set  according  to  Chapter  5  (table  6.1).  Verbal  description  of  NMES 
sensation was communicated before application to ensure that the participant knew what to expect 
from stimulation. The stimulation intensity was then increased in small increments, whilst receiving 
constant  feedback  about  the  sensation  from  the  participant.  Once  maximal  tolerated  has  been 







time  to  process  the  demands  of  study  involvement,  and  ensure  they  were  comfortable  with  the 
stimulation. 
 
Treatment  sessions  were  conducted  3  times  per  week,  for  a  period  of  6‐weeks.  Each  session 























Treatment  and  control  participants  participated  in  daily  standard  NHS  physiotherapy  programs. 
Physiotherapy  sessions  were  monitored  in  all  participants  on  a  daily  basis  (information  was 
extracted  from  medical  notes).  Physiotherapy  sessions  were  also  audited  by  the  research 




















treatment  protocol  to  be  established.  Volitional  Maximal  Isometric  force  production  (MIFP)  was 
assessed via  the Leg Measurement Device  (LMD) which was designed  to measure moments about 
the knee and ankle joints (for full details please see chapter 3). The participant was positioned in the 
device,  as  described  in  section  6.3  (60°  knee  flexion,  plantargrade  ankle  joint).  Research  indicates 











The maximal  attempt was  considered  as MIFP  throughout  analysis  as  encouragement  to  fulfil  the 
aims  of  this  study  (measure  maximal  strength).  The  use  of  maximal  data  has  been  shown  to  be 
indicative  of  reliable  analysis  (Roberts,  Denison  et  al.  2011).  The  data  from  both  muscles  was 







et al. 2001). The architecture of  the Lateral Gastrocnemius head  (LG) and the Vastus Lateralis  (VL) 
were  assessed  using  2D  ultrasonography.  Where  possible  the  participants  were  seated  in  the 
standard  testing  position  in  the  LMD  (knee  60°  flexion,  ankle  plantargrade).  Participants  often 
required padding in the frontal plane to maintain this position. If this were not possible due to probe 
orientation  or  specific  participant  needs,  participants  were  seated  as  close  to  this  position  as 
possible in a standard chair. In this instance a goniometer would be used to measure joint angle.  
 
In  order  to  reliably  re‐measure  muscle  architecture  probe  position  was  monitored  during 
assessment. LG was measured by identifying the central point between the proximal border of the 
muscle and  the myo‐tendinal  junction.    The probe was placed  longitudinally  at  the mid‐way point 








Three  images were  taken  from each muscle.  Images were extracted  from the Ultrasound machine 
via USB connection, and later analysed via the computer software ImageJ (ImageJ LTD). Images were 
analysed  with  the  intention  of  obtaining  as  many  measurements  on  one  image  as  possible.  The 
mean  of  the  measurements  was  considered  for  analysis.  Three  measurements  were  taken  as  a 
 182 
 
minimum.  This  reduced  the  impact  of  measurement  error.  Muscle  subcutaneous  adipose  layer, 
muscle  thickness  and  muscle  pennation  angle  were  identified  and  measured  for  each  image  as 
shown  in  figure  6.3.  When  referring  to  figure  6.3  below,  measurements  4,  5  and  6  refer  to  the 
distance between the lower layer of the epidermis and the top layer of the muscle aponeurosis. This 
was regarded as subcutaneous adipose layer. 1, 2, and 3 refer to the distance between the superior 
















Muscle  volume  of  the  affected  quadriceps  and  gastrocnemius  were  measured  via  Magnetic 










in  the chair using any appropriate walking aids. The  timed up and go  test has been validated as a 
useful  functional measure  in  assessing  changes  in walking  speed  in  Stroke  patients  (Ng,  Hui‐Chan 







Functional  changes  in  participants  were monitored  to  ascertain  any  developments  in  activities  of 
daily  living.  Two  qualitative  measures  were  used  to  asses  a  range  of  global  and  more  specific 
functions.  The Barthel  index  and  the Nottingham Extended Activities  of Daily  Living  questionnaire 
 184 
 
(NEADL) were  completed both  at  the beginning  and  end of  study  involvement.  Research  suggests 
that two scales to assess disability and function may be better than one (D'Olhaberriague, Litvan et 
al.  1996).  Both  questionnaires  have  been  validated,  and  are  in  regular  use  within  the  Stroke 




A  parametric  approach  to  data  analysis  was  conducted  to  ascertain  trends  within  groups  and 






Maximal  isometric  force  production  (MIFP)  was  first  considered  based  on  descriptive  statistics 
(mean, standard deviation) and graphs. This was important to establish the effect of treatment with 
NMES on the ability to produce a muscle force. Differences between both muscles were compared, 
to establish whether differences were equal between  the  two muscles  tested. A paired  t‐test was 
utilised to ascertain the effect of NMES on muscle force over the study time period.  
 
Muscle  architecture  was  measured  via  2D  ultrasonography.  Small  subject  numbers  resulted  in 
descriptive and graphical presentation of data  to demonstrate main  findings. T‐tests were used  to 
assess the level of change, however the small sample size resulted in wide confidence intervals and 
caution  is  required when  using  statistical  analysis.  The  relationship  between  pennation  angle  and 
 185 
 
Gastrocnemius MIFP was  investigated  via  graphs,  to  understand whether  the  results  in  this  study 
reflect  findings  from  strength  training  literature.  A  small  relationship  was  identified  which  is 









of  the  primary  goals  of  physiotherapy  post  stroke  is  to  improve  the  ability  to walk,  and  thus  the 
ability of NMES to  influence walking ability  is vital  to consider  in order  to  justify  further studies  in 
this  field.  Odds  ratios  were  used  to  interpret  the  effect  of  NMES  on  walking  ability.  Odds  ratio 














stroke ward at Aintree University Hospital.  Strict  inclusion criteria within  the 9‐month  recruitment 
period  prevented  the  last  participant  being  recruited.  Six  participants  completed  the  trial:  one 
withdrew due to constant neuralgic pain, one due to being unhappy with control arm allocation, and 
the third passed away before study completion (unrelated to study‐ pulmonary embolism). Of those 

































A  CONSORT  diagram  was  produced  based  on  guidelines  from  the  CONSORT  statement  (Schulz, 
Altman  et  al.  2010)  and  displayed  in  table  6.2.  Total  number  of  participants  screened  for  study 
enrolled was  high  in  comparison  to  the  number  recruited.  The  participants  not meeting  inclusion 


































1  T  64 (M)  R LAC 
3  T  75 (F)  R PAC 
4  T  79 (F)  L MCA 
7  T  49 (M)  R MCA 
2  C  54 (M)  R MCA 
5  C  69 (F)  L MCA 
6  C  74 (F)  R TAC 
8  C  69 (M)  R PAC 








67.4  years.  The  distribution  between  treatment  and  control  group  is  relatively  evenly  distributed, 
with the two youngest participants split between groups. A variety of types of stroke were recruited, 
with  the majority  of  participants  suffering  a medial  cerebral  artery  stroke  (MCA).  The majority  of 
strokes were right sided (N=7).  
 



























































Raw data of  volitional MIFP  throughout  the  study  is  presented  in  table  6.5.   When  looking  at  the 
quadriceps femoris both participant 1 (T) and 8 (C) were not able to produce any force throughout 
the duration of the study. The  largest  increase  in quadriceps force (19Nm) was demonstrated by a 
control participant; participant 2. Participant 2 suffered from spasticity in the hip flexors throughout 
study participation. This was followed by an increase of 4.2Nm and 7.5Nm for participant 3 (T) and 4 






treatment  participants  produced  a  mean  increase  of  4.2  Nm  of  quadriceps  force,  whereas  the 
control participants demonstrated a mean increase of 19 Nm (N=2).   
 
When  observing  changes  in  gastrocnemius MIFP,  participant  3  (T)  shows  the  greatest  increase  in 
force (26 Nm), where the improvement was obtained reasonably equally between both half’s of the 
study  (14Nm  in  first  3 weeks,  12Nm  in  second  3 weeks).  Participant  4  (T)  demonstrated  the  next 
highest  increase  (19.7Nm)  however  the majority  of  the  increase  (16Nm) was  obtained within  the 
second 3 weeks of  the study. Although demonstrating 19Nm of quadriceps  force, participant 2  (C) 
was  only  able  to  produce  2.6Nm worth  of  gastrocnemius  force  within  the  6  week  period.  Again, 
participant 1 and 8 did not show any signs of volitional muscle activity throughout the study. Mean 






   Pre  3wk  Post  Change  Pre  3wk  Post  Change 
1 (T)  0  0  0  0  0  0  0  0 
3 (T)  0  1.5  4.2  4.2  0  14  26  26 
4 (T)  0.4  3.5  7.5  7.1  1.3  6  21  19.7 
7 (T)  0  1.8  1.5  1.5  0  5  8.2  8.2 
2 (C)  0  13  19  19  0  1.1  2.6  2.6 



























































































Quadriceps  Pre‐Post  0.133  ‐8.18  1.78 




Stimulation  with  NMES  was  applied  with  maximal  tolerated  stimulation  intensity.  The  mean 
stimulation intensity utilised by each treatment participant is provided in table 6.7. A small range of 
mean  stimulation  intensities  were  demonstrated  (65‐76  ma),  with  small  associated  standard 
deviations.  This  implies  that  participants  were  able  to  adjust  to  stimulation  protocols  well. 
Participant  1  stimulated with  the  highest  intensity,  however  did  not  produce  a  force  output with 
either muscle  tested.  He was  the  only  participant  to  reach  the  highest  intensity  available  on  the 


















period  (6‐weeks)  by  2D  ultrasonography.  No  problems  with  measurement  protocols  were 
encountered during testing. Ease of measurement was enhanced if the participant was sitting in the 
leg  measurement  device  (LMD),  due  to  advantages  in  probe  alignment  and  limb  position. 
Measurements  of  subcutaneous  adipose  layer  and  pennation  angle  have  been  reported.  Images 




and  post  measurements  were  not  significant  (P=0.847  95%  CI  ‐2.49‐0.28)  indicating  that  the 
treatment  protocol  with  NMES  did  not  influence  the  subcutaneous  adipose  layer.  The  largest 
increase (0.3 mm) was witnessed in participant 1 (T), who did not respond to changes in force as a 
result of treatment. The biggest decrease in subcutaneous adipose layer (0.2 mm) was produced by 
participant 3  (T),  indicating  that NMES may have  influenced changes  in  lower  limb architecture.  It 








Raw  data  of  the  lateral  head  of  gastrocnemius  pennation  angle  is  displayed  in  table  6.8  for  all 
participants. All participants bar one increased pennation angle at study completion. Participant 1 (T) 
displayed  the  greatest  increase  in  pennation  angle, which was  equally  distributed  to  6  degrees  in 
both  halves  of  the  testing  duration.  Participant  8  (C)  produced  the  next  highest  increase  in  angle 
(6.6°); note that both these participants did not regain any force in either muscle group. Participant 
2 (C) was the only participant to show a decline in pennation angle (1.1°). Participant 7 received an 





   Pre  3wk  Post  Increase 
1 (T)  11.0  17.4  22.3  11.3 
3 (T)  12.2  13.3  16.2  4.0 
4 (T)  16.3  17.2  18.2  1.9 
7 (T)  13.4  14.0  17.0  3.6 
2 (C)  15.1  13.0  14.0  ‐1.1 









2.7°.  Participant  8  had  the  lowest  baseline pennation  angle, which was  10.6°  lower  than  the next 








Linear  regression  analysis  in  indicates  that  pennation  angle  is  shown  to  decrease  in  control 
participants (b1= ‐2.45). The clinical implications of this must be reflected upon; and the effect of the 
botulinum  toxin  in  a  treatment  participant  must  be  taken  into  consideration.  The  difference 













































angle  of  the muscle  fibers made measurement  difficult, which was  heightened  by  atrophy  in  this 








Half  of  the  participants  were  randomized  to  receive  an  MRI  scan  to  measure  muscle  volume  at 
recruitment.  Of  those  who  had  an  MRI  scan  at  baseline  (N=4),  two  had  a  6‐week  week  scan  at 

















perform  the  test  at  baseline,  due  to  inclusion  criteria preventing  the ability  to mobilize.  Table 6.9 
 199 
 
outlines  participants who were  able  to  conduct  the  test  at  the  completion  of  study  participation. 
Participant  1  and  8  were  unable  to  perform  the  test  at  6‐weeks,  however  all  other  participants 
completed the test. The mean time of completion for the treatment participants was 15.5 seconds, 1 



















Due  to  the  varying  nature  of  stroke  the  functional  changes  experienced  by  each  participant were 
considered on an  individual basis. Table 6.10 demonstrates the main functional changes witnessed 






































































































































































8)  did  not  demonstrate  change  on  either  questionnaire.  When  comparing  differences  between 
changes  in  both  questionnaires  there  was  a  small  relationship  identified  (R2=0.381),  however 






their  physiotherapy  intervention  is  3  times  more  likely  to  walk  than  somebody  receiving 
physiotherapy alone. The high confidence interval suggests that this method of analysis is reflective 














2  C  6  Hip flexion 
3  T  5   
4  T  6   











Maximal  isometric  force  production  (MIFP) was measured  in  the  leg measurement  device  (LMD). 
Interestingly the control group increased quadriceps force more than the treatment group, however 
this  was  confounded  by  the  control  sample  size  (N=1)  and  hip  flexor  spasticity  in  the  control 
participant. Gastrocnemius MIFP increased more in treatment participants than control participants, 
and  a  proportional  relationship  was  identified  between  the  two  muscles;  those  who  increased 
quadriceps MIFP also  increased gastrocnemius MIFP. All participants stimulated both muscles with 





When  considering  muscle  architecture  of  the  lateral  head  of  gastrocnemius  some  interesting 
observations  were  noted.  There  was  some  indication  that  the  NMES  protocol  influenced 
subcutaneous adipose layer, however the effect was greater when considering pennation angle. The 
participant  to  decrease  subcutaneous  adipose  layer  with  the  highest  value  was  in  the  treatment 
group.  There  was  a  larger  increase  in  pennation  angle  in  the  treatment  group  compared  to  the 
control  group,  suggesting  that  NMES  produced  adaptations  in  muscle  architecture.  Interestingly 
participant  1  produced  the  greatest  increase  in  pennation  angle,  however  did  not  demonstrate 
restoration of muscle strength. This suggests that NMES is able to improve internal muscle structure 
without volitional control of the muscle. Participant 8 was a control participant who also increased 
pennation  angle,  but  to  a  lesser  extent,  indicating  that  physiotherapy  has  the  ability  to  cause 





The  timed  up  and  go  test  was  shorter  in  the  treatment  participants  compared  to  the  control 
participant,  indicating that the control group improved gait speed more than the treatment group. 
The  sample  size  in  the  control  group  (N=1)  and  young  age  must  be  considered  here.  Four 
participants re‐gained the ability to walk after treatment with NMES; 3 treatment participants and 1 
control participant. This equated to a participant in the treatment group being 6 times more likely to 













































well  as  force  producing  capability  provides  a  greater  understanding  of  the  effects  of  a  NMES 
treatment protocol on skeletal muscle. Prevention of acute disuse atrophy as a result of post‐stroke 
forced  inactivity would enable  rehabilitation programmes  to progress  in a quicker  time  scale.  This 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study  was  successful  in  working  with  physiotherapists  to  incorporate  NMES  into  rehabilitation 
programmes.   
 
Participants were approached  to  take part  in  this  study once  they had been screened  for  relevant 
inclusion and exclusion criteria. Consultant opinion was critical  in determining whether the patient 
was  likely  to maintain medical  stability  throughout  the  study.  This  was  one  of  the more  difficult 
inclusion  criteria  to  fulfil,  as many  acute  stroke patients  have  co‐existing medical  problems  in  the 
acute  phase  of  hospitalization  (Diederichs, Muhlenbruch  et  al.  2011).  Awaiting medical  clearance 
often resulted in an extension beyond our 2‐6 week post stroke timescale.  
 
Medical  status  is  often  difficult  to  predict  in  the  acute  phase  of  hospitalization,  which  was 
highlighted by the withdrawal of participant 9 (passed away as a result of a pulmonary embolism). 




Another  inclusion  criterion  that  was  challenging  during  the  recruitment  process  was  severity  of 
stroke.  All  patients who  entered  the  acute  stroke ward were  screened  for  participation,  however 
many were  too  independent post  stroke  to  fulfil  criteria. As many patients as possible  (those who 
were  admitted  in  the  relevant  timescale,  and  those  who  consented)  were  thrombolysed  on 
admission to the unit. This was conducted in line with a research study that was running alongside 
this  study.  Some  patients  demonstrated  recovery  of  symptoms  through  re‐absorption  of  oedema 
and  haemorrhage  as  a  result  of  the  thrombolysis  (Ahmed,  Kellert  et  al.  2013),  resulting  in  a 
functional ability that excluded them from participation in this study. The recruitment period had to 
be extended as  a  result  of  these  issues.  Extension was however  limited due  to  funding  restraints, 
 206 
 
which  limited  the  number  of  participants  recruited.  Recruitment  resulted  in  9  participants 
consenting to take part in the study. All participants who were approached and maintained medical 
stability throughout the recruitment process (approximately three days once all relevant parties had 




Research  in  an  acute  medical  setting  runs  a  high  risk  of  participant  drop  out.  This  is  especially 
evident in a population such as stroke due to the advanced risk of acute medical conditions whilst in 
inpatient care. Three participants were lost throughout this study, which impacted an already small 
sample  in  terms  of  analysis.  The  withdrawal  in  all  three  participants  was  unrelated  to  the  study 

















Participant  9  passed  away  during  the  6‐week  period.  The  medical  condition  of  this  patient 
deteriorated  with  prolonged  bed  rest,  a  risk  that  is  unavoidable  in  acute  medical  research. 







were  encountered.  A  design  modification  was  employed  early  on  in  the  recruitment  process  to 
enable easier positioning of participants  into  the device. The sitting plate was extracted  to enable 
the  device  to  be  positioned  underneath  the  participant’s  femur without moving  them  from  their 
sitting  position.  This  was  necessary  as  the  level  of  stroke  severity  often  required  hoisting  the 
participant out of their chair to be positioned for the study. This was not always possible due to the 
number  of  staff  required  for  manual  handling  purposes.  The  changes  were  effective  at  easing 
positioning  of  the  patient,  however  contributed  to  a  reduction  in  positional  stability.  The  LMD 
remained  in  contact  with  the  chair,  and  this  sacrifice  was  deemed  necessary  for  completion  of 
outcome  measure  testing.  In  participants  with  a  flaccid  limb  presentation,  pillows  were  used  to 
maintain  the  leg  in  a  stable position.  Participants  reported  that  they  found  the  LMD comfortable, 
and the majority of participants enjoyed having their limb in a stable position. The portability of the 
LMD meant that we were able to transfer it in a car, to the hospital and between patient beds. It was 
also wipe  clean  in order  to adhere  to  infection  control policies. Both of  these  issues made  its use 
practical,  effective  and  easy  to  setup  in  an  acute  ward  environment.  Once  transferred  onto  a 






Participant  feedback  with  regard  to  the  sensation  associated  with  NMES  was  positive.  All 
participants  who  completed  the  study  were  comfortable  with  the  stimulation,  and  reported  that 
they  liked  seeing  their muscles  contracting,  when many were  unable  to  perform  this  volitionally. 
From  a  psychological  perspective,  this  was  important  to  maintain  their  motivational  levels  to 
participate  in  rehabilitation  protocols. Many  stroke  patients  find  it  difficult  to  accept  the  effect  a 
stroke has on their lifestyle, with the possibility that their functional independence may not be equal 
to  their  pre‐stroke  level  (Allan,  Rowan  et  al.  2013).  Upon  recruitment  into  the  study  many 
participants were apprehensive about the sensation of the stimulation. The acclimatisation session 
was  effective  at  reducing  any  anxiety,  and  allowed  participants  to  better  understand  what  the 
treatment  entailed.  Research  also  indicates  that  enhanced  stimulation  intensity  maximises  force 
output from the muscle, indicating the importance to acclimatise to the sensation (Stevens‐Lapsley, 
Balter  et  al.  2012).  Investigation  as  to  the  effects  of  the  stimulation  intensity  used  to  administer 
NMES  within  neurological  rehabilitation  is  still  to  be  conducted.  The  acclimatisation  session  also 
ensured that the participant had time to gain trust in the researcher, and that they would approach 
the application of NMES in a progressive manner.  By the end of the study all participants reported 
that  they would be happy  for NMES to be administered as part of  standard physiotherapy.   Along 
with  the effects on  the neuromuscular  system,  this  is  the most  important outcome of  this  trial.  If 




administered  on  an  acute  stroke  unit;  is  the  LMD  practical  and  accurate  when  testing  muscle 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strength  on  a  hospital  ward;  and  finally  can muscle  architecture  accurately  be measured  to  infer 
strength  gains  in  this  population.  Rationale  for  testing on  a  large population  is  limited  and  thus  a 
small  sample  size was deemed  sufficient  to  address  these primary  goals.  The  small  sample  is  also 
reflective of the funding available to conduct this study, and reflects the practical ability to recruit in 
a limited time period. A larger sample size would have enabled more statistical rigor when inferring 
from  results,  especially  given  the  high  probability  of  complications  that  result  in  an  acute 
neurological population. This was especially evident in the control group of this study (N=2), which 
demanded individual consideration of results. However, acknowledgement in the literature has been 
provided  that  feasibility and  logistical  implications often prevent appropriately  sized samples  from 
being  tested  (Tan,  Machin  et  al.  2012).  This  study  adopted  a  randomised  controlled  trial  (RCT) 
design, despite a small targeted sample size. A control group was deemed necessary to ascertain the 










more accurate and  repeatable due  to  its design. Participants were  tolerant and compliant with all 
study measurements. The participant was positioned in the LMD whilst measurements were taken, 
to  standardise  joint  position  and  the  gravitational  effects  on  flaccid  limbs.  The  small  sample  size 
made measurements  vital  to  obtain  if medically  and  practically  possible. Measurement  of muscle 
architecture  with  ultrasonography  was  also  conducted  in  the  LMD  to  maintain  a  standard  limb 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Neurological rehabilitation  is  fundamentally governed by maximising functional  independence. The 
ability  to  relate  the  results  to  functional  ability was  therefore paramount  in  achieving  the aims of 
this  study.  Lower  limb  rehabilitation  has  a  strong  associated with walking  ability,  as  the  ability  to 
mobilise dictates functional independence. Participants 3, 4 and 7 were all treatment subjects who 
demonstrated an improvement of walking ability. It is difficult to ascertain the probability of walking 
from  the  treatment group  compared  to  the  control  group,  as  the  randomisations were not equal, 
however odds ratio calculation indicates that a participant in the treatment group was 3 times more 
likely to walk than a control participant. Although the sample for using odds ratio analysis is small we 
feel  it  is  justified.  It  enables  probability  of  one  of  the  primary  goals  of  rehabilitation  to  be 
highlighted, and thus provides evidence  for a  larger  trial  to be conducted  (Schechtman 2002). The 








capability.  He  presented  with  a  dense  hemiplegia,  and  was  discharged  not  long  after  study 
completion  (2 weeks  after) walking with  a  stick.  Participant  7 was  the  youngest participant  in  the 
study  (49  years),  who  suffered  a  right  middle  cerebral  artery  stroke.  Neuroimaging  of  the  brain 
during  rehabilitation  is  creating  a  novel  insight  as  to  how  the  cortical  brain  reorganises  after 
neurological  insult.  Interestingly activated areas  in  the motor cortex are higher  in aged  individuals 
compared  to  a  younger  counter‐part,  suggesting  that  compensatory  actions  commonly  occur  in 




cardiovascular health  is  often  thought  to be  risk  factors  for  stroke  (Roger, Go et  al.  2011) making 
these  patients  vulnerable  to  a  longer  rehabilitation  period.    Participant  7  may  have  utilised 
compensation mechanisms or had a larger cognitive reserve due to his age; a larger amount of intact 
neurones that had not been effected by ageing pathology before the stroke (Scarmeas, Zarahn et al. 
2003). This  reserve of  function may have contributed  to  the  rapid advances  in walking ability  that 
were gained.  
 
Research  into mechanisms involved  in human locomotion  is developing, with the understanding of 
central pattern generators (CPG). CPG’s are a collection of neurones found at spinal cord level that 
combine to form a reflex that can be used to produce patterns of movement, such as gait (Grillner 





the activity of  the  spinal  reflex  is  thought  to be altered  (Dietz 2003).  This  interrupts processing of 
afferent  information  and  consequently  results  in  impaired  locomotion.  Restoration  of  this 
mechanism through exercise repetition has been documented as a potential mechanism responsible 
for  increased  function,  with  an  associated  increase  in  neurotransmitter  activity  (Marder,  Bucher 
2001).  This  suggests  that  rehabilitation  with  the  aim  of  developing  the  timing  of  associated 
movement reflex patterns will help to achieve functional  improvements  in performance. Motor re‐
learning  approaches  to  stroke  rehabilitation,  aid  this  process  (Langhammer,  Stanghelle  2000). 
Results  in  this  study  indicate  that  NMES  has  a  positive  effect  on  walking  ability.  Repetitive 
stimulation of afferent pathways that have been damaged during the stroke may result in a quicker 
recovery period. Inclusion of NMES into a physiotherapy treatment protocol would therefore reduce 






(54),  indicating  that  his  cognitive  reserve  may  have  enabled  him  to  progress  faster  with 
rehabilitation. Muscle spasticity was evident  in hip flexors and plantarflexors, although not directly 
measured  in  this  study  (concluded  by  consultant  opinion).  Spasticity  is  recently  thought  to  be  a 
transient  increase  in  muscle  tonicity,  to  which  the  incidence  declines  with  chronicity  (Bakheit, 
Fheodoroff  et  al.  2011).  Interestingly  plantarflexor  spasticity  has  been  shown  to  be  an  active 
restraint to dorsiflexor activity, contributing to their weakness. Dorsiflexors have been identified as a 





in  the  unaffected  arm.  It  may  be  that  the  dorsiflexors  of  this  participant  were  weak,  reducing 
stability during gait  (de Niet, Weerdesteyn et al. 2013); however the ability to compensate for this 
was  aided  by  his  age.  A  larger  sample  of  control  participants  is  required  ascertain  the  effects  of 




The aim of treatment with NMES  in this study was to demonstrate  improvements  in the voluntary 
force capability of muscle; measured via maximal isometric force production (MIFP). All participants 
who  regained  ability  to  generate  force  demonstrated  improvements  in  quadriceps  and 
gastrocnemius  force  production.  Interestingly  the  participant  who  demonstrated  greatest 
quadriceps  improvement  (19 Nm) was  in  the  control  group  (participant  2).  Although  showing  the 
greatest  increase  in  quadriceps muscle  force,  this  participant  demonstrated  little  improvement  in 
volitional  gastrocnemius  muscle  force  (2.6  Nm  over  6  weeks).  Although  activation  of  proximal 
muscles  tends  to  occur  before  distal  muscles,  the  vast  difference  indicates  that  the  quadriceps 





compensation  that  cannot  be  eliminated  for  research  purposes  via  the  LMD.  The  individuality  of 
symptom presentation in stroke patients would assume variation in results making testing of a larger 
sample  difficult,  and  therefore  indicates  that  individual  analysis  is  required.  Additional  testing  of 







Participant 7 was the participant to demonstrate  functional  improvement within the quickest  time 
period  (2  weeks).  The  increase  in  strength  of  both  muscles  was  the  lowest  of  the  treatment 
participants. As previously discussed,  the age of  this participant may be  reflective of an enhanced 
ability to restore pre‐learnt functional movement patterns. However the ability of this participant to 
ambulate  implies  that  the  level  of  force  required  to  walk  has  been met.  Threshold  of  functional 
muscle activation has been touched upon in a frail population, however only three studies are able 
to  guide  practice  (Fujita,  Kanehisa  et  al.  2011).  The  ability  to  transfer  this  finding  to  neurological 
recovery  has  not  been  investigated  on  completion  of  this  thesis.  The  level  of  isometric  torque 
required  to  perform  functional  daily  tasks  in  an  elderly  population  has  been  estimated  at  3  Nm, 
below  which  function  is  anticipated  to  reduce  (Ploutz‐Snyder,  Manini  et  al.  2002).  Interestingly 
participant 7 only achieved a maximum of 1.8 Nm of quadriceps force, which is below the threshold 
currently  indicated  for  functional  activity.  It  may  be  that  compensations  allowed  function  to  be 
achieved or that instruction as to the movement required for assessment could have been improved. 
More  time  spent  ensuring  outcome measures were  assessed  in  an  accurate  fashion  is  important, 
especially given possibility of damaged cognitive function and therefore understanding as a result of 
the  stroke.  Threshold  for  gastrocnemius  function  has  not  been  investigated.  Understanding  of  its 








to  correlate  with  improvements  in  muscle  strength  (Aagaard,  Andersen  et  al.  2001).  Although 
correlations  in  healthy  human muscle  have  been  observed,  little  research  has  been  conducted  in 
neurological impaired populations, and even less so in a stroke population (Gao, Grant et al. 2009). 
Research  into  muscle  architecture  in  stroke  has  focused  on  chronic  patients,  with  the  aim  of 
addressing the rate of atrophy. Investigation into pennation angle in this study therefore provides an 
insight  as  to  how  the  muscle  adapts  to  NMES  in  an  acute  time  period.  Pennation  angle  was 
demonstrated to increase more in treatment participants than control participants; which correlates 
with changes in maximal isometric force production (MIFP). This suggests that treatment with NMES 
demonstrated  changes  in muscle  architecture,  as  opposed  to  changes  in  neuromuscular  function. 
During  hypertrophy  of  skeletal  muscle,  satellite  cells  are  activated  to  formulate  and  regenerate 
muscle  fibres  (McCarthy, Mula et al. 2011). The  resultant  increase  in muscle  related proteins, and 
the  addition  of  sarcomeres  in  parallel  increases  the  physiological  cross  sectional  area  of  muscle 





at  the  end  of  the  study  than  when  he  enrolled  in  the  study.  However,  participant  1  did  not 
demonstrate any improvement in either quadriceps or gastrocnemius volitional force. A flaccid limb 
presentation was present throughout the testing period, with dependence on others for activities of 
daily  living.  Allocation  to  the  treatment  group  resulted  in  this  participant  receiving  6  weeks  of 
stimulation  with  NMES.  This  indicates  that  NMES  was  able  to  produce  improvements  in  internal 






be  that  this  increase  in pennation angle  is a vital aspect of  recovery,  resulting  in  the ability of  the 
muscle to contract if some functional capability were to be restored. Prevention of muscle atrophy 
in  this  acute  period  would  enable  rehabilitation  to  focus  on  functional  gains,  thus  decreasing 
rehabilitation time scales.  
 
Participant  8  (control  group)  also  demonstrated  an  increase  in  pennation  angle  over  the  6  week 
testing period despite no volitional muscle capability. The  increase was smaller  than participant 1, 
and  therefore  measurement  error  cannot  be  eliminated.  Further  reliability  testing  of  pennation 
angle  measurement  is  required  for  confirmation  of  this.  The  assumption  that  changes  in  muscle 
architecture  witnessed  in  control  participants  are  a  result  of  physiotherapy  input  cannot  be 
disregarded. Although muscle  contraction was not  initiated,  activation of  damaged  afferent  nerve 
pathways has been  shown  to be  initiated as  a  result  of  contralateral  limb movement  (Michielsen, 
Smits  et  al.  2011).  However,  the  activation  of  nerve  pathways  in  stroke  survivors  has  not  been 




this  small  sample.  The  knowledge  of  how  spasticity  affects  muscle  architectural  changes  on 
ultrasonography has not been fully explored. Research has been conducted in children with cerebral 
palsy,  indicating that fascicle  length  is shortened in children with spasticity (Shortland, Harris et al. 
2002).  Limited  research  has  been  conducted  using  pennation  angle  as  an  outcome  measure  in 
stroke, however it is suggested that smaller pennation angles may be indicative of fascicular tension 
as a result of spasticity  (Gao, Grant et al. 2009). Participant 2  (control) was the only participant  to 
decrease pennation  angle,  despite making  functional  changes over  the 6‐week monitoring period. 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Spasticity  of  the  gastrocnemius  was  documented  in  the  medical  notes  of  this  participant,  and 
although he did not receive treatment, the spasticity may have been responsible for the decrease in 
















and needles  in his quadriceps  femoris during  the  stimulation.  The  change  in  sensation progressed 
over the remaining 4 weeks to being able to fully feel the sensation when stimulating both muscles. 










motor  control and movement ability  in  chronic  stroke patients  (M.Dimitrijevic,  Stokie et al. 1996), 
demonstrating  the  ability  of  NMES  to  influence  multiple  functions.  The  repetitive  nature  of 
treatment with  NMES  could  result  in  a  process  known  as  sensitization.  Sensitization  is  a  learning 
response whereby a response to stimuli strengthens or amplifies (Shumway‐Cook, Woollacott 2007). 




a  greater  population  until  further  research  has  been  conducted  to  test  the  effect  of  NMES  on 




Functional  ability  of  participants  was  monitored  via  a  timed  up  and  go  test  and  functional 
questionnaires.  Statistical  analysis  of  functional  ability  was  difficult  to  perform  due  to  individual 
symptom presentation affecting outcome. Functional ability was therefore assessed on an individual 
basis. All treatment participants (except one) were able to be measured in the timed up and go test 




in  stroke  patients  (Ng,  Hui‐Chan  2005);  however  the  effect  of  age  on  the  test  has  not  been 
established  to date.  The age of  this participant must be  taken  into  consideration which may have 





treatment  effects  with  NMES  has  little  solid  link  to  improvements  in  functional  ability  in  stroke 
patients. A larger RCT with a primary goal of assessing functional ability should be conducted. NMES 








This  study  highlights  that  NMES  is  able  to  be  administered  on  an  acute  stroke  ward,  and  was 
accepted by  the clinical  staff. Both medical and physiotherapy staff were  tolerant of  the  research 
study,  and  took  time  to  assist with  study  processes.  Incorporation  of  NMES  into  an  acute  clinical 
setting  requires  acceptance  from  the multidisciplinary  team  in  order  for  its  use  to  be  effectively 
integrated  into  existing  protocols.  This  study  provides  a  further  step  towards  achieving  this  aim. 
Both the LMD and the ultrasound were measurement devices that had to ability to be used in an 
acute  clinical  setting with  little  disruption.  Both  devices were  accepted by  participants  and  staff, 




with  NMES  as  an  adjunct  to  physiotherapy  compared  to  physiotherapy  alone. 
Physiotherapy and natural  recovery of  symptoms are  thought  to  increase  the  likelihood of 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walking.  The  goal  of  NMES  would  be  to  decrease  the  rehabilitation  time  that  it  takes  to 
mobilise, with the aim of preventing unwanted deterioration of muscle function. It appears 
that NMES was  effective  in  achieving  this  aim,  and  further  investigation  is warranted  in  a 
larger study. 







voluntary  muscle  strength.  This  indicates  that  NMES  has  the  potential  to  maintain  or 
advance  internal  muscle  structure,  or  force  generating  capacity  in  a  population  who  is 
unable  to  achieve  this  by  volitional  means.  This  would  enable  the  individual  to  have  a 
greater likelihood of functional ability if natural recovery were delayed due to the stroke.   
• Cutaneous  sensation was  restored  in  a  participant who  received  treatment with  NMES. 
Restoration  of  sensation  was  initially  noticed  during  stimulation  sessions,  and  advanced 




The  findings  above  demonstrate  the  potential  of  NMES  for  use  in  an  acute  environment. 
Acknowledgement must  be made  to  the  small  sample  size, which  limits  the  ability  to  confidently 
attribute these findings with treatment. Individual description of participants is often required in this 
population due to the varied nature of clinical presentation. Further investigation on a larger scale is 
required  to  fully  investigate  the  trends  identified  in  this  study.  The  use  of  electromyography  to 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ascertain  effects  on  specific  muscles  would  help  to  develop  the  methodology  used  and  justify 
responses  obtained.  It would  also  be  useful  to  utilise  the  LMD  to  establish  the  effects  on muscle 
contractile properties, to ascertain whether these differ from a healthy elderly population. The time 
the muscle  takes  to  respond  to  a  stimulus may  differ  in  a  neurological  impaired  population.  The 
methodology used has been tested throughout  this  thesis, and the stimulation parameters appear 
effective  in  enhancing muscle  function  in  this  population. Despite  this,  the  response of muscle  to 
NMES  appears  to  vary  both between participants  and within  participants.  The muscle  response  is 
not constant despite a constant stimulus being applied. This indicates that other variable factors may 




















Previous  trials  in  this  thesis  have  investigated  the  use  of NMES  as  a  strength  training modality  in 
different  populations.  The  overriding  aim  of  the  thesis  is  to  treat  people  of  different  ages  and 
pathologies, making  the  conclusions as  clinically  relevant  as possible. When  considering older  and 
younger healthy  adults,  the  six week protocol was  effective  at  increasing maximal  isometric  force 
production  (MIFP):  9  participants  increased MIFP  in  both  age  groups  (n=10). Within  this  increase, 




to  hypertrophic  changes  in  muscle  in  the  initial  stages  of  a  strength  programme,  resulting  in  an 
improved firing rate or number of neurones within  the motor unit. NMES  is accepted to stimulate 
nerve fibres before muscle fibres, as the propagation threshold  is  lower  in neural tissue (Peckham, 
 223 
 
Knutson  2005).  This  supports  a  change  in  neural  control  when  stimulating  with  NMES,  which  is 
reinforced in current literature (Hortobagyi, Maffiuletti 2011).  
 
Changes  in  muscle  morphology  were  witnessed  in  participants  with  Stroke  (pennation  angle 
measured  via  ultrasonography),  despite  1  of  the  treatment  participant’s  not  demonstrating 
improvement  in MIFP.  This  indicates  that muscle  adaptation  is  able  to  occur within  the  six week 
training  period  used  throughout  this  thesis.  Both  studies  indicate  that  NMES  is  able  to  influence 
muscle tissue, with a variety of responses witnessed from participants. This variation of strength gain 




Literature  is  well  established  in  terms  of  how  the  body  responds  to  volitional  exercise  through 
research into blood components (Brancaccio, Maffulli et al. 2007). Research into the use of Creatine 
Kinase (Teixeira, Borges 2012) as a marker of muscle activity after exercise has developed over the 






research  has  been  conducted  on  human  muscle.  Understanding  of  biomarker  adaptation  during 
stimulation  with  NMES  would  be  beneficial  in  understanding  the  variability  of  strength  increase 
witnessed  throughout  previous  studies.  Investigation  into  human muscle’s  biomarker  response  to 
NMES  would  aid  the  understanding  of  mechanisms  involved  during  treatment.  This  level  of 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understanding  is  required  in order  for NMES  to be  accepted  in  the  clinical  community.  This  study 
aims  to  ascertain  the  response  of  healthy  human  muscle  tissue  to  NMES  at  a  cellular  level.  An 
understanding  of  muscle  response  to  treatment  with  NMES  would  highlight  responders,  and 
pharmaceutical  intervention  is  a  future  possibility  to  increase  responder  rates  in  neurological 
rehabilitation.  The  ability  to  identify  responders  to  treatment  would  enable  a  physiotherapist  to 
incorporate NMES into a patient’s rehabilitation program with an increased likelihood of success. 
 
It  is  expected  that  levels  of  CK will  increase  over  the  treatment  period, which would  correlate  to 










Design:  Experimental,  observational  study.  Ethical  approval was  obtained by  Keele University  (see 
appendix 8) 
 






around  the  university  campus.  The  research  team  was  contacted  by  email,  where  a  participant 
information  sheet was  sent  to  the potential participant  (appendix 9). An appointment  to attend a 
testing session was scheduled on expression of interest. 
 



















Lifestyle  questionnaire:  A  questionnaire was  completed  by  the  participant  once  informed  consent 
had  been  obtained  and  the  participant  had  been  screened  for  contraindications.  The  lifestyle 
questionnaire  gave  the  research  team  a  greater  understanding  of  the  participants  nutritional  and 
exercise status over the previous 24 hours. This enabled trends to be identified between deviations 
from normal blood concentration  levels and the participant’s  lifestyle, or allow us  to attribute any 











Testing position: The participant was not  supported  in  the Leg Measurement Device  (LMD) during 
this  study,  as  this would  limit  testing  to  one  participant  at  a  time.  The  LMD was  not  required  to 
extract outcome measures.  It  is not anticipated that  the cellular response would differ  if  isometric 
testing were conducted. Testing was conducted in a sitting position on a standard chair, with the hip 
at  90°  flexion,  and  the  knee  at  60°  flexion.  This  was  measured  by  a  goniometer.  The  ankle  was 
relaxed on  the  floor, or  supported on a  raised box  if necessary  to maintain knee position. Despite 
being instructed to maintain the limb position throughout testing procedures, we cannot be sure of 
exact position throughout  the  full  testing time period. Participants were verbally  instructed  if  they 








electrodes were  set  up on  the participants  right Quadriceps  Femoris.  Electrodes  (50mm X 90mm) 
were placed longitudinally across the muscle belly the first 5cm proximal to the apex of the patella, 
and  the  second  5cm  proximal  and  3cm  lateral  to  this.  This  corresponds  to  electrode  position  in 
previous studies, which was deemed appropriate in producing a strong tetanic contraction (chapter 













stimulation  frequency and pulse width are comparable  to previous  trials. The stimulation on  time, 
and treatment time has increased to maximise any change witnessed.  
 
Stimulation with NMES was not  commenced until  the baseline blood  sample was obtained. NMES 
was delivered over  a  30 minute period.  The parameters used  throughout  the  testing protocol  are 
identified in table 7.1. The participant was verbally introduced to the sensation of NMES, and what 
to expect. Stimulation  intensity was  introduced on the first muscle contraction at an  intensity that 
produced a visual muscle contraction. The value of this varied between participants. The stimulation 
intensity was increased during each contraction until the participant stated that they did not want to 
increase  further.  Constant  feedback  was  utilised  throughout  this  process.  Rapid  increases  were 
made  as  the  participant  became  accustomed  to  the  stimulation.  As  the  muscle  begun  to  show 
evidence of force decline (a visual assessment) the stimulation intensity was increased. This allowed 
the level of visual muscle contraction to be maintained throughout. The main researcher controlled 
the  increase  in stimulation  intensity  in all participants, and therefore aggressiveness  in  its  increase 
was  standardised.  This  study  aimed  to  elicit  a  supra‐maximal  muscle  contraction,  making  it 
imperative to maintain constant stimulation intensity increases as the intervention progressed. The 
participant was  instructed to relax  throughout  the stimulation, and allow the  leg  to respond  if  the 
muscle  contraction  produced movement.  Stimulation  with  NMES  continued  for  30  minutes,  with 


















Once  the  NMES  protocol  had  finished  the  participant  was  instructed  to  remain  seated  for  30 
minutes.  They were asked not  to walk around, or  consume  food or drink  in  this  time period.  This 
would  allow  us  to  investigate whether  any  effects  of  NMES would  carry  over  this  time  frame,  or 
whether any changes identified resumed to their resting levels immediately.  
 
After  30  minutes  rest  and  collection  of  the  final  blood  sample,  the  participant  was  offered 





an  untreated  vacutainer.  The  Vacutainer  contained  separation  gel  allowing  good  separation  of 





their  side.  The  phlebotomist  chose  which  arm  to  draw  blood  from  depending  on  the  venous 
presentation. A tourniquet was used above the venepuncture site (cubital fossa) to enlarge the vein, 
and the participant was asked to make a fist to encourage blood flow. The phlebotomist tapped the 









Labelling  of  samples  allowed  us  to  ascertain  which  participant,  and  which  time  frame  we  were 
analysing. 
 









Our  sole  outcome  measure  throughout  this  study  was  measurement  of  Creatine  Kinase  activity 
through blood assay preparation. All assays were purchased and used as suggested from suppliers. 




The  blood  samples  were  returned  to  room  temperature  immediately  prior  to  analysis.  Assay 
preparation was conducted using Abcam assay ab155901 (Abcam LTD), a colorimetric CK assay kit. 
This  specific  kit  converts  creatine  into  phosphocreatine  and  adenosine  diphosphate  (ADP).  The 
phosphocreatine  and  ADP  generated  react  with  the  CK  enzyme  mix  of  the  assay  kit  to  form  an 
intermediate.  This  creates  a  coloured product with  a high  absorbency  level  (λ  =  450 nm) which  is 
measured by a plate reader. Serum was pipetted in 2µl aliquots into a 96 well plate format. To this 
50µl of assay buffer was added and 48µl of reaction mixture, as per assay protocol. Using a Biotek 
Synergy  2  plate  reader  the  optical  density was measured  at  450 nm  for  each well, with  a  control 
buffer  background  being  taken.  A  CK  calibration was  also  carried  out  on  the  same  96 well  plate, 
using standard CK concentrations of 0, 2, 4, 6, 8 and 10 nm/well, again using a buffer background. A 














Statistical analysis was  limited  in  this  study due  to  the  relatively  low sample size and high  level of 
data  produced.  Statistical  findings  would  not  be  able  to  be  related  to  a  larger  sample  with 
confidence,  and  therefore  is  outside  the  scope  of  this  study.  It  is  acknowledged  that  this  is  a 





stimulation programme with NMES.  Further  division was made based on  response  to  the  lifestyle 
questionnaire; allowing  trends  in data based on current exercise  levels. Exercise  levels were  taken 
into  consideration  based  on  the  wide  range  of  influential  factors  reported  in  literature  that may 
influence results (Brancaccio, Maffulli et al. 2007). Where possible independent T‐tests and analysis 
of  variance  were  performed  to  indicate  any  significant  findings  within  the  time  periods.  Linear 
regression analysis also  indicated direction and rate of change. Results are discussed  in relation to 
percentage  of  baseline  to  show  comparison  based  on  small  changes,  however  actual  values were 
used, as this is deemed more clinically relevant. 
 
Stimulation  intensity  was  compared  to  mean  CK  concentration,  in  attempt  to  help  protocol 
development  based  on  muscle  response  to  NMES.  Stimulation  intensity  was  sub‐divided  into 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Forty  participants  completed  the  testing  procedure, with  no  adverse  events  reported  throughout. 
The  sample  size  for  analysis was  reduced  (N=32)  due  to  unforeseen  problems  extracting  blood  in 
some participants,  and  concentrations  in  some  samples being  too  low  for measurement  from  the 
kinetic  analysis.  Raw  data  is  presented  in  appendix  11.  Results  are  displayed  as  Mean:  Standard 
Deviation (SD).  
 
Participant demographics  are  summarised  in  table 7.2. A  greater number of males were  recruited 











Mean  26.3  1.7  72.5    Number  5  27 
SD  5.9  0.1  11.0         
Table 7.2 Summary of participant demographics 
 















1  3+  Intense  CV/ Power  RT 
2  3+  Moderate  Fitness  Squats 
3  No pattern  None  Fitness  None 
4  1  Light  Fitness  None 
5  1  Moderate  Fitness 
Brisk walking, 
core 
6  3+  Intense  CV/ Fitness  Cricket 
7  3+  Moderate  Power  Core/ RT 
8  3+  Moderate  CV/ Power  Aerobic/ weights 
9  No pattern  None  None  Wii Fit 
10  1/ month  Light  CV  None 
11  3+  Moderate  CV/ Power  Tennis match 
12  No pattern  None  None  Walking 
13  No pattern  Light  CV/ Power  None 
14  No pattern  Light  CV  None 
15  1  Light  Fitness  Walking 
16  No pattern  Moderate  CV  none 
17  3+  Intense  CV  45 min run  
18  3+  Moderate  CV  None 
19  1  Moderate  CV  5 mile walk  
21  3+  Moderate  CV/ Power  Half marathon  
22  3+  Intense  CV/ Power  RT 
24  1  Moderate  Fitness  Football match 
25  1  Moderate  Fitness  Running 
26  1  Moderate  Fitness  None 
27  3+  Intense  CV/ Fitness  None 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30  No pattern  None  Fitness  Walking 
31  1  Moderate  Fitness  Walking 
32  No pattern  Light  Fitness  UL RT 
33  3+  Intense  CV/ fitness  Martial Arts 
34  3+  Intense  CV/ Power  Running 
Table 7.3 Information from lifestyle questionnaire 
 
The  lifestyle  questionnaire  documented  ‘any  exercise  conducted  in  the  last  48  hours’,  which 
demonstrated a range of activities ranging from no exercise to having ran a half marathon. We asked 
















As  can  be  seen  from  table  7.4,  25%  of  participants  self‐reported  partaking  in  an  intense  level  of 
exercise,  and  16%  reported  not  taking  part  in  any  exercise.  The  majority  of  participants  (41%) 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reported  taking  part  in moderate  exercise.  This  information  will  be  used  in  conjunction  with  the 























Graph  7.1  presents  the  calibration  curve  constructed  for  CK  analysis,  demonstrating  linearity  and 











Baseline CK will be  referred  to as CK‐A. Analysis of baseline blood samples allowed comparison  to 
literature  in  terms of concentrations extracted and to establish a baseline  to  reference other  time 








Min  Max  Mean  SD 
CK‐A  27  0.33  5.01  0.83  0.86 
Table 7.6 Descriptive vales for CK at baseline (nmol/min/ml) 
 
Concentrations  were  considered  in  relation  to  self‐reported  exercise  levels  on  the  lifestyle 


























Descriptive  statistics  were  conducted  on  participants  with whom we  had  a  full  data  set  of  blood 
samples  for analysis  (table 7.6). These  indicate that a greater portion of our cohort participated  in 
regular exercise (N=21) than those who do not (N=6). Mean values indicate that those who partake 
in  regular  exercise  have  a  greater  baseline  CK  value  than  those  who  do  not  (0.21  nmol/min/ml 







No Exercise  6  0.33  1.24  0.66  0.32 














No Exercise  16  0.33  1.24  0.67  0.24 




Table 7.7  indicates  that baseline CK  levels  are higher  in  those who exercised  in  the past 48 hours 
(0.43 nmol/min/ml higher), which is 0.22 nmol/min/ml higher than those who report taking part in 







is  high  (SD  1.33  nmol/min/ml)  compared  to  that  in  the  group  who  have  not  exercised  (SD  0.24 
nmol/min/ml).  Confidence  intervals  indicate  that  there  is  variation within  the  dataset,  specifically 
















Analysis  of  the  treatment  programme  on  CK  activity  during  the  first  15  minutes  of  intervention 



















Despite clearly showing a decrease  in concentration over  the  first 15 minutes of  intervention with 
NMES, CK concentration displays some variability between the two time points. The SD for mean CK 
concentration is much larger at baseline compared to 15 minutes into treatment (0.57 nmol/min/ml 



























When  considering  self‐reported  exercise,  CK  concentration  levels  demonstrate  an  increase  when 

















Mean   0.67  0.66  0.68  0.64 





whereas  those  who  exercised  increased  0.01  nmol/min/ml.  The  scale  of  this  difference  does  not 











0.01  nmol/min/ml  lower).  At  15  minutes  into  treatment  CK  concentrations  are  higher  in  the  no 






         
   Time 







Mean   0.66  0.67  0.63  0.7 












either  general  exercise  or  exercise  conducted  in  the  previous  48  hours.  Other  influential 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characteristics  such  as  stimulation  intensity may have  impacted  the  response of muscle  to NMES. 
When looking at rate of change in the first 15 minutes of treatment based on stimulation intensity, 
we were able to  identify some trends (graph 7.8). Those that used a  low stimulation  intensity  (20‐
35ma) demonstrated a decline in CK concentration, and those who utilised a moderate stimulation 
intensity  (36‐50ma)  demonstrated  a  rise  in  CK  concentration.  The  finding  was  not  significant  on 
conducting an  independent samples  t‐test  (P= 0.259, CI  ‐0.1757—0.00501). However  this  indicates 
that a relationship exists between the two factors: the higher the stimulation intensity, the greater 
the  response  from  the  muscle.  When  considering  the  participant  who  used  a  high  stimulation 
intensity (n=1, participant 30, 52ma) a rise  in CK concentration was observed. Participant 30 was a 











Investigation  of  CK  activity  during  the  second  half  of  the  30  minute  treatment  period  compared 
blood  sample  CK‐B  (15  minutes)  and  blood  sample  CK‐C  (after  30  minutes).  This  allowed  us  to 







































   15  15  30  30 
 Exercise 48  Exercise  No Exercise  Exercise  No Exercise 
Mean   0.63  0.7  0.64  0.58 





















from actual  values. When  comparing CK‐B  and CK‐C  (the  final  15 minutes of  treatment)  based on 
exercise  in  the  previous  48  hours,  linear  regression  indicates  a  rise  in  CK  concentration,  and  a  b1 
value of 6.457. When producing error bars to visualise the difference, as shown by graph 7.12 mean 
CK  concentration  reduces  less  in  those  who  have  exercised  when  the  data  is  expressed  as  a 
percentage, and more in those who have exercised when expressed as actual values. Given our small 



























There  is  a  large SD  for CK‐D,  indicating  some variation  in our data  set  (graph 7.13). When  looking 
more specifically  for differences  in CK‐D participant 21 had a CK value of 5.77 nmol/min/ml. Once 
data  for  this  participant  was  removed  the  SD  reduced  to  0.19.  Participant  21  was  a  28  year  old 
British male, who ran a half marathon the previous day. He had also consumed a protein shake less 










with  NMES.  Both  groups  demonstrate  an  increase  of  CK  concentration  in  the  exercise  group 










The  greatest  increase  in  CK  concentration  between  time  points  was  witnessed  in  the  general 
exercise  category,  in  the  no  exercise  group  with  an  increase  of  0.2  nmol/min/ml.  This  is  0.17 
nmol/min/ml  larger  than  the  increase  demonstrated  in  the  exercise  sub‐category  of  the  general 
exercise group. When comparing changes over time, the no exercise group saw a 0.13 nmol/min/ml 
increase in the exercise general group, and the exercise group saw a 0.05 nmol/min/ml increase in 








Exercise    0.62 (0.22)  0.7 (0.15)    Exercise    0.64 (0.23)  0.67 (0.15) 







Linear  regression  analysis  indicates  some  variability  in  response  to  CK  concentration  after  a  30 


















values  ranged  from 21ma‐63ma.  Sensation produced  from NMES varies  in  individuals,  and  can be 
dependent on electrode adherence to skin, level of subcutaneous adipose tissue, and pain receptors 
(Baker, Wederich  et  al.  2000).  This  is  something  that  cannot  be  accounted  for  when  designing  a 
study, however must be considered throughout analysis. Intensity has been considered in three sub‐









20‐35  Low  10  0.59  0.2 
36‐40  Moderate  11  0.85  0.8 
51+  High  2  0.66  0.3 
Table 7.15 Intensity sub‐groups and relation to CK concentration 
 
From  table  7.15  it  is  evident  that  participants  who  used  a  moderate  intensity  throughout  their 
treatment demonstrated a higher mean CK concentration (69% increase) than those who used a low 
intensity. The  final blood  sample  (60 minutes) of participant 21 was excluded  from analysis  in  the 
moderate group as the value was abnormally high (5.76 nmol/min/ml) affecting interpretation. The 
mean CK concentration decreased  in  those who used a high  intensity  (n=2). The box plot  in graph 





























difference between 0 and 60 minutes  (the  relationship of mean CK concentration over  time) both 
the  low  and  high  stimulation  intensity  groups  demonstrate  increases:  0.01  and  0.3  nmol/min/ml 
respectively.  The  moderate  stimulation  intensity  group  demonstrates  a  decline  of  mean  CK 
concentration  over  time:  0.05  nmol/min/ml.  The  low  stimulation  intensity  sub‐group  is  the  only 
group  to  demonstrate  a  decline  between  0  and  15  minutes  (0.04  nmol/min/ml,  SD  0.19).  The 
moderate  rises by 0.11 nmol/min/ml, however has  the  largest  standard deviation  (0.32).  The high 
sub‐group has no standard deviation value as n=1. All stimulation intensity categories demonstrated 
decline in the 15‐30 minute time period. The moderate sub‐group demonstrated a decline in the 30‐






intensity category  0  15  30  60 
Low  0.62 (0.22)  0.58 (0.19)  0.52 (0.19)  0.63 (0.2) 
Moderate  0.73 (0.28)  0.84 (0.32)  0.78 (0.18)  0.68 (0.18) 




Participant  33  was  excluded  from  analysis,  due  to  the  high  baseline  CK  concentration,  and  its 
influence  in  data  interpretation.  CK  concentration  over  time  is  demonstrated  in  graph  7.18.  The 

















Analysis  of  CK  response  to  treatment  with  NMES  was  conducted  based  on  time  points.  Some 
interesting  findings  were  witnessed  with  relation  to  information  provided  on  the  lifestyle 
questionnaire, primarily exercise levels. At baseline CK response was found to be elevated in those 
who have exercised compared to those who have not. This is the first indication that lifestyle affects 
response  to  NMES. Within  the  first  15 minutes  of  treatment with  NMES  CK  did  not  respond  and 
remained  stable;  however  there  was  variability  within  this  finding.  It  appeared  that  exercise 
correlated to this variability; those who had exercised tended to show decline in CK concentration, 





shown  to  decline,  indicating  the muscle was  being  stimulated  to  produce  energy  for  contraction. 







The aim of  this  study was  to ascertain how Creatine Kinase  (CK)  responds  to a one off  30 minute 
treatment  session with NMES. This would give us an  indication as  to how  the muscle  responds  to 
NMES  in  comparison  to  volitional  exercise.  Commercially  available  assay  preparation  kits  allowed 
extraction  of  enzyme  concentration  with  confidence.  Blood  samples  were  successfully  extracted 
during  the  treatment  programme  with  NMES.  CK  assays  were  prepared  and  analysed  with  no 
problems,  allowing  concentration  levels  at  various  points  through  the  NMES  protocol  to  be 
investigated. This was able to be compared to similar durations of volitional exercise. 
 
Forty  participants  were  initially  recruited;  however  eight  were  excluded  during  the  treatment 
process  and  analysis.  Participation  required  four  blood  samples  to  be  extracted  from  each 
participant. This was verbalised  in  the  initial  recruitment email,  and participants put  forward  their 
interest to take part with this considered. Extraction of blood was more difficult in some participants 
than  others,  due  to  venous  presentation.  This  is  a  confounding  factor  associated  with  blood 
sampling that cannot be avoided. For this reason a trained phlebotomist was used to perform blood 
extractions, instead of training a member of the research team. This experience was deemed vital in 
reducing  the  number  of  participants  excluded  based  on  this  factor.  There  were  also  some 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participants who were  lost during  the analysis process. Kinetic analysis of blood was unable  to be 
performed  in  some preparations.  This  could  be  attributed  to  the  level  of  assay  concentration  not 
being high enough, or the equipment not reading the well in the plate. As each participant had four 
resulting assay readings  for each blood component,  if one was missing  the remaining results were 
carried forward for analysis. This enabled as many results to be utilised in analysis as possible. The 
larger  sample  size  recruited  allows  more  reliable  conclusions  to  be  inferred  from  these  results; 
however  recruitment  of  a  larger  sample  would  have  resulted  in  fewer  encumbrances  placed  on 
assay preparation.  
 
When  recruiting  a  convenience  sample  was  approached,  and  participants  were  recruited  on 
response to an email. The email was distributed amongst staff and students from the health faculty 
of  Keele  University  (Physiotherapy  department).  The  majority  of  participants  recruited  were 
students (staff n=4). This study recruited five female participants. Subjective feedback from female 
participants  was  positive,  with  no  adverse  reactions,  or  negative  comments  surrounding  blood 
extraction or  treatment with NMES. Females were able  to  tolerate NMES protocols  to a  level  that 
resulted in a strong tetanic muscle contraction. Although comparison with male response to NMES is 





extraction and strength  training.  Literature suggests  that both sexes are able  to be conditioned  to 
NMES protocols over  time.  Improved stimulation  tolerance may  influence  the high  failure  rates of 
NMES currently  seen  in  clinical  settings. However males have been  shown  to  tolerate  significantly 
more  stimulation  than  females,  which  has  been  linked  to  gender  differences  in  the  response  to 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noxious  stimuli  (Alon,  Smith  2005).  Females  may  be  adjourned  from  participation  based  on  the 
electrically  induced,  supra‐maximal  contraction  used  to  produce  strength  gains.  Females  are 
accepted to hold more adipose tissue than their male counterparts (Blaak 2001), with a difference in 
distribution  throughout  the  body. Males  tend  to  store  their  fat  in  the  abdominal  viscera  making 
them more at risk of cardiovascular disorders (Lemieux, Despres et al. 1994), whereas females tend 
to  have  a  wider  distribution,  specifically  around  the  gluteal  and  thigh  regions. When  penetrating 
through  adipose  tissue,  NMES  requires  a  higher  stimulation  intensity  to  produce  a  muscle 
contraction  (Baker,  Wederich  et  al.  2000).  The  comfort  of  stimulation  could  be  compromised  in 
female  participants,  making  them  less  likely  to  tolerate  stimulation  compared  to  their  male 
counterparts. Low levels of female participation may be related to the target audience in this study; 
males  may  be  more  amenable  to  participate  in  studies  of  this  nature.  There  has  been  no  link 
established  between  needle  phobia  and  gender  (Deacon,  Abramowitz  2006),  indicating  that  the 
inclusion  of  blood  sampling  should  not  have  influenced  our  sample  recruitment.  The  strong 
connotations  of  masculinity  associated  with  strength  training  remain  (Royce,  Gebelt  et  al.  2003), 
despite multiple  advances  in  female  participation  in  sport.  It must  be  considered  that  the  sample 
approached  may  be  predominantly  males:  therefore  attracting  a  relative  proportion  of  the 
population sampled.  If  conducting a  larger study,  the gender  ratio may be more  likely  to equalise. 
This  study may  be  difficult  to  draw  conclusion  based  on  gender,  and  therefore  results  have  been 
considered with mixed gender. A larger study would be needed to extrapolate this information.  
 
The  Leg Measurement Device  (LMD) was  not  utilised  in  outcome measure  assessment  as  used  in 
previous studies throughout this thesis. Although proof of concept, studies 1‐4 identified the effects 






wide  range  of  data  to  be  collected  during  analysis.  This  study  utilised  an  observational  design, 
highlighting  the  fact  that  blood  assay  analysis  was  a  suitable  outcome  measure.  Adaptations  to 
muscle  function  during  the  NMES  protocol  was  outside  the  scope  of  this  study,  and  should  be 
considered in a larger study to test the 30 minute protocol.  
 
The  lack  of  muscle  function  testing  at  baseline,  limits  the  consideration  for  participant 




thus  the  lifestyle  questionnaire  becomes  vital  in  inferring  to  the  sample.  The  LMD  would  have 
limited  the number of participants  recruited as  testing would be  restricted  to one participant at a 
time.  Study  participation  required  1.5  hours  of  time  per  participant.  If  testing  each  participant 
separately data collection would have progressed beyond the time available  in this PhD. Time was 
also  a  restriction  for  the  phlebotomist  extracting  blood  samples,  who  was  a  full  time  medical 
student. The rationale of this study predicted a varied response to NMES, therefore making a larger 
sample size vital  in order  to  reliably  infer  from the  results. Testing more  than one participant at a 





Throughout  analysis  participants  were  categorised  into  groups  based  on  their  response  to  the 
lifestyle questionnaire. The lifestyle questionnaire allowed any observations in blood concentration 





conducted  in  the previous 48 hours. Participants were divided  into  ‘exercise’ or  ‘no exercise’  sub‐
categories  for  each  group  (detailed  in  table  7.5).  This was  achieved  by  splitting  exercise  reported 
based  on  self  perceived  intensity.  The  process  was  conducted  by  two  members  of  the  research 
team, with  a  discussion  of  participants who  sat  on  the  border  of  a  sub‐category.  Subjectivity will 
have  influenced  this  process;  however  accuracy  was maximised  by  discussing  the  content  of  the 
exercise history. Analysis of results was conducted based on mean concentrations, however also by 
exercise category. This was important in obtaining the most information from our results, as plasma 
enzyme  concentrations  have  shown  to  have  a  high  variability  based  on  lifestyle  and  exercise 
(Brancaccio, Maffulli et al. 2007).  
 
Creatine Kinase  (CK) concentration has been shown to be a strong  indicator of muscle  fatigue and 
recovery both during  and  after  competitive  exercise  (Lazarim, Antunes‐Neto  et  al.  2009). As  CK  is 
released from the muscle membrane, growth factors are suggested to follow, resulting  in adaptive 
changes in muscle structure with exercise. This would result in a lower CK concentration at baseline, 
highlighting  the  need  to  understand  general  levels  of  exercise  for  data  interpretation.  It  is  well 
researched that plasma CK levels increase during exercise, and correspond with a decline of force in 
the muscle  (Hunkin,  Fahrner  et  al.  2014).  Increases  in  CK  concentration  can  remain  for  up  to  five 
days post exercise, indicating that those who have conducted exercise in the previous 48 hours may 
have a  raised concentration of CK at baseline. Without attributing variations witnessed within  this 
chapter  to  lifestyle,  it  is  difficult  to  make  assumptions.  Participants  were  asked  if  Creatine 





was  spent  expanding  on  information  provided  in  the  lifestyle  questionnaire  if  required,  to  aid 
analysis of results.  
 
This  study  recruited  forty  participants.  This  sample  size  was  determined  based  on  time  available 
from the phlebotomist and realistic time scales for data collection. Given the wide variability of CK 
concentration  reported  in  the  literature  with  exercise  (Brancaccio,  Maffulli  et  al.  2007),  a  larger 






be  used  to  ascertain  whether  the  concentrations  of  biomarkers  in  this  study  are  comparable  to 
previous work. The observational design adopted in this study resulted in a control group not being 







have  adopted  a  stringent  limb  position  throughout  testing  protocols  with  NMES  (for  description 
please  see chapter  four).  The  testing of muscle  response  to  treatment  required  that  limb position 
was  controlled.  However,  this  current  study  did  not  measure  muscle  function  in  response  to 
stimulation  with  NMES.  It  was  therefore  concluded  that  participant  position  was  not  vital  in 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achieving  the aims.  The participant was positioned  in a way  that  replicated  the  testing positioned 
used  throughout  this  thesis.  This position was modifiable  given  the  lack of  restriction  to  the  limb, 
and  time  required  to  be  seated.  A  knee  brace  could  have  been  adopted  to minimise movement 
available  at  the  lower  limb  joints,  however  participant  comfort  given  the  extended  testing  time 
resulted  in  this  not  being  carried out.  In  order  for  this  study  to have  clinical  relevance  it must  be 
comparable to previous findings relating to the effects of NMES on muscle function.  
 
Creatine  Kinase  was  analysed  based  on  time  points  during  the  treatment  protocol.  Within  this 
participants  were  compared  based  on  their  response  to  the  lifestyle  questionnaire.  When 
considering baseline CK concentration 27 samples were used for analysis; resulting in 5 samples not 




provides  some  confidence  in  our  data,  indicating  that  analysis  techniques  have  appropriate 
sensitivity.  High  intensity  musculoskeletal  exercise  commonly  results  in  a  high  degree  of  muscle 
damage  (Twist, Eston 2005), which has  the effect of  increasing  the membrane permeability of  the 
muscle cell. Increased permeability allows the release of CK into the plasma, which can last for up to 
five days post exercise (Hunkin, Fahrner et al. 2014). This elevated resting concentration may give an 
indication  to  the  existing  force  producing  condition  of  the  muscle,  and  how  it  will  respond  to  a 







sample.  The  exact  cause  for  this  increase  is  unknown,  and  the  outcome measures  utilised  in  this 
study do not provide reason for how this occurred.  
 
Type  of  exercise  conducted  in  the  previous  48  hours  has  not  been  linked  to  the  baseline  CK 
concentration.  Resistance  training  or  endurance  training  may  result  in  a  different  amount  of  CK 
release  due  to  the  type  of  respiration  exploited.  CK  has  been  associated  with  the  Kreb  cycle  of 
aerobic respiration (Baird, Graham et al. 2012), which would be utilised in endurance exercise, such 
as  long  distance  running.  Muscle  damage  associated  with  increased  cell  membrane  permeability 
often occurs of a result of eccentric muscle work (Wernbom, Paulsen et al. 2012), which would be 
employed during resistance or explosive anaerobic demands. Further investigation as to the type of 
exercise  conducted  would  be  useful  to  explore  the  effects  of  NMES  within  different  exercise 
demands. This study did not recruit a  large enough sample to perform stringent analysis based on 
exercise,  and  a  larger  cohort  should  be  employed  to  link  exercise  to  CK  markers.  The  effect  of 








times  a week.  The muscle  requirements  during martial  arts  training  indicates  that  a  high  level  of 
muscle damage would occur during a training protocol, which would give rise to a high baseline CK 
concentration  in  this  participant.  The  impact  of  exercising  on  previously  damaged  muscle  tissue 
(progressive  over‐load)  could  result  in  a  repetitive  build‐up  of  CK  in  the  plasma,  resulting  in  an 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elevated  baseline  (Mougios  2007).  Repeated  high  intense  exercise  could  result  in  over‐training 
syndrome (OTS), which is characterised by an acceptable level of training overload but accompanied 
by inadequate rest periods (Meeusen, Duclos et al. 2013). Performance decline and fatigue are the 
key  indicators  for OTS. CK  concentrations  are not  investigated at  a diagnostic  stage,  however  it  is 
anticipated that CK would be elevated given the repeated stress to the muscle. Clinical investigations 
of  CK  are made based on  indication of  pathology.  Rhabdomyolysis  is  a  condition whereby muscle 
tissue  is  damaged,  leading  to  myoglobin  being  released  into  the  blood  stream  often  resulting  in 
kidney  damage  (Anzalone,  Green  et  al.  2010).  Rhabdomyolysis  is  characterised  by  a  rise  in  CK 
concentration. The sharp decline of CK in this participant once treatment had commenced indicates 




a  link  between  baseline  CK  concentration  and  African‐Americans  has  been  documented  (Neal, 




The NMES  protocol was  commenced  once  the  baseline  sample  of  blood  had  been  extracted.  The 
following  blood  sample  was  collected  after  the  first  15  minutes  of  treatment,  whilst  treatment 
continued. No issues were reported with extracting blood samples whilst the NMES protocol was in 
progress, as the participant was required to relax throughout the protocol. The first 15 minutes of 
treatment has been considered with participant 33  removed  from analysis, due  to  the abnormally 
high baseline CK concentration described above. The mean CK concentration for all participants rises 
by  0.01  nmol/min/ml  between  baseline  and  15  minutes  of  treatment.  Fundamentally  CK  breaks 




activity. Despite a  small  increase  it  can be concluded  that CK concentration  remained quite  stable 
during  the  first  15  minutes  of  treatment  with  NMES.  Stability  indicates  that  the  muscle  did  not 





and  the  assumption  is made  that  the muscle  had  enough  resting  creatine  to  produce  the muscle 
response. The lack of desired muscle response to the NMES protocol should not be ruled out at this 




demonstrated  an  increase  in  CK  concentration  and  others  a  decline.  On  consideration  of  general 
exercise,  those who  report  exercising  demonstrate  an  increase  of  CK  over  the  first  15 minutes  of 
treatment,  and  those  who  do  not  exercise  exhibit  a  decline.  Although  this  is  not  considered  a 
significant finding, the clinical indications should be explored further. The muscle membrane may be 
more permeable  in  the exercise group, allowing a higher concentration of CK  to seep  through  the 
boundary.  The  non‐exercisers  may  demonstrate  a  similar  rise  in  CK  after  treatment  with  NMES, 
however  the membrane  is  not  adapted  to  regular  exercise,  and  thus  the  threshold  for  CK  release 
into  the  plasma  may  be  higher.  A  muscle  that  is  accustomed  to  regular  exercise  may  be  more 
responsive to the NMES treatment protocol. Regular exercise would indicate that the function of the 
neuromuscular system is heightened (Byrne, Twist et al. 2004), resulting in NMES producing a larger 
force  output  from  the muscle. Neuromuscular  adaptations  in  the  exercise  group  could  result  in  a 
higher CK  concentration  in  this  sample.  The  level  of  variability of  a muscle  response  to  treatment 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with  NMES  must  be  considered,  although  the  small  range  in  the  dataset  indicates  a  normal 
distribution,  and  testing over a  larger  sample would give a  clearer  indication of whether  this  is of 
relevance to this investigation. Participants who had exercised within 48 hours of study participation 
demonstrated  a  small  decline  in  CK  concentration  in  the  first  15 minutes.  This  indicates  that  the 










muscle  responded  to  NMES  over  time.  When  considering  all  participants  a  mean  decline  in  CK 
concentration  was  witnessed.  This  is  the  only  decline  in  mean  CK  concentration  over  the  entire 
NMES protocol. The decline in CK concentration during a training protocol with NMES indicates that 
artificial  stimulation  induces  similar  chemical  changes  to  muscle  function  as  volitional  exercise. 
NMES produces a muscle contraction via direct stimulation of the motor neurone. Volitional exercise 
utilises the central nervous system to emit an efferent response to the muscle, which is bypassed in 
artificial  contraction.  NMES  does  however  initiate  anti‐dromic  activation  patterns  of  the  neurone 
(Rushton 2003), resulting in stimulation of both the efferent and afferent response. The utilisation of 
the  CK  in  this  final  15  minutes  of  the  protocol  indicates  that  creatine  is  being  broken  down  to 
produce energy required for muscle contraction. The energy required may have been necessary to 
produce muscle  contraction  for  the  remaining protocol. During  the  treatment  session,  the muscle 
contraction  visibly  reduced  indicating  that  force  production  was  comprised;  a  sign  of  muscular 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fatigue  (Westerblad,  Allen  et  al.  2002).  The  stimulation  intensity  was  increased  throughout  the 
protocol to avoid unwanted fatigue, and this maintenance of contraction intensity may have been a 
factor  that  stimulated  the  break‐down  of  creatine  in  the  muscle  cell.  The  force  response  of  the 
muscle  was  not  monitored  in  this  study;  therefore  this  cannot  be  concluded  with  certainty.  The 
decline  of  CK witnessed  after  30 minutes  of NMES  indicates  that  it  can  be  used  in  a  pathological 





When  looking  at  the  final  15  minutes  of  treatment  of  NMES  with  reported  exercise  it  can  be 
concluded  that  there was a  smaller decline  in CK  concentration  in  those who  reported exercising. 
This  indicates  that muscle previously adapted  to exercise does not  require as much breakdown of 
creatine,  potentially  related  to  the  increased  baseline  value  documented.  Previous  demands  of 
exercise placed on the muscle may have induced a learning effect on the muscle resulting in a lower 
threshold of demand to produce similar work outputs. When conducting linear regression analysis, 
variability  was  witnessed.  Participants  who  reported  not  exercising  demonstrated  a  rise  in  CK 
concentration, and those who exercised produced a more varied response. Non‐exercisers required 
more CK to break down creatine than exercisers. This may be influenced by muscle structure based 
on  existing  demand,  or  a  methodological  issue  such  as  variation  of  stimulation  intensity.  It  is 
anticipated that people who report exercising would use a stimulation intensity that  is higher than 
those who do not. Regular exercise to  induce muscle hypertrophy requires a motivational  input to 
drive  the need  for  improvement  (Spiegel, Grant‐Pillow et al. 2004). This would  indicate  that  those 
who exercise have a higher drive to produce the greatest force output from the muscle. It would be 







CK  concentration may have  increased due  to  the predicted demand  to  carry  out  further  exercise. 
Research indicates that the muscle membrane will have increased its permeability (Hunkin, Fahrner 
et al. 2014), allowing an influx of CK into the plasma as a response to exercise. CK concentrations are 
being  investigated  as  a  marker  of  muscle  damage,  and  injury  prevention  in  elite  sport  (Lazarim, 
Antunes‐Neto et al. 2009). This elevated state of CK post exercise, indicates that the muscle may be 
in a state of fatigue, and thus continued exercise may induce injury. Participant 21 had an elevated 
CK  concentration  that  was  substantially  greater  than  other  participants.  This  participant  had 
completed  a  half marathon  the day  previous  to  study  testing, which  resulted  in  a  high  resting CK 
concentration, but also suggested that his muscle was accustomed to aerobic exercise. The elevated 
final blood sample may be reflective of his resting level; this participant completed the highest level 
of  aerobic exercise of  all  participants.  The  relationship between aerobic  training and  risk of  injury 
would  require a  threshold of CK  concentration  to be  set, however  the  sample  size  in  this  study  is 















the  30 minute  protocol.    Analysis was  conducted  by  grouping  the  SI  into  three  categories,  which 
allowed  any  trends  between  SI  and  mean  CK  concentration  to  be  identified.  The  majority  of 
participants  were  stimulated  in  the  low  or  moderate  categories,  with  10  and  11  participants 
respectively. Although this indicates that a tetanic muscle contraction was produced with a relatively 
low SI,  the participants  in  this  study were  reluctant  to  increase  SI  to high  intensities.  This may be 
reflective of the sample; students studying physiotherapy may be more likely to participate in sport. 
Weight  was  documented  in  the  lifestyle  questionnaire,  however  skin  fold  thickness  and 
anthropometric measurements of the muscles being tested may give more of an indication of how 
subcutaneous  fat  influenced  impedance  to  stimulation.  A  low  subcutaneous  adipose  layer  would 
allow better passage of the electrical current to the muscle, and therefore stimulation with a lower 
intensity would be sufficient to produce a similar muscle contraction (Baker, Wederich et al. 2000). 
This may  also  be  reflective  of  the method.  Participants may  be more  receptive  to  increasing  SI  if 
muscle force production were being tested as an outcome measure. The element of self‐competition 
to increase force production could have profound implications (Zilioli, Watson 2012) with respect to 
motivation  to  increase  SI  to  produce  a  strong  muscle  contraction.  Some  participants  appeared 
anxious about  increasing SI as  the effects  repeated stimulation over 30 minutes were unknown to 
them.  
 
When  comparing  the  three  categories,  a  positive  relationship  existed  between  the  category  and 
mean CK concentration; the higher the SI the higher the mean CK concentration. The rise in mean CK 





a SI that  is on the higher end of their tolerance  level, and should be  increased based on becoming 
accustomed to the sensation. When increasing the intensity in the high category a large amount of 
variation  was  witnessed.  The  CK  response  was  inconsistent,  indicating  that  a  clear  relationship 
cannot be identified. Application of NMES at a high intensity produced both a high and a low mean 
CK,  indicating  that  more  testing  needs  to  be  conducted  to  ascertain  the  effects  throughout  a 
treatment protocol. It may be that the linear response continues, and that the level of CK increases 
in a linear fashion, implying a larger force out from the muscle. The low CK response to the high SI 
may  indicate  that  the  participant  was  accustomed  to  high  intensity  exercise.  A  high  load  of 
resistance  training  has  been  shown  to  increase  muscle  soreness,  however  maintain  a  low  CK 






















































































The  aim  of  this  study  was  to  ascertain  whether  there  was  a  physiological  reason  behind  the 
variability  in  response  to NMES  that  has  been witnessed  in  previous  trials within  this  thesis.  This 
study  administered  a  one off  30 minute  treatment  session with NMES,  and monitored CK  activity 
throughout  the protocol, and  for 30 minutes after completion. Table 7.17  (above) summarises  the 
main  findings  and  clinical  relevance  of  this  study.  The  overall  pattern  of  CK  activity  during  the 
treatment  session  correlated  with  CK  monitoring  in  the  sporting  literature;  indicating  that 
treatment with NMES  requires  the muscle  to  produce  energy, which  is  likely  to  cause muscular 
adaptation. The fact that changes in muscle response have been noted in previous trials reinforces 
the  fact  that  NMES  has  the  ability  to  produce  adaptation.  Further  investigation  is  required  to 
ascertain  how  the  muscle  responds  to  a  full  treatment  protocol  (as  would  be  administered  if 
prescribing NMES to produce strength gains). This would allow study into how often sessions should 
be conducted per week. The synchronicity of firing which is well understood during NMES suggests 
that  fatigue of  the muscle may be a problem  in administering multiple sessions per week. Further 
development  in understanding of  this process would aid protocol development  in different clinical 
populations. The variability witnessed throughout previous trials in this thesis has been reinforced in 
this  study.  Although  the  variability  demonstrated  a  similar  overall  pattern,  some  participants 
responded better  than others.  It  appears  pre‐existing muscular  condition  (level  of  exercise) may 
influence how a muscle  responds  to NMES,  however a  larger  sample with  stratification based on 
lifestyle is warranted to fully understand this. Factors such as nutritional status, weight, and age may 
also  influence  how  a muscle  responds  to NMES.  Previous  thoughts  have  anticipated  that  artificial 









The  primary  aim  of  this  thesis  was  to  establish  the  role  of  neuromuscular  electrical  stimulation 
(NMES)  in  reversing  age‐related  and  pathological  muscle  atrophy.  Five  clinical  studies  were 






would  be  an  effective  adjunct  to  a  physiotherapy  programme;  however  some  variability  was 
witnessed  that  required  investigation.  The  final  clinical  study  aimed  to  ascertain  reason  for  this 
variability.  Blood  samples  were  extracted  during  a  NMES  treatment  session  to  determine 
physiological  muscle  response  to  treatment.  Various  findings  were  highlighted  throughout  the 


































































developed  to monitor  the muscle  response  to NMES  throughout  this  thesis.  The  LMD was able  to 
produce  accurate  measurement  of  knee  extensor  and  ankle  plantarflexor  moment;  key  muscles 
targeted in a rehabilitation setting for functional activity. The portability of the device enabled ease 
of use both in an outpatient or a hospital ward environment. The device was utilised both resting on 
a  chair  and positioned  in  a  hospital  bed  throughout  this  thesis,  highlighting  the  adaptability  of  its 
use. A measurement tool of this nature to be used in clinical practice is not currently available and 
allows measurements  to  be  conducted  for  both  research  and  clinical  use.  The  LMD  is  able  to  be 
modified  in  accordance  with  patient  limb  size,  which  is  simple  to  conduct  whilst  the  limb  is  in 
position  to  be  tested.  This  is  something  that  clinical  staff  could  perform  with  training  and  no 








the  patient  enabling  higher motivation  to  improve  strength  during  rehabilitation.  The  device was 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also  used  to  monitor  muscular  response  during  NMES  treatment  protocols.  This  allows  another 
biofeedback application during a treatment programme and a way of a clinician being confident  in 
the  appropriateness  of  treatment  for  the  specific  individual.  The  high  sensitivity  of  muscle  force 
change  monitored  by  the  LMD  would  allow  application  in  neurological  rehabilitation;  a  form  of 
physiotherapy that uses small  increases  in muscle strength to transfer to  large  increases  in muscle 
function (Umphred, Lazaro et al. 2013). Further development is warranted to ascertain the onset of 
muscle  contraction  in  relation  to  force  output  on  the  foot  plate.  Integrated  application  of 
electromyography  would  be  an  effective  tool  to  enable  this  and  would  be  able  to  monitor 
compensations to allow strength to be achieved. Compensations are strategies often employed by 
patients  and  although  allowing  functional  movement  patterns  to  be  produced,  they  highlight  a 
weakness that may hinder progression of rehabilitation. Further development and testing is required 






of  the muscle  over  the  programme.  Linear  regression  analysis  allowed  this  change  of  force  to  be 
identified  which  was  considered  appropriate  based  on  the  variable  response  to  stimulation  on 
assessment of maximal moment. Based on subsequent findings within this thesis, there appears to 
be  many  factors  affecting  the  response  of  muscle  to  NMES.  This  includes  application  variations 
(electrode position, impedance) as well as lifestyle factors, such as pre‐existing condition of muscle, 
nutritional  status  and  level  of  fitness.  It  may  be  that  further  investigation  into  lifestyle  groups  is 
required and a protocol devised for clinicians to apply NMES based on placing the  individual  to be 




contraction  (Lieber 2009). Debate exists  as  to  the mechanism of motor unit  recruitment; whether 
large  diameter motor  units  are  recruited  before  small  diameter,  or whether  a  random pattern  of 
recruitment  is  produced  (Kim,  Bangsbo  et  al.  1995).  Larger  axons  are  associated  with  type  two 
fatigable  muscle  fibres  and  are  considered  to  have  a  lower  threshold  for  stimulation  therefore 
highlighting  a  mechanism  of  muscle  fatigability  (Bickel,  Gregory  et  al.  2011).  The  supra‐maximal 








The muscle  that has undergone  little pre‐conditioning will  suffer  substantial effects of  fatigue and 
effectively produce an automatic protective decline in force output in response. The levels of energy 
source  associated with muscle  contraction  (adenosine‐triphosphate)  have  been  depleted  and  not 
restored to allow further contraction.  It  is not proposed that the under conditioned muscle should 
not  be  included  in  a  NMES  treatment  session,  but  instead  that  stimulation  intensity  is  gradually 








a  week  over  6‐weeks  for  remaining  studies.  NMES  literature  is  ambiguous  with  regard  to  the 
duration and intensity of muscle contraction required to induce hypertrophy (Maffiuletti, Pensini et 
al.  2002).  Recommendation  for  the  duration  of  treatment  in  this  protocol  was  obtained  from 
volitional  strength  training  literature. Outcome measures were utilised  to establish any changes  in 
muscle architecture; giving a true indication of muscle response to treatment. This thesis proposes 
the use of NMES as adjunct to a physiotherapy programme, as opposed to a stand‐alone treatment. 
However,  application  in  solitude  was  necessary  to  establish  that  NMES  was  producing  desired 
muscle  effects.  In  reality NMES may  only  be  utilised  until  the muscle  is  able  to  achieve  sufficient 
contraction intensities to induce hypertrophy; as a means of preventing muscle atrophy associated 
with  weakness.  The  muscle  displayed  a  small  average  decline  of  force  over  the  45  muscle 
contractions. This response is suggested to be a beneficial stimulus for hypertrophic process to occur 








protocol.  The  time  of  muscle  contraction  increased  during  the  6‐week  period  indicating  that  the 
muscle adapted its response time as a reaction to stimulation. Firstly, when administering NMES in a 
clinical environment, it is suggested that the protocol is applied with a greater ‘on’ time than what is 
required.  This  thesis  stimulated  for  3  seconds  a  time  frame  that was  chosen  to mimic  a  burst  of 
muscle activity  that would be utilised  to maximise muscle  strength  through a voluntary  resistance 
training  programme.  However,  it  is  recommended  that  this  time  frame  is  doubled  to  6  seconds; 
 283 
 
which  would  result  in  2.7  seconds  of  actual  muscle  work.  This  figure  would  be  anticipated  to 
increase  as  the  muscle  became  more  responsive  to  treatment.  The  ‘on’  time  inputted  into  the 
stimulator does not consider the time frame of the neuromuscular system to detect a stimulus and 
initiate  its  response.  This  time  appears  to  reduce with  a  strength  training  protocol with NMES.  A 
quicker  neuromuscular  response  indicates  that  the  muscle  will  be  able  to  produce  more  muscle 














Results  indicate  that  both  young  and  older muscle  require  similar  intensities  to  produce  strength 
improvements  with  NMES.  The  older  muscle  demonstrated  a  rapid  initial  adaptation  and  then 
demonstrated  steady  improvements  over  the  remaining  training  period.  This  suggests  that  the 














that  this may be  an  effective  treatment  to  use  in  a  clinical  setting.  There was  however  variability 





et al. 2005).  Initial advances  in  force production are attributed to an  increased neural drive to  the 
muscle,  both  in  young  and  old  muscle.  Ultrasonography  was  utilised  as  an  outcome measure  to 
ascertain differences  in pennation angle of  the muscle.  The pennation angle  is  the angle at which 
muscle  fibres  attach  into  the  aponeurosis  of  muscle  and  are  thought  to  have  a  proportional 
relationship  with  strength  gains  (Aagaard,  Andersen  et  al.  2001).  However  some  authors  dispute 
this,  indicating  that  the  two  processes  have  little  relationship  (O'Sullivan,  Sainsbury  et  al.  2009). 















in  achieving  adaptation  of  muscle.  Results  have  to  be  considered  on  an  individual  basis  as  a 
consequence of the small sample in this study. Small advances in strength were gained after the 6‐
week NMES intervention, which were higher than the control counterparts. This indicates that NMES 
was  able  to  induce  hypertrophic  muscle  adaptation,  which  was  confirmed  by  ultrasonography 




associated  with  conditions  such  as  stroke  is  rapid,  especially  considering  the  advanced  age  of 




enable  functional  mobility  (such  as  transition  from  sitting  to  standing)  to  be  conducted  with  a 
quicker onset. This would also be beneficial  in orthopaedic rehabilitation allowing muscle structure 





During  rehabilitation  of  a  patient  after  a  stroke  accurate  measurement  of  strength  is  rarely 
conducted. Muscle strength is monitored through manual assessment, however is often thought to 
be subjective and difficult to compare between examiners (Pradon, Roche et al. 2013). The use of a 
device  such  as  that  designed  in  this  thesis would  enable  accurate measurement  to  be  performed 
within  all  severities  of  stroke.  The  level  of  strength  required  to  conduct  functional  activities  after 
neurological insult has not been investigated to date. The introduction highlights the concept of an 
independence  threshold;  the  level  of  muscle  contraction  required  for  independent  function. 
Although not directly measured in this thesis, progress has been made in identifying this threshold. 
Measurement  of  quadriceps  moment  during  sit  to  stand  would  indicate  the  level  of  quadriceps 





Chan  et  al.  2005).  This  indicates  that  isometric  application  of  NMES  has  the  ability  to  transfer  to 
functional  ability  and  thus  assumption  can  be  proposed  that  isometric  strength  can  transfer  to 
functional  strength.  Knowledge  of  the  strength  threshold  for  independent  function would  allow  a 
goal of the NMES strength training protocol in initial rehabilitation stages post stroke. 
 
Another  interesting  finding  when  NMES  was  applied  to  participants  with  acute  stroke  was  the 
restoration  of  cutaneous  sensation  as  a  result  of  NMES.  It  is  difficult  not  to  rule  out  the  role  of 
natural recovery in this; however sensation progressed during application of the protocol and it was 





mechanoreceptors  are  located  superficially  within  the  skins  epidermis  and  thus  stimulation  that 
penetrates  through  to  innervate motor  axons will  also  initiate  a  response  in  anything  that  travels 
within its path (Baker, Wederich et al. 2000). Stimulation of the mechanoreceptors will have resulted 
in  a  repetitive  afferent  response  from  them which may  have  developed  restoration  of  sensation. 
Cutaneous  sensation  becomes  vitally  important  for  self‐management  of  a  neurological  condition. 
Ability to monitor changes in pressure can prevent pressure sores which can often result in infection 
and a prolonged period of  bed‐rest  as  a  treatment method.  Stroke patients  are often  required  to 
wear  orthotic  devices  as  a means  of  safety  to mobilise  (Carse,  Bowers  et  al.  2014).  The  ability  to 












slightly  to maximise  the activity of  the muscle  in  a  single  application. Baseline CK was elevated  in 








active  muscle  involvement  in  contraction,  consideration  should  be  given  to  spending  some  time 
replicating  the movement  volitionally.  It  would  be  interesting  to  see whether  NMES  triggered  by 
electromyography  would  enhance  this  effect,  potentially  increasing  response  of  the  muscle  to 
treatment  even  further.  This  response  is  easier  to manipulate  in  a musculoskeletal  population  as 
they have the ability to generate if not attempt muscle contraction to assist the NMES programme.  
 
Creatine  kinase  (CK)  concentration  has  been  shown  to  elevate  during  high  intensity  exercise  that 
induces muscular hypertrophy (Brancaccio, Maffulli et al. 2007). This is produced in response to high 
intensity exercise damaging the membrane permeability of the muscle cell. CK  is stored within the 
M‐line  of  the  sarcolemma  and  thus  released  in  response  to  permeability  changes.  The  lack  of  CK 
response  to  treatment  after  15 minutes  indicates  that  the muscle  had  enough  resting  energy  to 
produce contraction or the muscle was not working to a sufficient level or long enough duration to 
induce  membrane  damage.  This  highlights  the  importance  of  NMES  being  applied  at  a  maximal 
tolerated  intensity  and  increasing  the  stimulation  intensity  as  the  participant  begins  to  show  a 
reduced  force  output.  The  requirement  of  a  treatment  protocol  to  last more  than  15 minutes  in 
order to work the muscle over a sufficient time period also appears vital.  
 
As  the  treatment  with  NMES  progressed  the  response  of  CK  was  similar  to  that  of  volitional 
resistance training; a depletion following by a corresponding increased concentration. This indicates 
that NMES is producing similar effects to volitional exercise despite the variability witnessed within 
results of  this  thesis. Although application of  the protocol was  slightly different,  this  suggests  that 










is  highly  relevant  given  the  non‐selective  recruitment  of  fatigable  muscle  fibres  in  artificial 
contraction.  CK  concentration  increased  after  30 minutes  rest  with  NMES,  however  this  increase 
may  have  continued  if  tested  over  a  longer  period  of  time.  The  intensive  nature  of  the  strength 
protocol may have  caused undue  fatigue,  thus  limiting  the  strengthening effects witnessed  in  this 
application.  Parameter  setting  has  been  established  and  tested  within  this  thesis;  however  the 
protocol design was influenced through volitional literature for easy comparison. Further testing of 
the training regimen would enable the protocol to be administered with more certainty. The effects 
of CK elevation may be present after  the  initial  few applications of  the protocol, hence  the  full  6‐
weeks  of  training  may  not  be  required  to  inducing  fatiguing  effects  in  the  muscle.  This  would 
become problematic  in a population who use NMES for strength training as an  intensive means of 
training before voluntary training commences. However, the results from clinical studies imply that 




with  NMES.  The  variability  witnessed  in  CK  concentration  demonstrated  trends  in  relation  to 





















• Gradually  increase stimulation  intensity  in  line 
with a visual decline in muscle force 











the  level  of  physical  activity  concomitantly  reduces.  This  poses  two problems;  the  individual  loses 
confidence  in  their  ability  to  mobilise  (which  deepens  the  problem),  and  their  muscles  will 
experience significant disuse atrophy. This  is heightened by age, with age related muscle disorders 
such  as  sarcopenia  adding  to  the  effect  of  disuse.  Frailty  renders  an  individual  more  prone  to 
pathology such as stroke. This process can be exacerbated in someone who has a stroke, with forced 




The  Leg  Measurement  Device  (LMD)  was  designed  and  developed  in  this  thesis  to  accurately 




clean  use were  key  attributes  to  its  successful  integration  in  testing  a  clinical  population.  A  small 






explore  parameter  setting  has  been  conducted.  Frequency  was  investigated  as  the  dependant 
variable,  as  the  inversely  related  pulse  duration  and  stimulation  intensity  are  better  understood. 
Stimulating at a frequency of 50 Hz has been shown to produce the greatest rate of change in force 








reduced with  training,  and  the muscle did not  receive  the  full  stimulation  time  set.  It  is  therefore 
suggested  that  the  stimulation  time  is  increased  beyond  what  is  considered  a  desired  length  of 




The  treatment  programme  was  tested  in  a  population  who  had  suffered  a  stroke,  and  results 
indicate  that  strength  can be advanced  in  this population.  Strength  increases were  small however 
were able to transfer to functional ability alongside traditional rehabilitation.  It must be taken into 
consideration  that  the  sample  size was  small,  and  the  results were  forced  to be considered on an 
individual  basis  which  limits  the  interpretations  that  can  be  made.  Pennation  angle  was  seen  to 






enhance  rehabilitation.  Cortical  control  of  sensation  would  enable  key  determinants  in  a 
physiotherapy  programme,  such  as  balance  to  be  restored  in  a  shorter  time  scale.  Despite  these 
findings,  a  high  level  of  variability  was  presented  in  the  findings,  with  the  small  sample  sizes 
(indicative of proof of concept) making the variability difficult to account for.  
 
Creatine  Kinase  is  a  biomarker  which  was  monitored  through  a  treatment  session  with  NMES. 
Creatine  kinase  displayed  similar  responses  in  concentration  as  volitional  strength  training, 
highlighting that the protocol is effective despite the variability witnessed. It also gives an indication 








provide  firm  conclusions.  It  is  noted  that  the  studies  described  in  this  thesis  recruited  a  small 
convenience sample, which was imperative for establishing trends to justify further investigation. It 
can  be  concluded  that  the  results  provide  scientific  justification  for  larger  randomised  controlled 
trials, with a higher powered methodology to be conducted. Although control groups were utilised 
where appropriate, blinding was not performed throughout this thesis mainly as a consequence of 








1. Development of  the  Leg Measurement Device  (LMD). Although  the  LMD was  successful  in 
achieving  the aims of  this  thesis,  further development  is  required  to enable amalgamation 





real  time moment values during testing would allow  instant  feedback to participants using 
the  device;  something  that  would  be  important  to  include  if  utilised  on  patients  for 
discharge criteria. At present  the LMD  is  indicative of a  research  tool;  something  that was 




2. Establishing  stimulation  parameters  for  secondary  aims  of  NMES.  The  stimulation 
parameters in this thesis have been specific for the use in strength training. NMES has been 
postulated  to  have  other  uses,  such  as  improving  voluntary  muscle  activation,  assisting 
recovery  after  injury  and  improving  the  endurance  properties  of  muscle  (Deley,  Babault 
2014). All  aims have been  identified  to use differing  stimulation parameters,  and  research 
now  needs  to  address  this  issue.  It  is  the  hope  that  a  stimulator  with  programmed 






3. Identifying  the  level  of  strength  required  for  functional  independence  in  stroke 
rehabilitation.  Monitoring  of  the  knee  extensor  moment  required  for  functional 
independence  in  stroke  would  enable  a  strength  training  programme  with  NMES  to  be 
administered  with  a  primary  goal;  to  reach  the  strength  threshold.  Use  of  the  LMD  to 
monitor  strength during  rehabilitation would enable  this  level of  functional  strength  to be 
identified. 
  
4. Investigating  concentration  of  Creatine  Kinase  to  assist  with  development  of  training 
intensity.  Creatine  Kinase  has  been  shown  to  elevate  for  up  to  five  days  after  volitional 
strength  training.  Monitoring  of  concentration  ceased  after  30  minutes  in  this  thesis. 
Monitoring  over  a  longer  period  of  time  (5  days)  may  demonstrate  further  increases  in 
concentration; something that may be indicative of the synchronous firing pattern of NMES 
during  application.  Elevated  Creatine  Kinase  in  the muscle  is  suggested  to  be  a marker  of 
muscle  fatigue,  and  risk  of  injury  in  sports medicine  (Lazarim,  Antunes‐Neto  et  al.  2009). 
Elevated Creatine Kinase may be able to guide development of the training intensity used to 
administer  the  stimulation  protocol  with  greater  accuracy,  to  avoid  detrimental  fatigue. 
Fatigue associated with NMES has been highlighted as a barrier to clinicians incorporating it 
into  clinical  treatments,  and  work  of  this  nature  may  help  NMES  integrate  into  clinical 
practice. 
 
5. The  ability  to  increase  strength  in  an  elderly  population  has  been  indicated.  It  would  be 
interesting to ascertain whether a ceiling effect exists as to the level of strength that can be 





The  primary  aim  of  this  thesis  was  to  ascertain  the  role  of  NMES  in  preventing  age‐related  and 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(Hz) 20_1 20_2 30_1 30_2 40_1 40_2 50_1 50_2 60_1 60_2 70_1 70_2 80_1 80_2 100_1 100_2 
                 
1 13.67 15.23 16.05 19.27 16.98 19.65 19.23 21.67 25.50 23.56 21.85 32.73 23.63 22.65 24.54 31.73 
2 17.73 15.11 23.59 28.76 23.87 22.98 77.10 81.37 24.16 31.67 26.75 27.16 32.61 30.74 35.58 29.82 
3 6.69 9.67 6.77 9.76 7.36 9.65 8.11 9.26 34.96 36.98 28.34 30.19 16.06 20.34 42.07 39.67 
5 9.54 9.74 14.35 15.21 15.70 21.56 13.56 11.24 10.86 11.59 11.31 10.23 13.46 12.63 15.10 13.63 
6 5.34 10.13 5.47 7.34 7.20 11.87 8.65 8.43 10.59 12.45 11.46 12.84 12.00 12.98 11.75 15.65 
8 7.84 10.21 7.95 8.76 5.91 6.21 7.54 9.23 7.50 9.78 8.05 10.36 7.85 8.92 8.90 10.87 
9 7.93 9.65 12.31 14.32 10.76 13.54 4.24 5.78 15.56 19.99 9.29 12.62 10.63 14.64 10.78 19.87 
11 15.51 13.22 9.07 10.87 15.55 15.76 12.38 14.64 16.78 24.76 15.88 15.76 16.92 24.76 17.98 22.64 
12 1.84 6.54 2.06 6.76 3.19 6.87 2.87 3.98 5.28 9.37 7.15 9.27 6.42 5.49 6.48 11.67 
14 13.12 15.48 10.98 12.98 9.64 11.22 11.00 12.11 8.93 14.74 7.24 8.21 9.59 7.92 10.19 8.45 
15 4.16 8.64 4.32 5.67 4.77 10.08 4.68 5.23 3.77 6.21 5.89 7.26 3.17 9.47 2.46 9.34 
16 23.83 19.69 28.89 26.72 35.64 30.37 33.10 29.82 25.90 24.99 28.51 30.64 32.05 26.96 24.86 27.89 
17 5.09 8.45 2.99 7.32 7.54 9.54 7.54 8.67 6.46 8.64 11.15 8.76 13.16 15.73 19.38 15.32 
18 10.28 13.43 10.49 9.76 8.30 10.25 11.82 13.34 12.14 14.27 11.24 10.29 8.27 11.38 9.94 11.26 
19 8.14 11.12 8.89 9.21 9.64 9.60 10.24 9.24 8.84 8.66 9.30 11.67 9.30 11.97 4.49 5.04 
                                  
                 
Mean 10.05 11.75 10.94 12.85 12.14 13.94 15.47 16.27 14.48 17.18 14.23 15.87 14.34 15.77 16.30 18.19 
SD 5.82 3.50 7.43 7.06 8.49 6.83 18.56 19.19 9.18 9.33 8.07 9.23 8.78 7.58 11.34 10.08 
SE 1.56 0.93 1.98 1.89 2.27 1.82 4.96 5.13 2.45 2.49 2.16 2.47 2.35 2.03 3.03 2.69 
                Mean 
day 1 
and 2 10.90   11.90   13.04   15.87   15.83   15.05   15.06   17.24   
                 
Study one raw data: Maximal Moment for each frequency. Data presented in Nm. 1: day one of testing, 2: day two of testing, SD: Standard Deviation, SE: 






Attempt  P1  P2  P3  P4  P5  P6  P7  P8  P9  P10  P11 
1  11.3  16.9  53.0  9.6  10.2  17.1  39.3  5.9  34.4  10.6  13.2 
2  11.8  17.1  56.4  11.0  11.4  22.8  42.0  8.2  33.4  8.5  13.1 
3  11.0  17.3  59.7  11.6  15.2  26.0  41.1  8.1  34.7  12.4  11.6 
4  10.8  18.0  66.4  11.6  15.6  10.3  43.2  7.3  33.2  13.5  11.6 
5  12.1  19.5  67.6  12.0  14.7  15.7  44.4  6.9  34.8  8.5  11.6 
6  10.8  18.4  67.1  12.1  15.3  12.7  42.4  6.1  34.5  7.7  12.0 
7  11.0  16.4  68.5  11.0  15.3  10.9  43.8  4.6  35.1  8.7  12.2 
8  11.1  18.3  67.9  12.2  16.0  10.7  43.5  3.9  36.6  5.7  11.8 
9  10.4  19.1  62.9  10.7  16.3  11.3  42.9  4.4  35.4  8.4  12.0 
10  12.9  17.9  61.6  11.4  16.0  12.6  42.6  5.4  35.4  6.9  15.5 
11  13.6  16.3  63.2  11.3  16.4  7.5  44.5  7.0  35.7  8.8  16.0 
12  13.3  18.0  61.1  10.0  15.7  2.6  44.7  6.0  36.3  7.5  15.8 
13  12.4  16.0  60.5  13.1  16.7  3.3  44.1  5.7  36.8  9.3  16.2 
14  12.7  20.4  60.1  10.9  16.3  3.1  44.3  6.6  37.2  8.9  14.8 
15  12.6  16.6  61.5  9.7  15.8  4.7  44.6  6.7  38.3  10.7  14.4 
16  10.7  15.2  56.0  10.1  16.0  12.3  48.3  6.6  37.9  5.4  11.8 
17  17.5  16.0  56.3  10.9  16.9  11.2  44.6  8.7  41.4  4.4  11.9 
18  13.2  17.9  63.3  11.1  17.5  9.9  44.8  10.0  40.8  4.0  10.9 
19  12.8  20.3  61.1  10.9  17.4  16.2  45.0  7.2  40.0  4.0  11.3 
20  11.5  16.9  57.8  12.5  18.3  9.7  46.7  3.0  41.3  5.2  12.4 
21  12.3  18.3  58.4  9.4  17.1  11.6  46.7  2.9  40.3  3.4  11.9 
22  11.9  17.0  56.1  11.0  19.4  11.3  47.3  3.5  40.2  1.8  11.5 
23  11.8  16.9  55.0  13.2  17.1  6.3  46.2  4.0  40.8  3.9  12.2 
24  12.0  19.4  55.4  14.2  20.3  11.8  47.5  3.8  41.1  3.4  12.3 
25  11.2  15.8  62.4  14.9  17.7  10.3  47.9  11.3  41.0  4.4  12.5 
26  11.9  17.0  63.0  13.7  16.7  7.7  48.5  9.4  42.0  3.8  11.0 
27  12.3  15.7  62.1  12.9  18.4  7.0  47.1  11.7  41.4  2.8  10.7 
28  13.2  20.5  65.9  13.2  16.4  3.7  48.8  5.7  40.8  3.2  10.7 
29  14.7  16.3  64.9  13.2  17.9  5.1  47.8  10.3  42.0  2.3  10.0 
30  12.6  16.3  65.2  11.1  17.4  0.4  49.5  5.6  42.1  1.8  10.3 
31  8.7  17.8  51.2  9.9  14.2  8.4  49.0  7.5  39.9  5.9  10.7 
32  8.5  18.9  51.2  9.7  16.4  8.2  47.5  3.5  38.3  5.0  9.7 
33  9.1  18.3  53.4  10.3  16.0  8.7  48.5  9.6  38.5  5.8  12.1 
34  10.6  23.9  53.0  12.0  13.9  7.8  47.4  11.6  34.6  6.0  11.6 
35  9.8  21.2  43.3  9.6  13.7  8.4  48.2  12.6  36.5  5.3  12.0 
36  9.2  20.3  42.4  13.1  14.9  7.1  50.0  12.0  34.9  6.1  10.6 
37  8.3  20.2  42.9  10.7  16.1  6.2  48.6  6.8  35.3  4.7  12.2 
38  8.1  18.9  42.2  11.3  16.0  6.3  49.4  10.9  34.8  5.2  10.7 
39  8.1  20.1  42.5  10.6  15.0  10.1  51.1  14.3  34.4  4.0  12.3 
40  7.3  20.4  41.9  10.5  15.7  8.4  48.3  13.0  32.6  6.1  11.4 
41  8.6  19.0  43.1  10.5  16.1  5.7  48.3  9.5  35.5  3.5  10.2 
42  8.4  21.0  44.1  11.6  14.4  5.8  48.6  13.1  34.7  3.2  10.3 
43  9.0  19.7  40.7  12.9  16.1  5.2  49.2  8.1  37.0  3.6  10.7 
 333 
 
44  8.0  23.3  41.2  12.3  15.1  3.4  50.5  8.6  35.8  2.5  10.9 
45  7.6  19.8  40.7  11.9  16.3  6.8  51.6  6.3  35.4  3.5  10.8 
Average  11.0  18.4  55.9  11.5  16.0  9.2  46.4  7.6  37.4  5.8  12.0 






























S2P1  T60  11.7  19.4  21.6  17.57  21.60  5.20  21.3  20.3  26.4  22.67  26.40  3.27  4.80 
S2P2  C60  45.2  58.6  67.9  57.23  67.90  11.41  73.5  87.5  86.4  82.47  87.50  7.78  19.60 
S2P3  T60  22.3  28.2  41.6  30.70  41.60  9.89  72.5  78.7  70.8  74.00  78.70  4.16  37.10 
S2P4  T30  na  na  na  na     na  na  na  na  na     na  0.00 
S2P5  C30  31.3  34.5  32.6  32.80  34.50  1.61  37.3  32.1  29.4  32.93  37.30  4.02  2.80 
S2P6  T60  60.1  70.7  67.5  66.10  70.70  5.44  72.6  62.7  67.2  67.50  72.60  4.96  1.90 
S2P7  C60  0  0  0  0.00  0.00  0.00  0  0  0  0.00  0.00  0.00  0.00 
S2P8  C30  34.4  62.8  68.8  55.33  68.80  18.38  23.6  54.2  67.4  48.40  67.40  22.47  ‐1.40 
S2P9  C30  39.3  55.1  61  51.80  61.00  11.22  63.2  54.1  36.3  51.20  63.20  13.68  2.20 
S2P10  C60  53.7  71.3  70.4  65.13  71.30  9.91  38.8  54.5  66.1  53.13  66.10  13.70  ‐5.20 
S2P11  T30  58.5  79.8  88.7  75.67  88.70  15.52  120.8  133.2  144.3  132.77  144.30  11.76  55.60 
S2P12  T30  89.9  96  97.8  94.57  97.80  4.14  141.2  149.2  164  151.47  164.00  11.57  66.20 
S2P13  T60  59.8  61.3  52.9  58.00  61.30  4.48  68.1  69.8  73.5  70.47  73.50  2.76  12.20 
S2P14  T60  24.6  31.8  26.4  27.60  31.80  3.75  66.9  69.5  73.4  69.93  73.40  3.27  41.60 
S2P15  C30  46.7  71.9  49.6  56.07  71.90  13.79  72.5  75.1  62.7  70.10  75.10  6.54  3.20 
S2P16  T30  67.5  59.5  50.7  59.23  67.50  8.40  42.8  57.4  66.2  55.47  66.20  11.82  ‐1.30 
S2P17  C60  36.4  38.7  44.2  39.77  44.20  4.01  33.4  38.3  40.7  37.47  40.70  3.72  ‐3.50 
S2P18  T30  52.1  43.4  48.3  47.93  52.10  4.36  58.9  64.2  54.3  59.13  64.20  4.95  12.10 
S2P19  C60  34.2  43.1  40.8  39.37  43.10  4.62  42.4  52.3  31.7  42.13  52.30  10.30  9.20 
S2P20  C30  78.4  79.2  68.9  75.50  79.20  5.73  77.1  74.3  71.2  74.20  77.10  2.95  ‐2.10 
























1  T60  11  15  ‐0.6    12  C60  12  13  1.7 
1  T60  11  13  0.5    12  C60  13  14  3.1 
1  T60  10  15  0.2    12  C60  15  14  0.1 
2  T60  15  13  0.4    13  C30  16  17  0.9 
2  T60  10  13  ‐0.2    13  C30  14  17  3.3 
2  T60  11  11  0.5    13  C30  16  16  0.4 
3  T60  13  15  1.3    14  C30  11  11  3.8 
3  T60  11  13  ‐0.3    14  C30  10  10  ‐1.7 
3  T60  11  15  ‐0.1    14  C30  12  13  ‐1.4 
4  T60  10  13  0.7    15  C60  12  12  4.8 
4  T60  10  16  ‐1.2    15  C60  12  12  ‐0.1 
4  T60  10  13  1.3    15  C60  12  13  1.2 
5  T60  12  13  0.1    16  C30  15  16  0.2 
5  T60  13  13  0.4    16  C30  16  16  ‐0.2 
5  T60  11  12  0.5    16  C30  16  16  1.1 
6  T30  10  12  1    17  C30  11  12  0.6 
6  T30  10  13  ‐0.4    17  C30  12  11  0.7 
6  T30  13  13  0.3    17  C30  11  11  ‐1.7 
7  T30  15  17  2.6    18  C60  8  10  3.5 
7  T30  16  17  2.5    18  C60  9  9  5.5 
7  T30  15  18  4    18  C60  9  9  2.1 
8  T30  15  20  ‐1.6    19  C60  10  10  2 
8  T30  16  16  3.4    19  C60  9  10  1.1 
8  T30  16  17  ‐0.3    19  C60  9  10  3.4 
9  T30  11  14  1.1    20  C60  13  13  3.2 
9  T30  11  15  0.5    20  C60  12  10  4.5 
9  T30  11  15  0.8    20  C60  11  12  3.6 
11  C30  18  22  4.4             
11  C30  20  19  1.7             
11  C30  22  20  4.3             









Participant Week Attempt Day MFP-ES DUR  
Participant Week Attempt Day MFP-ES DUR 
1 1 1 1 18.859 0.8  1 1 15 2 13.76 0.65 
1 1 2 1 19.114 0.75  1 1 16 2 7.492 0.7 
1 1 3 1 19.114 0.75  1 1 17 2 8.697 0.75 
1 1 4 1 19.519 0.85  1 1 18 2 9.935 1.6 
1 1 5 1 20.324 0.75  1 1 19 2 10.956 0.6 
1 1 6 1 19.267 0.75  1 1 20 2 8.046 0.6 
1 1 7 1 19.165 0.75  1 1 21 2 9.106 0.65 
1 1 8 1 20.159 0.85  1 1 22 2 10.154 0.6 
1 1 9 1 21.004 0.8  1 1 23 2 9.098 0.6 
1 1 10 1 20.447 0.75  1 1 24 2 9.098 1.45 
1 1 11 1 20.283 0.75  1 1 25 2 8.992 1.85 
1 1 12 1 18.393 0.55  1 1 26 2 6.632 0.55 
1 1 13 1 18.247 0.8  1 1 27 2 5.737 0.65 
1 1 14 1 18.062 0.8  1 1 28 2 6.141 0.6 
1 1 15 1 17.708 0.75  1 1 29 2 7.091 0.7 
1 1 16 1 16.94 0.85  1 1 30 2 4.571 0.55 
1 1 17 1 16.135 0.85  1 1 1 3 19.056 0.8 
1 1 18 1 16.736 0.75  1 1 2 3 20.505 0.85 
1 1 19 1 15.436 0.8  1 1 3 3 20.462 0.8 
1 1 20 1 16.802 0.75  1 1 4 3 20.859 0.7 
1 1 21 1 17.108 0.8  1 1 5 3 21.157 0.75 
1 1 22 1 16.703 0.85  1 1 6 3 21.008 0.75 
1 1 23 1 15.538 0.8  1 1 7 3 20.859 0.7 
1 1 24 1 16.39 0.85  1 1 8 3 21.255 0.75 
1 1 25 1 16.189 0.8  1 1 9 3 20.29 0.75 
1 1 26 1 15.53 0.75  1 1 10 3 20.541 0.75 
1 1 27 1 15.181 1.2  1 1 11 3 19.984 0.8 
1 1 28 1 15.137 0.85  1 1 12 3 19.937 0.7 
1 1 29 1 15.042 0.85  1 1 13 3 20.286 0.75 
1 1 30 1 14.944 0.8  1 1 14 3 20.232 0.75 
1 1 31 1 16.94 0.85  1 1 15 3 20.931 0.75 
1 1 32 1 16.135 0.85  1 1 16 3 16.095 0.75 
1 1 33 1 16.736 0.75  1 1 17 3 15.789 0.75 
1 1 34 1 15.436 0.8  1 1 18 3 15.636 0.8 
1 1 35 1 16.802 0.75  1 1 19 3 15.691 0.75 
1 1 36 1 17.108 0.8  1 1 20 3 15.49 0.75 
1 1 37 1 16.703 0.85  1 1 21 3 16.834 0.85 
1 1 38 1 15.538 0.8  1 1 22 3 16.535 0.8 
1 1 39 1 16.39 0.85  1 1 23 3 15.534 0.75 
1 1 40 1 16.189 0.8  1 1 24 3 16.084 0.75 
1 1 41 1 15.53 0.75  1 1 25 3 15.235 0.75 
1 1 42 1 15.181 1.2  1 1 26 3 15.33 0.75 
1 1 43 1 15.137 0.85  1 1 27 3 14.427 0.75 
1 1 44 1 15.042 0.85  1 1 28 3 15.086 0.8 
1 1 45 1 14.944 0.8  1 1 29 3 14.838 0.8 
1 1 1 2 13.429 1.9  1 1 30 3 15.385 0.75 
1 1 2 2 12.424 0.65  1 1 31 3 13.276 0.75 
1 1 3 2 10.409 0.6  1 1 32 3 13.531 0.75 
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1 1 4 2 13.429 0.6  1 1 33 3 12.795 0.7 
1 1 5 2 14.78 0.8  1 1 34 3 13.09 0.7 
1 1 6 2 15.118 0.8  1 1 35 3 10.254 0.7 
1 1 7 2 11.502 0.6  1 1 36 3 9.445 0.75 
1 1 8 2 14.361 0.6  1 1 37 3 10.381 0.75 
1 1 9 2 13.454 0.55  1 1 38 3 9.98 0.75 
1 1 10 2 13.163 0.6  1 1 39 3 13.189 0.75 
1 1 11 2 14.721 0.6  1 1 40 3 12.69 0.7 
1 1 12 2 16.12 0.55  1 1 41 3 12.18 0.75 
1 1 13 2 15.37 0.55  1 1 42 3 13.829 0.75 
1 1 14 2 13.665 0.55  1 1 43 3 10.894 0.75 
       1 1 44 3 10.84 0.75 
       1 1 45 3 12.446 0.75 
             
Raw data study three: A sample of the data extracted from the LMD. Data relates to participant one. MFP-ES: 


















Information Sheet for:  
Strength training with electrical stimulation – Is this is a viable method of facilitating 
independent mobility and improving quality of life after a moderate to severe stroke? 
 
                We would like to invite you to take part in a study of a treatment which may be used to improve your 
leg strength and therefore help you walk better. If you are interested in supporting this research project, then it is 
important that you understand why the research is being done and what it will involve.  Please read the following 
information carefully, and discuss it with others, if you wish, prior to confirming your willingness to participate in 
this study.  If any information is unclear, or if you would like more information, please contact Dr Ramesh 
Durairaj. Do take time to decide whether you wish to take part. If you do not want to take part in this study, we 
would like to assure you that your current medical care will not be affected or compromised in anyway and we 
would like to thank you for giving us a bit of your time. 
The purpose for this study 
Loss of strength in the leg muscle can compromise the ability to independently walk after a stroke. Treatment 
with electrical stimulation can be used to strengthen muscles that cannot be exercised actively and as a result 
the ability to walk may improve.  The aim of this study is to find out whether treatment with electrical stimulation 
can be used to help with the recovery of walking function after a stroke. This study forms part of an educational 
program undertaken by Ms Leanne Claydon, registered physiotherapist.  
What is Electrical Stimulation (ES)? 
ES is a way of using small electrical impulses to the cause paralysed muscles to contract. Two self-adhesive 
pads (electrodes) are placed on the skin close to the nerve that activates the muscle or over the muscle itself. 
The electrodes are connected to a small battery powered stimulator, which supplies the electrical impulses that 
cause the muscle to contract.  
 
Who is it suitable for? 
Aintree Hospitals 














It is most commonly used for people who have suffered a stroke, but it is also used for people with multiple 
sclerosis, cerebral palsy, incomplete spinal cord injury and with some people who have had head injuries. 
How is it used?   
To exercise and strengthen muscles. ES is used to exercise muscles in the legs and also in the arm and hand. 
The stimulation can also help to relax muscles that are tight. This may be done as part of a physiotherapy 
treatment programme. Patients typically use electrical stimulation for 30 – 60 minutes a day and continue to use 
the stimulator until the goals of the treatment are reached. 
 
What are the risks? 
ES causes a ‘tingling’ sensation (a bit like pins & needles). Most people get used to this quite quickly and do not 
find it uncomfortable. Some people do not like the sensation and may decide not to continue with ES. 
Occasionally there may be some slight skin irritation from the electrodes. If this problem persists then 
hypoallergenic electrodes can be used. ES is not suitable for use by people who have poorly controlled epilepsy, 
people with implanted electronic devices (e.g. cardiac pacemakers). ES should not be used during pregnancy.  
 
 














Who is eligible to participate in this study 
All adult patients admitted to the Aintree Combined Stroke Unit who have lost the ability to walk after their stroke 
but who are able to sit will be eligible to participate. Not all people can be treated with electrical stimulation and 
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you will be required to undergo a screening process to check you have no contraindications to treatment once 
consent has been given for study participation.  
Do I have to take part? 
Participation in this clinical trial is entirely voluntary. You are not obliged to support this clinical trial and the 
standard of care you receive will not be affected in any way. 
However, if you do decide to take part you will be given this information sheet to keep and be asked to sign a 
Consent Form. Also, even if you decide to take part you are still free to withdraw at any time without giving 
reason.  A decision to withdraw at any time, will not affect the standard of care you receive. 
 
What will happen, if I decide to take part in this trial and what will I have to do? 
If you are interested in supporting this trial and have read the information leaflet you will be asked to sign the 
consent form. We will then ask you questions about your health and wellbeing, consult your medical notes for 
information relating to your stroke, perform a medical examination to see how the stroke has affected you and 
take some measurements of your muscle structure using an ultrasound scanner and an MRI scanner. We will 
also carry out tests to see that it is safe to treat you with electrical stimulation. The time taken for this initial 
assessment will, normally, not exceed two hours in total.  
• On completion of these initial assessments you will be randomly allocated into one of two groups 
(T-group and C-group). Neither you nor the researcher will have any influence on which treatment 
group you are allocated to. This will be done independently by a computer. Randomization means 
that you are put into a group by chance. It is like flipping a coin. Which group you are put in is done 
by a computer. Neither you nor the researcher will choose what group you will be in. This is known 
as 'blinding'. You will have a 1 in 2 chance of being placed in any group.  
 
• People in the T-group will be given additional treatment with electrical stimulation once a day each 
(from Monday to Friday) over a period of 6 weeks. Stretching will be carried out daily and 
strengthening treatment will be done on alternate days. 
 
• People in C-group will receive no additional treatment. 
 
Some important points related that to the study treatment are described below. 
• Everyone recruited to this trial will still get NHS based rehabilitation therapy as normal. 
• We will keep a diary to record the sessions of all treatment that you receive. 
• All treatment will be provided by a state registered and trained physiotherapist. 
 
Both groups will be treated the same in every way apart from the fact that one group receives the electrical 
stimulation and the other one does not. This will enable us to make comparisons and to find out whether the 
electrical stimulation helps with the recovery of arm function or not. 
 
To identify any benefits associated with treatment we will assess your recovery six-week treatment period.  This 
will involve a visit to the hospital to see a member of our team who will ask you questions about your recovery 
and repeat some of the assessments taken at the start of the trial.  The time required for these should not 
normally exceed two hours. If you have already been discharged from hospital by the time of these assessments 
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we will arrange free transport for you to come to the clinic, if you wish. You will have to travel to the hospital for 
18 visits in total.  
 
Details of treatment 
The equipment that is used for electrical stimulation is shown in the picture (this machine is very similar to a 
TENS machine which is used to treat pain).  The electrodes that deliver treatment are placed on the surface of 
the skin as shown on the picture on the left.  You will be seated comfortably on a chair or a plinth (a specialised 
bed used for physiotherapy treatment). Your leg will be placed on a support or left free (depending on whether 
you have a scheduled exercise or stretching session respectively). Electrodes will be placed over your muscle. 
Once you are ready treatment will commence. A small electrical current will then be passed via the electrodes to 
your muscles. This will result in  
• a muscle contraction and a movement of the limb (the same as you would when you move your limb 
actively by yourself) accompanied by a mild to moderate tingling sensation if you are participating in the 
stretching protocol or 
• a muscle contraction (a tightening of the muscle without movement) accompanied by a strong tingling 
sensation (this may be uncomfortable but should not cause pain) if you are participating in the 
strengthening protocol.  
 
We have experience of using this equipment and do not expect it to cause any significant side effects. However, 
some people may find the initial sensation of their limbs moving automatically disturbing.  
 
     
 
Device to rest your leg, and measure your strength  Equipment used to deliver Electrical Stimulation 
During each treatment session (a maximum of one hour in any session) you will be required to sit and relax as 
much as possible, however, if you feel any discomfort or have any concerns you must inform the therapist 
immediately. When treatment is completed the equipment will be taken off and you can then move about and 
carry on with other things. [NB: A therapist will supervise all treatment sessions for this study.]  
 
Are there any alternatives to the treatment that is being used? 





What are the possible disadvantages and advantages of taking part in the research? 
 To the best of our current knowledge, there is no known disadvantage of taking part in this research study, as 
we would have ensured that you have no contraindications to treatment (and informed you of this) prior to the 
commencement of this study. It is possible that you may see faint redness of the skin under or surrounding the 
electrode pad following treatment and this is nothing to be concerned about. However, if the redness persists you 
will need to inform the treatment therapist or your doctor/nurse. As stated before, some people may find the initial 
sensation of their muscles moving automatically during treatment with electrical stimulation disturbing. 
 
What if new information becomes available? 
If this happens we will give this information to you and then discuss with you whether you want to continue in the 
study.  If you decide to withdraw, your medical treatment and therapy will not be affected in any way.  However, if 
you decide to continue in the study you will be asked to sign an updated consent form. 
 
What happens when the research study stops? 
The treatment that we are testing is currently not available via the NHS. However, if you wish to continue 
treatment after the study period is completed then the NHS consultant will review your case and prescribe the 
appropriate treatment required for you. 
 
What if something goes wrong during this study? 
Although the risks associated with treatment involving electrical stimulation are low it is important to point out that 
if taking part in this research project harms you there are no special compensation arrangements.  If you are 
harmed due to someone’s negligence, then you may have grounds for a legal action but you may have to pay for 
it.  Regardless of this, if you wish to complain, or have any concerns about any aspect of the way you have been 
approached or treated during the course of this study, the normal National Health Service complaints 
mechanisms will be available to you. 
 
Will my taking part in this study be kept confidential? 
If you consent to take part in the research we will need to look at your medical records and notes.  However, your 
name and contact details will not be divulged to any third party outside the research team. Also it will not be 
possible to identify you from the data collected. Any data we have of you will be stored on a secure computer. 
Any information, about you, which leaves the hospital, will have your name and address removed so that you 
cannot be recognised from it. We will inform your GP about your participation in this study if you provide us with 
permission to do the same. 
 
What will happen to the results of the research study? 
On completing this trial we will need to analyse the data to identify whether early treatment with electrical 
stimulation can help with strengthening and/or walking ability. The results of this study will be published in 
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Conferences and Medical Journals. Copies of any such publications can be obtained by contacting Dr. Ramesh 
Durairaj. Once again we would like to stress that you will not be identified from the published data. 
It is also possible that we will want to use the data collected in this study to support our other research projects. If 
you have no objections for us to use the data collected from you during the course of this study, you will need to 
indicate this on the appropriate section in the consent form. If the data is used to support future research it will 
not be possible to specifically identify you from the data. 
 
We would now like to thank you for having taken the time to enquire about our study. If you have any further 
questions please contact us and we will be happy to answer all your questions. 
 
If we have answered all your questions and you want to support this study you will now need to sign the consent 
 form. If however, you have decided not to participate, we would like to thank you for taking the time to find out 
about this study. 
 
Thank you.  
 
Dr Ramesh Durairaj 
Consultant Physician for Stroke and General 
Medicine 
Dept of Medicine for the Elderly 








 Dr. A D Pandyan 
Senior Lecturer 
School of Health & Rehab 
Keele University 
Keele 
Staffs – ST5 5BG 
Tel – 01782 584252 
Fax – 01782  584255 
a.d.pandyan@keele.ac.uk 






































































10 = independent                   ______ 
 
 
































































































1  Treatment  0  0  0  0  0  0  0  0 
2  Control  0  13  19  19  0  1.1  2.6  2.6 
3  Treatment  0  1.5  4.2  4.2  0  14  26  26 
4  Treatment  0.4  3.5  7.5  7.1  1.3  6  21  19.7 
7  Treatment  0  1.8  1.5  1.5  0  5  8.2  8.2 
8  Control  0  0  0  0  0  0  0  0 





































































































































































































Once a week       





























I take supplements to enhance my healthy diet           
I generally eat healthily, however like to indulge now and again       
I generally don’t have time to prepare healthy meals         
I eat a mix of ‘heat up’ meals and take‐aways           









































General CKA CKB CKC CKD %CKA %CKB %CKC %CKD 
1 63 1 1 0.612 0.679 0.612 0.702 100 111.0 100.0 114.7 
2 21.5 1 1 0.783 0.742   0.796 100 94.8   101.7 
3 22 0 0 0.329   0.158   100   48.1   
4 21 0 0 0.549 0.554 0.631 0.434 100 100.8 114.9 79.1 
5 25 0 1 0.581 0.432     100 74.5     
6 21 1 1   0.675 0.711 0.846         
7 35 0 1 0.729 1.007 0.594 0.904 100 138.2 81.5 124.0 
8 31 1 1   0.428 0.675 0.581         
9 31 0 0   0.428 0.423 0.401         
10 33 0 0 0.477 0.419 0.414 0.396 100 87.8 86.8 83.1 
11   1 1 0.554 0.657 0.230   100 118.7 41.6   
12   0 0   0.383 0.652 0.679         
13 33 0 1 0.504 0.500 0.576 0.450 100 99.1 114.3 89.3 
14 28 0 1 0.432 0.369 0.239   100 85.4 55.3   
15 36 0 1   1.007 0.774 0.603         
16 44 0 1 0.455 0.625 0.477 0.464 100 137.5 104.9 102.0 
17 42 1 1 0.374 0.527     100 140.9     
18 35 0 1 1.117 0.707 0.568 0.686 100 63.3 50.8 61.4 
19 41 1 1 0.359 0.441 0.873 0.593 100 122.8 243.2 165.2 
21 46 1 1 0.655 0.367 0.276 5.765 100 56.1 42.1 879.7 
22 50 1 1 0.805 0.760 0.635 0.949 100 94.4 78.9 117.9 
24 37 1 1 1.042 1.136 0.976 0.509 100 109.0 93.7 48.8 
25 34 1 1 0.714 0.684 0.706 0.832 100 95.7 98.9 116.5 
26 40 0 1 0.702 0.634 0.926 0.670 100 90.4 132.0 95.5 
27 48 0 1 0.742 1.121 0.778 0.594 100 151.1 104.8 80.0 
28 39 0 0 1.241 1.457 0.729 0.982 100 117.4 58.7 79.2 
29   0 1 0.702       100       
30 52 0 0 0.634   0.275 1.129 100   43.3 177.9 
31 37 0 1 0.819 0.967 1.048   100 118.1 128.0   
32 47 0 0 0.733 0.576 0.625 0.711 100 78.6 85.3 96.9 
33   1 1 5.012 1.270 0.504 0.495 100 25.3 10.1 9.9 
34   1 1 0.661 0.493 0.666 0.679 100 74.5 100.8 102.8 
                       
Raw data study five: Creatine Kinease analysis (CK) measured in nmol/ml/min. A/B/C/D refer to time points in 
analysis. 0: no exercise, 1: exercise 
 
 
 
